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Abstract 
This research is to investigate the potential protective effect of seaweed extract: 
against the carbon tetrachloride (CCl4)- and trichloroethylene (TCE)-induced toxicity 
in male Sprague Dawley rats. Three species of seaweeds: Myagropsis myagroides, 
Sargassum henslowianum and S. siliquastrum, collected from Tung Ping Chau, Hong 
Kong were screened for their protective activity. 
A single oral dosage o f l .25 ml/kg of20% CCl4 in com oil was able to produce 
significantly elevated level of semm glutamic pyruvic transaminase (SGPT) and 
semm glutamic oxaloacetic transaminase (SGOT) activities together with th。 
massive centrilobular necrosis and fatty accumulation in the histopathological 
examination. In the curative test of aqueous extracts of these fresh seaweeds at 
three different dosages (15, 30 and 60 mg/ml saline), S. henslowianum exhibited the 
most prominent hepatoprotective effect not only suppressed the elevation of SGPT 
and SGOT levels seen in CCl4-t0xicity in rats but also promoted the recovery or 
persevered the structural integrity of liver cells. However, S. siliquastrum exhibited 
significant protective effect only when the higher dosages (30 and 60 mg/ml saline) 
were applied. Based on the present preventive test, the protective function of all 
aqueous extracts of these seaweeds could not be demonstrated biochemically and 
histologically in the liver of the experimental animals. 
The study o fTCE toxicity test showed that the 1.25 ml/kg of20% TCE in com 
oil by intraperitoneal injection could cause significantly elevated level of SGPT and 
SGOT with no mortality of rat occurred. But the histopathological study could not 
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show markedly injury in the tissues of the liver and kidney. The pattem and 
organization of liver and kidney cells revealed no difference when compared with 
those of the control group administered with saline-vehicle only. The result of the 
one-time and two-time gavage oral dosage of TCE in the same dosage could not 
produce conspicuous increase of SGPT and SGOT. In the present test, it appeared 
that the main target site(s) of TCE might not be the liver or kidney. However, the 
actual target site(s), which could be used to explain the acute elevation of SGOT, 
was still unknown. Hence, 1.25 ml/kg of 20% TCE by i.p. (effective dose) was used 
as a toxin model to raise transaminase activity with the aim for the evaluation of 
protective effect of seaweed extracts against the TCE-induced acute elevated level of 
SGPT and SGOT only. 
In the curative test ofTCE effective dose, the extract S. henslowianum exhibited 
the most prominent protective effect against the elevation of SGPT and SGOT levels, 
whereas S. siliquastrum exhibited significant protective effect only at the higher 
dosages applied. In the preventive test, all seaweed extracts demonstrated significant 
effect in reducing the elevated level of SGOT only. Nevertheless, the effect was not 
as good as that of curative one. 
In another experiment, dimethyl sulfoxide (DMSO) and N-acetylcysteine (NAC) 
could be demonstrated to have protective effect against both the CCl4-an^ 
TCE-induced toxicity in the curative test. Especially in the NAC treatment at the 
higher dosages, it significantly reduced the SGPT and SGOT levels. This is in line 
with the convincing evidence from histopathological examinations in CCl4-induced 
hepatotoxicity rats. Moreover, the result obtained from biochemical and 
ii 
histopathological tests were quite similar to that of S. henslowianum extract 
treatment against CCl4-induced hepatotoxicity at the corresponding dosages. 
Nevertheless, the overall performance of DMSO and NAC in the preventive test 
showed a poor protective effect against both toxins-induced toxicity. Even at the 
highest dosage applied, the effect was not prominent. 
In the primary test on the methanol extract of fresh seaweeds, oral 
administration of 30 mg/ml saline dosage of seaweeds' methanol extracts from S. 
henslowianum and S. siliquastrum could significantly reduce the CCl4-induced acute 
elevation of the levels of SGPT and SGOT in rats. Histopathological study of liver 
tissue also showed signs of partial recovery or inhibition of the massive centrilobular 
necrosis and fatty accumulation induced by CCl4. However, M. myagroides extract 
produced poor curative effect in lowering the levels of SGPT and SGOT. However, 
in the TCE-induced toxicity test in which the same treatment was performed, M. 
myagroides exhibited prominent protective effect in lowering both serum enzymes 
GPT and GOT. The result ofbiochemical analysis showed that the methanol extracts 
exhibited better effect than that of the aqueous extracts at the same dosage or even 
higher. However, there was no significant evidence of tissue recovery in the 
histological study. This showed that the action mechanism(s) of methanol extract of 
seaweeds in vivo were not the same as the aqueous one. Moreover, the possible 
active agent(s) was not the same either. 
The present results indicate that the seaweeds under investigation may possess 
active component(s) in the aqueous and methanol extracts, which may act as an 
antidote to protect the toxicity induced by CCl4 and TCE in rats. The active 
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j • 
component(s) which may contain antioxidant or free radical scavenging activity to 
inhibit or prevent the toxicity produced. The actual protective mechanism is still 
speculative at this stage. Further investigation is necessary to clarify and characterize 
the possible active component(s) in the extracts. Hopefully, the active component(s) 





對 於 C C U & T C E在大老鼠體内所產生的毒性之抑制作用。於這個測試 
中，用作研究的海藻有三種，它們分別是從香港東平洲採摘得來的揭藻 
類： { M y a g r o p s i s myagroides, Sargassum henslowianum and S. siliquastrum)。 
以1.25 m l / k g劑量的 2 0 % CCl4 (強飼）能使血液中的血清穀 # ^丙酮轉 
| ^ ( S G P T ) 及血清穀氨丁 _乙轉氧濟 ( 8 0 0 丁）有明顯的急性提升。同 
時，在細胞組織病理學的研究中亦發現此劑量的C C U亦能使肝赋組織產 
生大量的中央小葉細胞壞疽和累積過多的脂肪。於補救測試（cura t ive^s t ) 
顯示，用了三個不同劑量 ( 1 5 ’ 3 0和6 0爪8/工1盛水）的海藻水性抽取物進 
行試，其中褐藻 （X henslowianum)表現出最顯著的保肝作用，它不但能 
抑制€0 4所引致大老氣血液中的 8 0 ?丁和 8 0 0丁的提升，並且能促進肝 
細胞的復元或穩固肝細胞組織結構上的完整。然而，褐藻OS. siliquastrum) 
卻要在較高的劑量（ 3 0 * 6 0 m g / m l 敷水 )才能展示出明顯的保護作用。 
不過，即使轉 # ^ _有所降低，肝臓細胞組織仍然是有非常明顯的損傷。 
此外，在預防測試（p r e v e n t i v e ^ s t )中，所有海藻水性抽取物都不能於生 
化及肝臓組織研究中證明有保護肝職的效用。 
於毒性劑量測試中，證實腹腔注射1 . 2 5 m l / k g的 2 0 % T C E能引致S G P T 
和S G O T的顯著提升’並且沒有導致大老鼠死亡。但是，從細胞組織病 
理學的研究中，老鼠的肝赋及賢臓組織並沒有明顯的損傷變化；組織的結 
構及排列跟控制組別的大老鼠（只是供給蠻水及媒介物）沒有任何分 
別。此外，於同等劑量 T C E (—劑及兩劑）的測試中（強飼）’亦不能引 
致S G P T和S G O T的明顯提升°於這項T C E毒性測試中，可以推斷1^：£所 
損害的主要器官並不是肝臓及賢赋 °但是，哪一個器官因 1 1： £毒性而引 
起S G O T的提升仍然是不清楚 °因此，腹腔注射 1 . 2 5 m l / k g的 2 0 % T C E 
XXV 
(有效劑量）只可以作為一個毒性的模型，以用來測試海藻抽取物對抑 
制 T C E 所產生 S G P T 和 S G O T 之急性提升的影響。 
在補救測試中，海藻 (S .hens low ianum)對抑制丁〇£(有效劑量）所引起的 
S G P T 和 S G O T 的 急 性 提 升 有 顯 著 的 保 護 作 用 ； 然 而 ， 海 藻 （ & 
siHqmrnrum)只能於較高的劑量才能產生明顯的保護作用°但是，在預防 
測試中，所有海藻抽取物只有對於 8 0 0丁才有明顯的抑制作用。不過，效 
果並不及補救測試的好。 
於其他的預防測試中，實驗言正明二甲基氧化硫（D M S O )和N -乙跳半胱 
氨酸（NAC) n C C l 4和T C E所產生的毒性有抑制的作用，特別是於高 
劑量的 N A C 測試中，它對 S G P T 和 S G O T 的抑制尤其顯著。這些抑制 
的效果大可與細胞組織病理學研究中，N A C對C C U所引致大老鼠肝職毒 
性的抑制結果互相吻合。這些結果跟海藻（5； henslowianum)抽取物的保 
肝作用有所相似。然而， D M S O 和 N A C 在預防測試中均對抑制上述兩 
種毒素表現出不理想的保護效果；即使給予最高的劑量，效果也不顯著。 
於 初 步 測 試 用 甲 醇 提 取 的 海 藻 研 究 中 ， 發 現 用 劑 量 ： 3 0 mg/ml 25% 
D M S O 的海藻 QS. henslowianum 和5". siliquastrum)能對€€14 所 引 致 
S G P T和S G O T的急性提升有著明顯的抑制作用，此外，它亦能對肝職 
細胞組織的中央小葉壞疽和脂肪累積有著緩和的作用。但是，海藻 (从 
myagroides)抽取物在這項補救測試中，對於降低80?丁和800丁卻表現 







C C U和T C E所產生的毒性。這類物質可能擁有抗氧化或清除自由基的作 
用；以抑制或防止毒性的產生。於現階段，只可用純理論性推測來解釋這 
項保護機制。日後有待更深入的研究去加以闡明，並找出抽取物的有效成 
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Fig. 4.37 Effect o fNAC (at dosages of 150 mg/kg, 300 mg/kg and 185 
600 mg/kg) on CCl4-induced elevation of SGOT activity (Curative) 
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Fig.4.75 Micrograph of the liver of rats from no treatment group 222 
showing normal hepatocytes around the central vein region 
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Fig. 4.79 Micrograph of the liver of rat from the vehicle-saline curative 226 
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Fig. 4.80 Micrograph of the liver of CCl4-treated rat from toxin control 228 
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around the central vein region as compared with the control group 
Fig. 4.81 Micrograph of the liver of CCl4-treated rat from toxin control 228 
curative group showing extensive necrosis ofhepatocytes 
around the central vein region as compared with the control group 
Fig. 4.82 Micrograph of the liver of CCl4-treated rat from toxin control 230 
curative group showing extensive necrosis ofhepatocytes around 
the central vein region as compared with the control group 
Fig. 4.83 Effect of seaweed extract (S#2: S. henslowianum, 15 mg/ml saline) 230 
on the liver of CCl4-treated rat showing extensive necrosis of 
hepatocytes around the central vein region as compared with 
the toxin control curative group 
Fig. 4.84 Effect of seaweed extract (S#2: S. henslowianum, 15 mg/ml saline) 232 
on the liver 0fCCl4-treated rat showing extensive necrosis of 
hepatocytes around the central vein region as compared with 
the toxin control curative group 
Fig. 4.85 Effect of seaweed extract (S#2: S. henslowianum, 60 mg/ml saline) 232 
on the liver of CCl4-treated rat showing very little necrosis of 
hepatocytes around the central vein region as compared with 
the toxin control curative group 
Fig. 4.86 Effect of the seaweed extract (S#2: S. henslowianum, 60 mg/ml 234 
saline) on the liver of CCl4-treated rat (duplicated) showing very 
little necrosis ofhepatocytes around the central vein region as 
compared with the toxin control curative group 
Fig. 4.87 Effect of the seaweed extract (S#2: S. henslowianum, 60 mg/ml 234 
saline) on the liver of CCl4-treated rat (duplicated) showing very 
little necrosis ofhepatocytes around the central vein region as 
compared with the toxin control curative group. But, vacuolation 
can still be observed around the central vein 
Fig. 4.88 Effect of the seaweed extract (S#2: S. henslowianum, 60 mg/ml 236 
saline) on the liver of CCl4-treated rat (duplicated) showing 
very little necrosis ofhepatocytes around the central vein 
region as compared with the toxin control curative group. 
But, vacuolation can still be observed around the central 
vein. Large regeneration zone can be seen 
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Fig. 4.100 Micrograph of the liver of CCl4-treated rat from toxin control 248 
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curative group 
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Fig. 4.112 Transmission electron micrograph of the liver of CCl4-treated 260 
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rat from effective dose of curative group showing normal 
hepatocyte cords linings 
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Fig. 4.127 Transmission electron micrograph of liver of 20% TCE-treated 276 
xxiii 
(i.p.) rat from effective dose of curative group showing hepatocyte 
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curative group (DMSO 25% and saline treatment) 
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Chapter 1 INTRODUCTION 
It is a well-known fact that the Chinese people have been using seaweeds for 
various medicinal purposes such as for treatment of goiter and scrofula. Early records 
of medicinal seaweeds appeared in Chinese literature about two thousand years ago 
(Tseng & Chang，1984). Some brown macroalgae were reported to have certain 
chemical compounds such as organic acids and phenolic compounds, especially 
polyphenols or tannins which were shown to have antimicrobial activity (Glombitza, 
1979; Rosell & Srivastava, 1987). Several other studies have reported that marine 
algae (microalgae or macroalgae) contain various biologically active compound<= 
(Baker, 1984; Tutour, 1990; Lee et al., 1996; Harada et al., 1997). Furthermore, some 
macroalgae, especially brown seaweeds, have been shown to have antioxidant 
activities in their extracts (Tutour, 1990; Lee et al., 1996). However, scientific 
studies on the protective effect of Hong Kong seaweeds in acute liver damage are 
lacking and in this investigation the local seaweeds (brown macroalgae): Myagropsis 
myagroides (Fig. 1.1)，Sargassum henslowianum (Fig. 1.2) and S. siliquastrum (Fig. 
l.:5) collected from Tung Ping Chau, Hong Kong were selected mainly to study their 
protective effects on carbon tetrachloride (CCl4)- induced acute hepatotoxicity iri 
male Sprague Dawley rats. In addition, acute hepatotoxic effect of seaweeds were 
also investigated to study any adverse or acute toxic effect on liver. In this study, 
aqueous extracts of seaweeds were mainly used for the test. Besides, methanol 
extracts ofseaweeds were also used for preliminary investigation only. 
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Fig. 1.1 Fresh seaweed sample (young Myagropsis myagroides: S#3) 
^ h A * ^ | i 
^ B j B 
"^SK^^ 
^Wf^ 
Collection l)atc: (M Nov 97 
( 'o l lcc l ion sile: l ,mig l ,ok Shi i i 
Fig. 1.2 Fresh seaweed sample (young Sargassum henslowianum: M2) 
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Fig. 1.3 Fresh seaweed sample (young Sargassum siliquastrum: S#4) 
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In order to investigate the hepatoprotective effect of seaweeds' extract. Acute 
liver injuries were induced by chemicals, such as CCl4, which has been used as a 
model hepatotoxin for many years to study the presence ofhepatoprotective agents in 
experimental animals (Montilla et al., 1990; Gilani & Janbaz，1995a, b and c; Jazbaz 
& Gilani，1995; Gilani et aL, 1996; L in et al., 1996; Hase et al., 1997; Jeong et al, 
1997; Wong et al., 1999). CCl4 is a well-known hepatotoxin and an environmental 
contaminant which causes centrilobular necrosis and fatty accumulation in the liver 
accompanied by the elevated level of transaminases activity (SGPT and SGOT) in 
blood (Recknagel, 1967; Klaassen & Plaa, 1969; Harris et al., 1982). Elevated serum 
level of enzymes that are uniquely concentrated in the liver, especially SGPT, are 
reliable reflections of hepatic injury (Zimmerman & Seeff, 1970). Traditionally, the 
combined microscopic and biochemical techniques are important to establish the 
toxic or nontoxic character of a test compound at any early stage of investigation 
(Iglesia et al., 1982). As a result, i f either the gross pathological changes or the 
severity of histopathology were graded and compared to the elevation in 
transaminases, there was a very good correlation between the elevation in 
transaminase activity and the severity of the lesion (Balazs et al., 1961; Plaa et al., 
1982). 
Owing to the widespread usage of tichloroethylene (TCE), it has been found as 
a contaminant in ground and surface water supplies (Murray & Riley, 1973). Even in 
extremely isolated areas, its toxicity presents a serious problem in both occupational 
and environmental health (Larson & Bull, 1989). However, the hepatotoxicity of 
TCE is not well established and the data are relatively inconclusive (USEPA, 1985; 
Waters et al., 1977). Nevertheless, conspicuous hepatotoxic response of TCE can be 
evaluated by the determination of serum transaminase activities 24 h after an 
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intraperitoneal injection pretreatment with cytochrome P-450 inducer, 
phenobarbital (Rouisse & Chakrabarti, 1986). In the present study, toxicity of TCE 
was investigated via oral and intraperitoneal routes of administration to find the 
possible elevated levels of serum transaminases without the pretreatment of 
phenobarbital. Furthermore, whether the main target site of TCE is the liver or not 
was also investigated. The result showed the effective dose of TCE which could 
induce the acute elevated level of SGPT and SGOT. Hopefully, the induced elevated 
levels of serum transaminases may be used as a toxin model for the hepatoprotective 
study of seaweed extracts similar to that of the CCl4 model. In addition, the 
additional one seaweed (red species), Galaxaura sp. (Fig. 1.4)，was also used for the 
hepatotprotective test in TCE model. 
In addition, N-acetylcysteine fNAC) and dimethyl sulfoxide (DMSO) are both 
reported to have antioxidant properties to relieve the CCl4-induced toxicity in mice 
(Achudume, 1991; Kroger et al., 1997). In this research, they were selected for the 
study oftheir possible hepatoprotective effects on CCl4 and TCE-induced toxicity in 
rats. Generally, it is likely that potent antiperoxidative agents can protect the rats' 
liver by preventing a CCl3-induced peroxidative degradation ofmembranes (Yasuda 
et al., 1986). In fact, many hepatoprotective agents have a remarkable 
antiperoxidative action, which is considered to be at least one of the action 
mechanisms for their hepatoprotective effect (Castro et al., 1973; Yasuda et al., 
1980). Yet, scientific reports on their effect against liver damage in rats are lacking. 




^ H ^ f f ^ ^ ^ p 
Fig. 1.4 Fresh seaweed sample {Galaxaura sp.: Gal) 
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Thus, the present project aims to further conclude the hepatoprotective effect of 
DMSO and NAC against CCl4-induced hepatotoxicity in rats. In addition, their 
potential protective action against the effective dose of TCE-induced toxicity was 
also investigated. 
The objectives ofthis research are summarized as follows: 
1. to adopt a suitable dosage of CCl4 as a toxin model for screening 
hepatoprotective substances. 
2. to study the protective effect of aqueous seaweed extracts against 
CCl4-induced hepatotoxicity. 
3. to test the possible acute hepatotoxic effect of aqueous seaweed extracts. 
4. to investigate the toxicity of TCE in oral and i.p. routes in rats. 
5. to elucidate whether the liver is the main target site of TCE toxicity. 
6. to identify the effective toxic dose of TCE as a toxin model for 
hepatoprotective substance screening. 
7. to study the protective effect of aqueous seaweed extracts againsl 
TCE-induced toxicity. 
8. to study the potential protective effect of DMSO and NAC against CCl4-
and TCE-induced poisoning in rats. 
9. to test the protective effect of methanol seaweed extracts against CCl4- and 
TCE-induced poisoning in rats by curative mode. 
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Chapter 2 LITERATURE REVIEW 
2.1 Toxicology. 
Toxicology is defined as the study of the adverse effects of substances on living 
organisms. The adverse effects include their biochemical, cellular and molecular 
mechanisms of action (Klaassen and Eaton, 1991). The mode of action of toxic 
substances in the interaction with cellular components, and at the molecular level 
with structural proteins and other macromolecules, enzymes and receptors, and the 
types of toxic response produced, are key factors to determine the toxicity effects 
(Timbrell, 1994). Actually, different kinds of toxicants possess different modes of 
action, target organs and potencies. In order to study the hepatoprotective effect of 
seaweed, N-acetylcysteine and dimethyl sulfoxide, carbon tetrachloride was used as 
a toxic model to induce acute toxicity (short term) to the liver. The liver is the critical 
organ for metabolism, detoxification, and elimination of many chemicals that may be 
absorbed. As such, it is a likely target organ for toxic effects (Plaa, 1991). In addition, 
acute toxicological studies of trichloroethylene were also conducted in the present 
study. Hopefully, trichloroethylene may also be used as a toxic model as same as 
carbon tetrachloride for the screening ofhepatoprotective substance. 
2.1.1 Acute toxicity test. 
The definition of acute toxicity is the adverse effects occurring within a short 
time of administration of a single or multiple dosages of a substance given within 24 
hours (Organization for Economic Cooperation and Development, 1981). Acute 
toxicity of carbon tetrachloride to the liver has been extensively studied during thc 
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past 40 years (Rechnagel, 1967; Recknagel et al., 1989). The suitable dosage 
(found to be 1.25 ml/kg body weight) of carbon tetrachloride is applied to the rat to 
generate acute toxicity in a severe centrilobular type of necrosis and fatty 
degeneration of the liver with the acute elevated levels of SGPT and SGOT (Slater, 
1966). In the present study, this dosage was used for the study of hepatoprotective 
effects of seaweed extracts and other substances. On the other hand, the 
hepatotoxicity o f trichloroethylene is not well established and the data are relatively 
inconclusive (Waters et al, 1977; USEPA, 1985; Borzelleca et al, 1990;). Therefore, 
the acute hepatotoxicity test of trichloroethylene were studied in different aspects. 
2.1.2 Biochemical analysis. 
Animal serum contains many different kinds of transaminases. Biochemical 
analysis of blood serum is vital to evaluate target organ toxicity and provides 
information to determine the injuries on the target organ. Measurement of enzyme 
levels of the serum permits detection of hepatic toxicity with far less labor than that 
required for other biochemical tests or histologic analysis. The value of 
determination of serum transaminases as an aid in the diagnosis of necrosis of 
hepatic cells has been well established (Reitman & Frankel，1957; Amador & 
Wacker, 1962; Amador et al., 1967). Serum glutamate pyruvate transaminase (SGPT) 
was also referred to as alanine aminotransferase (ALT) and serum glutamate 
oxaloacetate transaminase (SGOT) was also referred to as aspartate aminotransferase 
(AST). SGPT catalyzes the transfer of an amino group from the amino acid alanine 
to oxoglutarate (keto acid) to produce glutamate and SGOT catalyzes the transfer of 
an amino group from the amino acid aspartate to oxoglutarate (keto acid) to form 




Alanine + a-ketoglutarate ^ ——^- glutamate + pyruvate 
SGOT 
Aspartate +a-ketoglutarate , ^ - glutamate + oxaloacetate 
Normally, SGPT and SGOT can be found in cellular cytosol. They are present 
in blood in relatively low concentrations (Zimmerman, 1982). SGOT is a 
cytoplasmic and mitochondrial isoenzyme and is widely distributed in tissues and 
cells including hepatocytes, kidney cells, red blood cells, myocardium, pancreas and 
skeletal tissue O^Jakamura et al., 1965; Amador et al., 1966; Zimmerman & Seeff， 
1970). A raised activity of SGOT may be due to liver disease, myocardial disease, 
skeletal muscle disease, renal infarction, haemolysis or hypothyroidism (Jones & 
Berk, 1979). SGPT exists mainly in the cytosol and is specific for hepatocytes (Ooi, 
1996). As a result, an elevated level of SGPT would be a good indicator of 
hepatocellular injury (Balazs et aL, 1962; Jones & Berk，1979). In the rats, SGPT is 
almost as sensitive as SGOT (Zimmerman & Seeff, 1970). This biochemical analysis 
method was well adopted in the recent pharmacological studies of hepatoprotective 
or antidotal effects of potential substances (Montil la et al., 1990; Gilani & Janaz， 
1995a; Gilani & Janaz, 1995b; Gilani & Janaz, 1995c; Janbaz & Gilani，1995; Gilani 
et al., 1996; L in et al., 1996; Ooi, 1996; Jeong et al., 1997; Wong et al., 1999). 
2.1.3 Organ weights. 
In the present study, organ weights of the liver and kidney from the test animals 
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were measured after 24 hours experimental time and compared with those of 
control animals. This provides a primary screening of injured organs which may be 
subjected to further histopathological study. 
2.2 Histology. 
2.2.1 Light microscopy. 
Light microscopy (LM) is a basic and traditional method for studying and 
defining the type of toxic hepatic injury (Rouiller, 1964; Zimmerman, 1978). It gives 
the yardstick against which other abnormalities can be measured <Cutler, 1974). The 
significance of adverse biochemical changes as indices of hepatic injury should be 
judged by the supporting evidence of remarkable necrosis or steatosis (Curtis, 1972). 
As a result, it demonstrates a frank lesion (Zimmerman, 1982). However, L M cannot 
quantify the degree of liver damage. These qualitative observations do not take into 
consideration any parameter regarding the fibrosis because they do not provide 
numerical data (Gaudio et al., 1993). It provides only a crude estimation. 
2.2.2 Electron microscopy. 
Electron microscope is an important instrument to study the ultrastructural 
abnormalities in the experimental hepatotoxicity (Rouiller, 1964; Schaffner and 
Popper, 1975). It provides a much earlier demonstration of hepatocyte injury and 
permits the recognition of injury too subtle to be achieved by light microscopy 
(Zimmerman, 1982). It can also yield clues to the mechanisms of hepatotoxicity by 
studying the structural changes and rate of its development induced by toxic agents 
(Zimmerman, 1982). Two types of electron microscope were used in this study 
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Jeol-5300 SEM scanning electronic microscope (SEM) and Jeol JEM-1200 EX 
transmission electron microscope (TEM). 
In this study, light microscopy study was performed on the liver and kidney of 
the treated rats. Hematoxylin and eosin staining were used to stain the cells. Besides, 
TEM and SEM were also used to study the liver cells ofthe carbon tetrachloride- and 
trichloroethylene-treated rats only (toxin control model). 
2.3 Tissue injury. 
2.3.1 Free-radical mechanisms. 
Tissue injury can occur in many ways. An important way of injury is the 
production of free radical intermediates to trigger an expanding network of 
multifarious disturbances (Slater, 1984). Free radicals are defined as molecules or 
molecular fragments with one or more unpaired electron (Halliwell & Gutteridge, 
1984; Slater, 1984). Free radicals can be positively charged, negatively charged or 
electrically neutral in nature. The unpaired electron causes certain unique properties 
to the free radical such as paramagnetism. In general, typical reactions of free 
radicals are (a) electron donation (from a reducing radical) and electron acceptance 
(for an oxidizing radical); (b) hydrogen abstraction; (c) addition reactions; (d) 
disproportionations; and (e) self-annihilation reactions as follows (Slater, 1984): 
(a) OH • + RS • • OH- + RS. 
(b) CCl3 • + RH • CHCl3 + R • 
(c) CCl3. + CH2=CH2 • CH2(CCl3)-CH2 
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(d) CCl3 • + CCl3 • ^ C2Cl6 
(e) CH3CH2 • + CH3CH2 • • CH2=CH2 + CH2-CH3 
Free radicals generated by hepatic metabolism or by drug biotransformation 
reactions can also cause cell injury by oxidation of unsaturated fatty acids of 
phospholipids (Marzella & Trump，1991). The chemical reactivity offree radicals is 
usually high to cause direct or indirect biological damaging effects. For example: 
Free radicals react with the double bonds of unsaturated fatty acids and with 
sulphydryl groups in proteins. Hydroxyl radical is primarily involved in lipid damage. 
It can react with the unsaturated bonds to produce a lipid free radical, which in tum 
to form a lipid peroxide by the reaction with oxygen (Recknagel, 1967; Recknagel et 
al., 1989). The lipid peroxide formed can act as a free radical to react with a ftirther 
unsaturated bond of a fatty acid to establish an autocatalytic chain reaction 
(MacSween & Whaley，1992). As a result, the membrane permeability change is due 
to the damage of phospholipids (Slater, 1966). In addition, free radicals react with 
sulphydryl groups to form disulphide bonds with cross-linking ofproteins. This may 
affect the enzyme function or produce focal increases in membrane permeability 
(Slater, 1984). 
2.3.2 Lipid peroxidation. 
Lipid peroxidation is defined as the metabolism of lipids through pathways 
involving formation of intermediates such as lipid peroxides, hydroperoxides and 
endoperoxides (Recknagel et al., 1989). The peroxidation of polyunsaturated fatty 
acids or membrane phospholipids are a feature of many types ofcel l injury in which 
free radical intermediates are produced in excess of local defence mechanisms to 
obtain sufficient reactivity to abstract a hydrogen atom (Halliwell & Gutteridge， 
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1984; Slater, 1984; Groot et al., 1988). The equations (1) below shows that 
hydrogen atom abstracted from the lipid leaves behind an unpaired electron. The 
carbon radical in that polyunsaturated fatty acid tends to be stabilized by a molecula/ 
rearrangement. The conjugated diene obtained which reacts with oxygen to give a 
hydroperoxy radical in equation (2). Hydroperoxy radicals formed abstract hydrogen 
atoms from other lipid molecules to continue the self-propagating chain reaction of 
lipid peroxidation. The hydroperoxy radical combines with the hydrogen atom that it 
abstracts to form a lipid hydroperoxide in equation (3). This process is commonly 
referred to as "propagation of lipid peroxidation" (Recknagel & Glende，1977). For 
example, the bioactivation of carbon tetrachloride and the initiation of the 
self-propagating lipid peroxidation, working in tandem, destroy the cellular 
membranes leading to cell death (Mehendale, 1991). 
Equation (1): Lipid-H + • OH • Lipid • + H2O 
Equation (2): Lipid • + • O2 • Lipid-O2 . 
After molecular rearrangement 
Equation (3): Lipid-O2 • + Lipid-H • Lipid-O2H + Lipid • 
2.4 Carbon tetrachloride (CCI4). 
Carbon tetrachloride (CCl4) is a simple molecule (Fig. 2 . 1) and a well-known 
hepatotoxin, which has been extensively studied (Slater, 1966; Recknagel, 1989). 
The primary use of CCl4 is in the chemical manufacture of dry cleaning agent, 
fluorocarbon refrigerants, organic solvents, and aerosol propellants (Trevethick, 
1980). Accumulating evidence over the years has shown CCl4 to be one ofthe most 
toxic common solvents (Hamilton & Hardy, 1974). By the 1930s, it was widely used 
as a dry cleaning agent and constituent of fire extinguishers 0s[ielsen & Larsen, 1965; 
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USEPA, 1984). The banning of use of CCl4 in fire extinguishers by the early 1960s 
was due to the recognition of its fatalities resulting from thermal decomposition. 
Moreover, industrial use of CCl4 began declining in the 1950s as its acute toxicity 
and fatalities became well known. Therefore, it has been banned in all products 
except where it is an unavoidable by product. As a result, exposure is limited to its 
industrial use in the production of solvents, aerosol propellants and refrigerants 
(USEPA, 1984). However, it has lost its early predominance as a cheap 
nonflammable chlorinated solvent for use in degreasing and dry cleaning. Less toxic 
agent such as trichloroethylene has served as admirable substitutes (Hamilton & 
Hardy, 1974). 
CI 
C I — C — C I 
CI 
Fig. 2.1 Structural formula of carbon tetrachloride (CCl4) 
2.4.1 Mechanisms of carbon tetrachloride toxicity. 
The mechanism of CCl4 hepatotoxicity has been studied in great detail by 
Rechnagel (1967). The collected evidence indicates that the two prime pathologic 
observations, fatty degeneration and centrilobular necrosis, have distinct 
pathogenesis. Although a clear understanding of its mechanisms in hepatotoxicity 
has not yet been reached, several reviews describing the mechanism 0fCCl4 toxicity 
have been published (Slater, 1966; Recknagel, 1967; Recknagel et al., 1989; 
Mehendale, 1991). Early investigations proved that the leading theory for the CCU 
hepatotoxicity is initially catalyzed by cytochrome P-450 in the endoplasmic 
reticulum (ER) ofhepatocytes (Recknagel, 1967; Slater, 1984). 
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It has been well known for many years that CCl4 is metabolized by the 
monooxygenase system of the ER. The enzyme system acts as a reductase to catalyze 
one-electron reductive dehalogenation, cleavage of C-C1 bond to yield 
trichloromethyl and monoatomic chlorine free radicals intemediates (Recknagel et al., 
1989; Wang et al., 1996) (Fig. 2.2). The trichloromethyl radical ( CCl3) may then 
react with oxygen to give the trichloromethylperoxy radical ( CCl3O2). Alternatively, 
the CCl3 can abstract a hydrogen atom from polyunsaturated lipids and thereby form 
a lipid radical and a stable product, chloroform (CHCl3). The lipid radical can then 
proceed to react with other cellular constituents by oxygen addition and cause a 
cascade of disturbance with the cell, including peroxidation of lipids in endoplasmic 
reticulum (Packer et al., 1978; Recknagel et al., 1989). Alternatively, covalent 
binding of the CCl3 to liver microsomal proteins and lipids may presumably occurr 
(Slater, 1966; Packer et al., 1978; Slater, 1984). The CCl3O2 is believed to be the 
reactive metabolite responsible for lipid peroxidation (Recknagel et al., 1989). 
However, various studies have suggested that although the initiating event may b^ 
the formation of the trichloromethyl radical, this is not the major cause of damage 
(Packer et al., 1978; Recknagel et al., 1989; Slater, 1984). As the destructive range 
of CCl3 and CCl3O2 to the hepatocyte is restricted due to their limited spreading 
ability from the original sites (Recknagel et al., 1989)，the extensive hepatotoxicity of 
CCl4 is probably augmented by the formation of other products in overall process 
(Slater, 1984). Moreover, it has become clear that the presumably existence of a 
cascade of secondary mechanisms is evoked by the initial events 0fCCl4 metabolism, 
and that the secondary mechanisms are responsible for ultimate plasma membrane 
disruption, degenerative effects on other substructural organelles of the cells and 
death of the cell (Recknagel et al., 1989; Shah et al., 1979). 
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Carbon tetrachloride Trichloromethyl radical Trichloromethylperoxy 
radical 
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Fig. 2.2 The mechanism of microsomal enzyme mediated metabolic activation of 
carbon tetrachloride. (Adopted from Timbrell, 1994) 
As indicated above in section 2.3.2, lipid peroxidation has been shown to play 
an important role in the hepatotoxicity of CCl4. However, the role of free radicals or 
lipid peroxidation in CCl4-induced nephrotoxicity remains unclear (Elfarra, 1993). 
Many common strains of laboratory rats are relatively resistant to the acute 
nephrotoxic effects of CCl4 (Kluwe, 1981). In rats, ^^CCl4 administration results in 
covalent binding of the radiolabel to kidney and liver proteins and lipids (Villarruel 
et al., 1977). However, change in kidney morphology, for example, was not detected 
in rats after single or multiple dosages of CCl4, though severe necrosis and cirrhosis 
were detected in the liver (Perassi & Martin, 1973; Soni & Mehendale，1993). 
Moreover, no change in kidney morphology was visible at the level of light 
microscopy in Sprague-Dawley rats treated orally with 2.5 ml/kg CCl4 though an 
increase in kidney weight, elevation of serum creatinine and a transient diuresis wer^ 
evident (Striker et al.，1968). 
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2.5 TrichlororethyIene (TCE). 
Trichlororethylene (TCE) was first synthesized in 1864 by Fischer, patented in 
1906，and introduced as a nonflammable narcotic in 1911 for medical practice 
(Defalque, 1961). Table 1 shows chronologically the primary use patterns of TCE 
from discovery in the late 19th century through the proposed ban for use in food. 
Trichloroethylene is an unsaturated halogenated hydrocarbon (Fig. 2.3) with an 
empirical formula C2HCl3 and a molecular weight of 131.4. It exists as a colorless, 
volatile liquid with a somewhat sweet odor and a sweet, burning taste resemble that 
ofchloroform (Defalque, 1961; Elcombe et al., 1985). The solvent properties o fTCE 
were not known until the early 1900s (Defalque, 1961). Because of its excellent fat 
solvent properties, chemical stability and relatively low acute toxicity (World Health 
Organization, 1985; Dekant et al., 1990)，TCE has enjoyed widespread industrial use 
as industrial solvent for vapor degreasing of fabricated metal parts prior to painting, 
anodizing and electroplating (Elcombe et aL, 1985; Kimbrough et al., 1985). 
Furthermore, it can be used as an household degreasing and cleaning agent 
(Allemand et al., 1978; Soni et al., 1998). It is also an extraction medium (for spices, 
coffee) and occasionally used in anesthesia as well as an ingredient in adhesives. 
typewriter correction fluid, paint removers and spot removers (Waters et al., 1977; 
Allemand et al.，1978; Larson & Bull, 1989; Hanioka et al., 1997). Historically, TCE 
has had a multitude uses: mordant and dye fixative, desizer for textiles, cauiking 
substance for shipbuilding, antifoaming agent, solvent for rubber and insecticides as 
well as defatting agent for skins and hides (Allemand et al., 1978). In addition, the 
reason why it is so common is due to its production price. Production of TCE is 
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inexpensive, and can be prepared by treating ethylene with chlorine to form 
tetrachlorethane，which reacts with lime slurry to give trichloroethylene (Defalque, 
1961): 
C2H2 + 2 Cl2 • C2H2Cl4 
2 C2H2Cl4 + Ca(OH)2 • 2 C2HCl2 + CaCl2 + 2 H2O 
However, TCE can easily decompose. In the presence of light, especially 
ultraviolet light (UV) and moisture, it decomposes to form acidic products including 
hydrogen chloride. Nevertheless, the decomposition is retarded by storage in amber 
colored bottles and addition of 0.01% thymol blue (Defalque, 1961). 
Table 1. Historv of trichloroethvlene (Adopted from Waters et al., 1977) 
Year History of trichloroethylene 
1864 First prepared by Fischer 
1906 First patent held by Konsortium Fur Elektrochemische Industrie, Nunberg 
1911 Narcotic properties discovered by Lehman 
1914-1918 Limited use as a degreaser and solvent 
1915 Trigeminal analgesia reported by Plessner 
1920s More widespread use in metal degreasing 
1930s Use spreads to dry-cleaning industry 
193 3 Jackson successfully anesthetizes dogs 
1940s Use in Great Britain as inexpensive, nonexplosive anesthetic 
1945 Use as anesthetic spreads to the United States, does not gain widespread 
popularity 
1960s "Carbona-cult" solvent-sniffing 
1966 Use as a solvent curtailed in Los Angeles County, California, as a resuit of 
evidence implicating TCE in severe smog formation 
1975 Preliminary report indicating carcinogenicity 
1975 Invocation of Delaney clause sought to ban all uses in foods 
1976 FDA drafting order to ban TCE 
1976 Other Chlorinated solvents proposed as substitutes: methyl chloroform, 
perchloroethylene, methylene chloride 
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C K ^ C I 〉 = < 
c r � 
Fig. 2.3: Structural formula of trichloroethylene 
Actually, as illustrated in the table below (Table 2)，the general public is 
exposed to extremely low levels of trichloroethylene in water, air, and food.. But, 
trichloroethylene does not accumulate significantly in the food chain as it can be 
degraded by both abiotic and biotic processes. Its persistence in various 
environmental compartments is rather short, of the order of days or months rather 
than years (World Health Organization, 1985). 
Table 2: Maximum observed concentration of trichloroethylene in 
environmental media (Adopted from World Health Organization, 
1985) 
Media Maximum observed concentration 
Open water reservoir 220 ^ig/litre 
Industrial discharge water 200 ^g/Htre 
Rain water 〜1 ^g/litre 
Atmosphere 〜40 ^g/m^ 
Dairy foods 10 ^ig/kg 
Meat 22 ^ig/kg 
Fats and oil \ 9 |j^g/kg 
Owing to the medical and industrial use of trichloroethylene (TCE), the 
National Institute for Occupational Safety and Health CNIOSH) carried out a survey 
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in 1975, which indicated that nearly 3,000,000 industrial workers are exposed to 
TCE each year, often in massive dosages, and approximately 5,000 operating room 
personnel and dentists have regular contact (Waters et al., 1977). Occupational 
exposure of TCE is of concern because of the toxic effects of TCE observed in mice 
and rats (Waters et al., 1977). 
2.5.1 Mechanisms of trichloroethylene toxicity. 
Trichloroethylene is absorbed into the animal system by oral, dermal and 
inhalational routes (Hamilton & Hardy, 1974). According to some reports published, 
TCE passes across the gastrointestinal wall easily, as illustrated by many cases of 
poisoning following oral ingestion o fTCE (Waters et al., 1977). 
According to Fig. 2.4，oxidation of TCE through intermediates to chloral 
hydrate is mediated by a reduced nicotinamide adenine dinucleotide 
phosphate/oxygen O^ADPH/O2)-dependent reaction taking place in liver microsomes 
in a reaction requiring NADPH and oxygen (Byington & Leibman, 1965; Leibman, 
1965). Moreover, chloral hydrate is known to be the common intermediate from 
which the major urinary metabolites trichloroacetic acid (TCA) and trichloroethanol 
(TCEtOH) are derived (Byington & Leibman, 1965). The reduction of chloral to 
TCEtOH is catalyzed by alcohol dehydrogenase and requires NADH. However, the 
oxidation of chloral hydrate to TCA requires NAD+ and is catalyzed by chloral 
hydrate dehydrogenase (Sato et al., 1981). 
The metabolism of trichloroethylene is thought to proceed via an unstable 
reactive intermediate mediated by hepatic microsomal mixed-function oxidase (MFO) 
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system which contains cytochrome P-450 (Reynolds and Moslen, 1977; Rouisse 
and Chakrabarti, 1986). TCE is metabolized by this cytochrome P-450 into a 
chemically reactive metabolite which reacts with, and binds to either glutathione or 
protein or undergoes spontaneous rearrangement to chloral hydrate leading to either 
tichloroethanol or to trichloroacetic acid. Based on the three reactions mentioned, the 
process of binding of TCE to protein may lead to the production of liver lesion 
(Allemand et al., 1978). 
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Fig. 2.4 Proposed intermediary metabolism o fTCE 
(Adopted from Waters et al., 1977) 
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Owing to the unstable properties, the chemically reactive metabolites are 
difficult to identify. Among those whose chemical structure is reasonably well 
established, there are a number of epoxides (Allemand et al., 1978). Besides, an 
epoxide intermediates (Fig. 2.5) is thought to occur. It is due to the initial oxidation 
product of TCE by the microsomal mixed-function oxidase system (Allemand et al., 
1978; Byington & Leibman, 1965). The presumed trichloroethylene epoxide may 
directly undergo three different reactions as mentioned above. And, the reactive 
metabolite covalently binds to hepatic proteins may cause liver cell necrosis 
(Allemand et aL, 1978). 
CI2C = CHCl 
trichloroethylene 
^^^>^ Covalent binding to 
^ ^ " ^ proteins 
CI2C;;^ CHCI 
N / 、 0 J \ 
Trichloroehtylene \ ^ 





CI2C ——CH2.OH C I 2 C — C O O H 
Trichloroethanol Trichloroacetic acid 
Fig. 2.5 Proposed metabolism of trichloroethylene. Trichloroethylene is 
metabolized by the microsomal mixed-function oxidase system to an 
unstable intermediate, probably trichloroethylene epoxide. The unstable 
intermediate may undergo three different reactions: 1) covalent binding 
to proteins, 2) covalent binding to glutathione or 3) spontaneous 
rearrangement to chloral hydrate which may be reduced to 
trichloroethanol or oxidized to trichloroacetic acid. 
(Adopted from Allemand et al., 1978) 
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Although exposure to large amount of trichloroethylene can induce hepatic and 
renal injury, many studies in animals illustrate that TCE is only a weak hepatotoxin 
compared with carbon tetrachloride (CCl4). Repeated exposure to excessive levels of 
TCE resulted in multiple episodes of chemical hepatitis followed by hypertension 
and cirrhosis (Thiele et al., 1982). The final episode of hepatitis was caused by 
trichloroethane. Based on recent animal and epidemiological studies, TCE has little i f 
any hepatotoxic effect in the accepted range of occupational TCE exposure (Waters 
et al., 1977). Most of the studies show that conspicuous hepatotoxicity of TCE 
(dosage dissolved in corn oil administered intraperitoneally) develops only in rats 
pretreated with phenobarbital (Rouisse and Chakrabarti, 1986; Borzelleca et al., 
1990). The hepatotoxicity o fTCE is not well established due to the fact that the data 
are relatively inconclusive (Waters et al., 1977; USEPA, 1985). 
2.6 Dimethyl sulfoxide (DMSO). 
Dimethyl sulfoxide (DMSO) is a remarkable and controversial chemical 
compound. It is prepared by Alexander Saylzeff in 1866 (Leake, 1967). DMSO is 
dipolar aprotic solvent. So, it differs from water which is protic solvent, as its 
tendency to accept protons. It can be represented in the polarized form as follows 
(Fig. 2.6): 
0 • • 
：0 ： 
© 
H3C S CH3 
• • 
Fig. 2.6: Structure ofDMSO in polarized form 
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Based on the structure, oxygen and sulfur have unshared electron pairs. As a 
result, DMSO has the ability to form either stable solvates by dipole-dipole 
interactions or solvent-solute associations by hydrophobic interactions (Rammler & 
Zaffaroni, 1967). Therefore, it is extremely hygroscopic and miscible with water. 
Furthermore, it is also employed to remove paint and vamish (Manahan, 1992). 
Owing to its broad solvent characteristics, DMSO is one of the solvents frequently 
used in pharmacological or toxicological experiments to improve the solubility of 
poorly soluble compounds (Siegers, 1978). 
DMSO is an important chemical antioxidant (Achudume, 1991) with its 
anti-ischemic and anti-inflammatory properties (Lind and Gandolf, 1997). Besides, 
DMSO is reported to have cryoprotective and radioprotective properties (Sieger, 
1978). It has been shown to protect the liver against injury produced by drugs and 
chemicals such as acetaminophen and carbon tetrachloride in mice only (Siegers, 
1978; Achudume, 1991). But, DMSO is an inhibitor of cytochrome P-450-based 
biotransformation (Sieger, 1978; Jeffrey et al., 1988; Lind and Gandolf, 1997). So, 
the hepatoprotective effect illustrated above was most likely due to a lack of 
bioactivation of the compounds to their reactive toxic metabolites. In the present 
study, DMSO in different percentages were used to test its hepatoprotective effects ir. 
male Sprague-Dawley rats. Furthermore, the least hepatoprotective percentage was 
adopted as a vehicle to dissolve the poorly soluble methanol extracts of seaweeds for 
the preliminary test. 
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2.7 N-acetylcysteine (NAC). 
N-acetylcysteine O^AC) was first introduced as a mucolytic agent in the 1960s 
and has since found wide use in clinical toxicology as a cytoprotective agent in acute 
acetaminophen (paracetamol) poisoning (Flanagan and Meredith, 1991). It is a 
well-known fact that acetaminophen has found increasing use in recent years as a 
substitute for aspirin, but it can cause liver damage in rats, mice and human (Kroger 
et al., 1997). Oral and intravenous administration of NAC can mitigate 
acetaminophen-induced hepatotoxicity by sulfate replenishment to restore 
intracellular GSH (Flanagan and Meredith, 1991). As GSH contributes significantly 
to the intracellular antioxidant defense system to be a powerful consumer of 
superoxide, singlet oxygen, and hydroxyl radicals (Miesel & Zuber, 1993). There is 
an evidence that NAC is an antioxidant to react with oxygen free radicals but is also 
used for the synthesis of cysteine and GSH (Sies, 1993). Moreover, it has been well 
reported that treatment with cysteine pro-drug such as NAC, cimetidine and 
meso-2,3-dimercaptosuccinic acid (DMSA) etc., can protect against acetaminophen 
hepatotoxicity in rats (Harman & Self，1986; Speeg et al., 1985). Recently, NAC has 
been shown to have ability to inhibit inflammatory stimulations, including that of 
HIV replication (Roederer et al., 1993). Thus, it is suggested to be a potential drug 
for AIDS therapy and is used as an adjunct in the treatment o f A I D S (Roederer et al., 
1993). In the present study, hepatoprotective effects of NAC were studied in CCl4 
toxicity in rats. Furthermore, TCE toxicity was also investigated to test the protective 
effects produced from NAC. 
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Chapter 3 MATERIALS AND METHODS 
3.1 Materials . 
Hong Kong Seaweeds. 
Four species of marine macroalgae: Myagropsis myagroides, Sargassum 
henslowianum, S. siliquastrum (brown macroalgae) and Galaxaura sp. (red 
macroalgae) were collected from Tung Ping Chau, Hong Kong by Prof. Put 0 . Ang, 
Jr. (Department of Biology, The Chinese University of Hong Kong) during 
spring-summer period (April-July/1997 and April-July/1998). 
Animals. 
Seven to eight weeks old male Sprague-Dawley rats, weighing 150g-250g, were 
obtained from the Laboratory Animals Service Centre, The Chinese University of 
Hong Kong. They were housed in a controlled-environment of 18-20 °C, humidity 
54-56 % with 12-hour light-dark cycle and were supplied with standard rodent chows 
(Supastok Autoclavable Rodent Diet, Ridley Agriproducts, Australia) and tap water 
ad libitum. The food was withdrawn about 18 h before the experiment. 
Chemicals. 
Phosphate buffer. pH 7.5 
Phosphate buffer was made by mixing 840 ml of 0.1 M disodium hydrogen 
orthophosphate (14.2 g Na2HPO4, anhydrous, Ajax, Australia) and 160 ml 0.1 M of 
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potassium dihydrogen orthophosphate (6.80 g KH2PO4, Ajax, Australia). The 
solution was adjusted to pH 7.5 by using l M sodium hydroxide or l M hydrochloric 
acid. 
Sodium pyruvate 
Calibration solution of SGPT and SGOT enzyme assay (1.5 mM of sodium 
pyruvate) was made by adding 0.017 g sodium pyruvate (Sigma, U.S.A) in 100 ml 
phosphate buffer (pH 7.5). The final solution was stored in the refrigerator at 2 ° to 6 
°C and stable for about one month. 
2.4-dinitrophenvlhydrazine 
The color reagent was prepared by adding 0.02 g of 2,4-dinitrophenylhydrazine 
(Sigma, U.S.A) to 100 ml of 1 N hydrochloric acid. The fmal solution was stored in 
the refrigerator at 2® to 6 °C and stable for about one month. 
GPT substrate solution 
The GPT substrate solution was prepared by mixing 4.45 g of dL-alanine 
(Sigma, U.S.A) and 0.066 g of a-ketoglutaric acid (Sigma, U.S.A) in 250 ml 
phosphate buffer (pH 7.5). The final solution was stored in refrigerator at 2° to 6 °C 
and stable for about one month. 
GOT substrate solution 
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The GOT substrate solution was prepared by mixing 6.66 g of dL-aspartic acid, 
monosodium salt (Sigma, U.S.A) and 0.066 g of a-ketoglutaric acid (Sigma, U.S.A) 
in 250 ml phosphate buffer (pH 7.5). The final solution was stored in the refrigerator 
at 2° to 6 °C and stable for about one month. 
Bouin's fluid 
The Bouin's fluid was prepared by mixing 600 ml of picric acid, saturated 
(Hopkin and Willams, England), 160 ml of formalin, commercial (Ajax, Australia) 
and 40 ml of acetic acid, glacial (Ajax, Australia). The final solution was stored in 
room temperature ready for use. 
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3.2 Methods. 
3.2.1 Acute hepatotoxicity test on aqueous seaweed extracts. 
3.2.1.1 Preparation of aqueous extracts of seaweeds. 
Aqueous extracts of fresh samples of Myagropsis myagroides (S#3), Sargassum 
henslowianum (S#2), S. siliquastrum (S#4) and Galaxaura sp. (Gal) were used for 
the investigation. For extraction, washed seaweeds were weighed and blended with 
distilled water. They were kept at 4 °C for 1 day and then filtered through cotton 
gauze. The filtrates were centrifuged at 23,700 g (12000 rpm) for 20 min. After 
centrifugation, the supernatants were freeze-dried. The resulting lyophilized powders 
were weighed and kept in the desiccator ready for use (Fig 3.1 to Fig. 3.4). 
3.2.1.2 Experimental protocol. 
The experimental animals were divided into three groups, namely: the normal 
no treatment group (5 rats); the control group (5 rats) which received the vehicle 
(6.25 ml/kg, corn oil, Mazole, U.S.A.) orally by gavage oral administration (Fig. 3.5) 
and normal saline (10 ml/kg) was also administered orally 6 h after the vehicle 
treatment; the third group (5 rats) which was treated similarly to group 2 except that 
each seaweed extract was individually administered instead of saline for the primary 
evaluation ofseaweeds' toxicity. Three dosages of seaweed extracts (150 mg/kg, 300 
mg/kg and 600 mg/kg, dissolved in 10 ml saline) were used. Seven animals received 
one dosage of each seaweed extract except Galaxaura sp. extract (150 and 300 
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mg/kg). A l l treated animals were sacrificed 24 h after receiving the administration of 
the hepatotoxin (CCl4). 
3.2.1.3 Biochemical assays. 
Enzyme activities of serum glutamic pyruvic transaminase (SGPT) and serum 
glutamic oxaloacetic transaminase (SGOT) in blood serum served as indicators to 
illustrate the extent of hepatotoxicity in the rats. These enzymes, especially SGPT, 
are highly localized in hepatocyte cytosols. 
The animals were anaesthetized with ether 24 h after the hepatotoxin treatment 
and blood (~5 ml) was withdrawn with sterile disposable syringes equipped with 
hypodermic needles from posterior vena cava (Fig. 3.6). Serum was separated by 
centrifugation at 1,100 g (3000 rpm) for 15 min. Plasma was separated from the cells 
immediately to avoid interference caused by haemolysis as red blood cells also 
contain SGOT. The serum was then diluted 10 fold with 0.9% (v/v) saline. The 
serum enzyme levels of SGPT and SGOT were estimated according to the method of 
Reitman and Frankel immediately after the separation of plasma from the blood 
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3.2.1.4 Organ weights. 
The livers and kidneys of each treatment group were dissected out from the 
animals' bodies followed by the measurement ofl iver and kidney weight. 
3.2.1.5 Histopathological examination. 
(i) Light microscopy 
A portion of the median lobe of the liver and left kidney were fixed in 
Bouin's fluid for 24 h and dehydrated though an ascending series of different 
percentage of ethanol; cleared in xylene. The liver and kidney specimens were then 
embedded in paraffin (melting point 56-58。C), cut to 5-7 ^im thickness by a 
microtome, and stained with Mayer's hematoxylin and eosin (H&E) for 
histopathological examination under light microscope. Detailed procedures for the 
histopathological processing are outlined in the Appendix B. 
3.2.1.6 Statistical analysis. 
For statistical analysis of the data, the Student's t-test and ANOVA were used to 
compare the levels of SGPT and SGOT in different treatments. A l l results are 
expressed in arithmetical means 土 standard errors mean. The data were regarded as 
significance and very significance i f p< 0.05 and p< 0.005 respectively. A two-way 
ANOVA was used to assess the difference in the effect of different treatments and 
their concentrations on affecting the levels of SGPT and SGOT. Where significant 
differences have been detected, a Tukey HSD Test was used to identify the group(s) 
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responsible for such differences. 
3.2.2 Curative and preventive tests of seaweed aqueous extracts against the 
CCl4-induced hepatotoxicity. 
3.2.2.1 Preparation of aqueous extracts of seaweeds. 
Aqueous extracts of fresh samples of Myagropsis myagroides (S#3), Sargassum 
henslowianum (S#2) and S. siliquastrum (S#4) were used for the investigation. For 
extraction, the method used was the same as that described in the section 3.2.1.1. 
3.2.2.2 Experimental protocol (Fig. 3.7). 
Carbon tetrachloride produces hepatotoxicity when taken in suitable dosage 
(1.25 ml/kg) (Slater, 1966). The 20% (v/v) CCl4 (Ajax Chemicals, Australia) was 
made by dissolving CCl4 in corn oil (Mazola, U.S.A.) and was administered orally to 
the stomach of the rats through an intragastric tube. 
The experimental animals were divided into four groups, namely: the normal no 
treatment group (10 rats); the control group (10 rats) which received the vehicle, com 
oil (Mazole, U.S.A.) by gavage oral administration in the dosage of 6.25 ml/kg and 
normal saline (10 ml/kg) was administered orally 6 h after the vehicle treatment; the 
toxin control group (10 rats) which received carbon tetrachloride to induce chemical 
hepatitis followed 6 h later by oral saline administration; and the fourth group which 
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was treated similarly to toxin control group except that each seaweed extract was 
individually administered instead of saline to evaluate their curative effects. Three 
dosages ofseaweed extracts (150 mg/kg, 300 mg/kg and 600 mg/kg, dissolved in 10 
ml saline) were used. Ten animals received one dosage of each seaweed extract. A l l 
treated animals were sacrificed 24 h after receiving the administration ofthe vehicle 
(corn oil) or hepatotoxin (CCl4). 
The preventive test was done in the same way as the curative test, except that 
the CCl4 was administered 6 h before the treatment of saline and each seaweed 
extract. Seven rats were used in each treatment group. The CCl4 (Merck, Germany) 
was used in the preventive test instead 0fCCl4 (Ajax, Australia). 
3.2.2.3 Biochemical assays. 
The method used for determination of activities of serum glutamic pyruvic 
transaminase (SGPT) and serum glutamic oxaloacetic transaminase (SGOT) 
followed that described in the section 3.2.1.3. 
3.2.2.4 Organ weights. 
The livers and kidneys of each treatment group were dissected out from the 
animals' bodies followed by the measurement ofl iver and kidney weight. 
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3.2.2.5 Histopathological examination. 
(i) Light microscopy 
A portion of the median lobe of the liver and left kidney were fixed in Bouin's 
fluid for 24 h and dehydrated though an ascending series of different percentage of 
ethanol; cleared in xylene. The liver and kidney specimens were then embedded in 
paraffin (melting point 56-58。C), cut to 5-7 ^im thickness by a microtome, and 
stained with Mayer's hematoxylin and eosin (H&E) for histopathological 
examination under light microscope. Detailed procedures for the histopathological 
processing were outlined in the Appendix B. 
(ii) Electron microscopy 
The livers from the second group of the curative test receiving CCl4 and saline 
only were isolated and sliced into small pieces in cold 0.1 M phosphate buffer (pH 
7.2). The samples were fixed in 1% glutaraldehyde in 0.1 M phosphate buffer, pH 
7.2，with a final concentration of 2% paraformaldehyde added. The fixation was 
carried out at 4 °C for 2 h. The samples were then dehydrated in a series of ethanol 
(50%, 70%, 85%, 95% and three changes for absolute ethanol, 15 min for each 
change). The tissues were then infiltrated in a series of Spurr's epoxy resin medium 
at room tempeature, and embedded in pure Spurr's epoxy resin, polymerized at 68 °C 
in Reichert KT100 incubator for 18 h. The specimens were sectioned with Reichert 
0m2 ultracut using LKB KnifeMaker type 801B glass knife. The section was cut to 
60 to 150 nm thickness. The thin sections were mounted on 200 mesh degreased 
copper grid. The sections were stained with 2% uranyl acetate in absolute ethanol 
and lead citrate for 30 min of each stain. The stained sections were examined under 
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Jeol JEM-1200 EX transmission electron microscope. 
The same set of samples were studied with scanning electron microscopy. The 
fixation and dehydration procedures followed those in transmission electron 
microscopy except that they were carried out through the critical point drying 
process by LADD Research Industries' Critical Point Dryer (cat No: 28000128002) 
after dehydrated in absolute ethanol. The specimens were then coated with 
gold-palladium alloy by Edward's Sputter Coater S150B, and observed under Jeol 
JSM-5300 scanning electron microscope. The detailed procedures of reagent and 
tissue preparation for SEM and TEM were outlined in the Appendixes C to F. 
3.2.2.6 Statistical analysis 
For statistical analysis of the data, the Student's t-test and ANOVA were used to 
compare the levels of SGPT and SGOT in different treatments. A l l results are 
expressed in arithmetical means 土 standard error of means. The data were regarded 
as significant and very significant i f p< 0.05 and p< 0.005 respectively. A two-way 
ANOVA was used to assess the difference in the effect of different treatments and 
their concentrations on affecting the levels of SGPT and SGOT. Where significant 
differences have been detected, a Tukey HSD Test was used to identify the group(s) 
responsible for such differences. 
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3.2.3 Acute hepatotoxicity test of trichlororethylene in rats administered by oral 
and intraperitoneal routes. 
3.2.3.1 Experimental protocol. 
Trichloroethylene, which was used for studying the acute hepatotoxicity when 
taken dosage (1.25 ml/kg) the same as the CCl4 treatment group in the section 3.2.2.2 
for comparison. The different dosages of TCE (Sigma, U.S.A.) was made by 
dissolving in corn oil (Mazola, U.S.A.) and was administered intraperitoneally to the 
rats through the sterile disposable syringes equipped with hypodermic needles. 
The experiments were divided into four sets, namely: the TCE-1 (one-time 
oral group) which received trichloroethylene (TCE) to study its acute hepatotoxicity. 
Five dosages ofTCE-1 group (20%，30% and 35% ofTCE with 7 rats in each group; 
40% TCE with 12 rats and 60% of TCE with 10 rats), which were given by gavage 
oral administration followed 6 h later by saline orally (10 ml/kg); the second set, 
namely: the TCE-2 (two-time oral group) which received TCE in four dosages 
with the experimental animals number (20% of TCE with 7 rats; 40% of TCE with 
10 rats; and 50% and 60% of TCE with 5 rats in each group), which were given the 
first dosage of TCE in each dosage by gavage oral administration and 3 h later by 
second dosage of TCE, followed 6 h later from the first dosage, were given by saline 
orally (10 ml/kg). The second set was compared with no treatment group (10 rats) 
and vehicle-saline group (10 rats); the third set, namely the TCE-3 (i.p. group) 
which was treated similarly to that of the TCE-1 group except that intraperitoneal 
route was adopted instead of oral route. Six dosages of TCE-3 (i.p. group) with the 
experimental animals number (20% o fTCE with 11 rats; 25% and 40% o fTCE with 
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10 rats; and 50% and 60% of TCE with 5 rats in each group), which were given by 
i.p. administration followed 6 h later by saline intraperitoneally (10 ml/kg). The third 
set was compared with no treatment group (7 rats) and vehicle-saline control group 
(10 rats), which vehicle, corn oil (Mazole, U.S.A) was administered in i.p. route 
followed 6 h later by saline orally. 
Based on the toxicity test performed above, the effective toxic dose o fTCE was 
identified and a time course of this effective toxic dose was made to investigate the 
changes in the transaminase activity (SGPT and SGOT) in rats. Seven sets of time 
points with experimental animals number (6 h with 8 rats; 12 h with 7 rats; 27 h, 36 h, 
48 h, 72 h and 102 h with 6 rats in each) which were given TCE as same as that of 
the effective toxic group followed 6 h later by saline orally (10 ml/kg). 
3.2.3.2 Biochemical assays. 
The method used for determination of transaminase activities of serum glutamic 
pyruvic transaminase (SGPT) and serum glutamic oxaloacetic transaminase (SGOT) 
followed that described in the section 3.2.1.3. except that the serum was not diluted 
with saline. 
3.2.3.3 Organ weights. 
The livers and kidneys of each treatment group were dissected out from the 
bodies of the rats followed by the measurement of liver and kidney weight. 
43 
3.2.3.4 Histopathological examination. 
(i) Light microscopy 
A portion of the median lobe of the liver and left kidney of the TCE effective 
toxic dose group were investigated only. The method used in light microscopy was 
the same as described in section 3.2.1.5. 
(ii) Electron microscopy 
The livers from the TCE effective toxic dose group were isolated and sliced into 
small pieces in cold 0.1 M phosphate buffer (pH 7.2). The method used in electron 
microscopy was the same as described in section 3.2.2.5. 
3.2.3.5 Statistical analysis. 
For statistical analysis of the data, the Student's t-test was used to compare the 
levels of SGPT and SGOT in different treatments. A l l results are expressed in 
arithmetical mean 士 standard error of means. The data were regarded as 
significance and very significance i f p<0.05 and p<0.005 respectively. 
3.2.4 Curative and Preventive tests of seaweed aqueous extracts against the TCE 
effective dose-induced toxicity. 
3.2.4.1 Preparation of aqueous extracts of seaweeds. 
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Aqueous extracts of fresh samples of Myagropsis myagroides (S#3), Sargassum 
henslowianum (S#2), S. siliquastrum (S#4) and Galaxaura sp. (Gal) were used for 
the investigation. For extraction, the method used was the same as described in the 
section 3.2.1.1. 
3.2.4.2 Experimental protocol (Fig. 3.7). 
Trichlororethylene produces significant toxic effect when taken in suitable 
dosage (1.25 ml/kg). The 20% (v/v) TCE (Sigma, U.S.A.) was made by dissolving 
TCE in corn oil (Mazola, U.S.A.) and was administered intraperitoneally to the rats 
through the sterile disposable syringes equipped with hypodermic needles. 
The experimental animals were divided into four groups, namely: the normal no 
treatment group (5 rats); the control group (5 rats) which received the vehicle (6.25 
ml/kg, corn oil, Mazole, U.S.A.) by intraperitoneal route and normal saline (10 ml/kg) 
was also administered orally 6 h after the vehicle treatment; the third group (5 rats) 
which was treated similarly to group 2 except that 1.25 ml/kg o f20% (v/v) TCE was 
administered instead of vehicle; the fourth group which was treated similarly to 
group 3 except that each seaweed extract was individually administered instead of 
saline: A group of experimental animals (66 rats) which received TCE at effective 
toxic dose to induce toxic effect were followed 6 h later by seaweed extract to 
evaluate their curative effect. Three dosages of seaweed extracts (150 mg/kg, 300 
mg/kg and 600 mg/kg, dissolved in 10 ml saline) except Galaxaura sp. extract (150 
mg/kg and 300 mg/kg only, dissolved in 10 ml saline) were used. Six animals 
received one dosage of each seaweed extract. A l l treated animals were sacrificed 24 
h after the administration of TCE. These animals were compared with the no 
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treatment group, vehicle-saline group and TCE effective toxic dose. 
The preventive test was done in the same way as the curative test, except that 
the TCE was administered 6 h before the treatment of saline (5 rats) and each 
seaweed extract (6 rats in each treatment). The vehicle-saline group (control group, 5 
rats) in the preventive test, which received normal saline (10 ml/kg) orally 6 h before 
the vehicle (6.25 ml/kg), corn oil (Mazole, U.S.A), which was administered 
intraperitoneally. 
3.2.4.3 Biochemical assays. 
The method used for determination of transaminases activities of serum 
glutamic pyruvic transaminase (SGPT) and serum glutamic oxaloacetic transaminase 
(SGOT) followed that described in the section 3.2.1.3 except that the semm was not 
diluted with saline. 
3.2.4.4 Organ weights. 
The livers and kidneys of each treatment group were dissected out from the 
bodies of the rats followed by the measurement of liver and kidney weight. 
3.2.4.5 HistopathologicaI examination. 
Light microscopy 
A portion of the median lobe of the liver and left kidney of all treatment group 
was investigated. The method used in light microscopy was the same as that 
46 
described in the section 3.2.1.5. 
3.2.5 Antidotal effects of dimethyl sulfoxide (DMSO) and N-acetylcysteine (NAC) 
against CCI4- and TCE-induced poisoning in rats. 
3.2.5.1 Experimental protocol (Fig. 3.7). 
Carbon tetrachloride and trichloroethylene produce hepatotoxicity when taken 
in suitable dosage (1.25 ml/kg). The 20% (v/v) of CCl4 (Sigma, U.S.A.) and TCE 
(Sigma, U.S.A.) were made by dissolving CCl4 and TCE individually in corn oil 
(Mazola, U.S.A.) and were administered to the rats by gavage oral administration 
and intraperitoneal route respectively. 
The preventive test was done in the same way as the curative test, except that 
the CCl4 and TCE were administered 6 h before the treatment of saline, different 
dosages treatment of DMSO and NAC (7 rats in each CCl4 treatment, 6 rats in each 
TCE treatment). The vehicle-saline group in the preventive test, which received 
normal saline (10 ml/kg) orally 6 h before the vehicle (6.25 ml/kg), corn oil (Mazole, 
U.S.A)，which was administered orally and intraperitoneally in CCl4 group and TCE 
group respectively. 
The experimental animals were divided into four groups, namely: CCl4 group 
and TCE group. The CCl4 group (7 rats) which received carbon tetrachloride to 
induce chemical hepatitis followed 6 h later by oral saline administration; and the 
TCE group (6 rats) which received trichlororethylene to induce effective toxic effect 
followed 6 h later by oral saline administration. The third and the fourth group, 
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which were treated similarly to CCl4 and TCE group except that dimethyl sulfoxide 
(DMSO) (Ajax, Australia) and N-acetylcysteine (NAC) (Sigma, U.S.A.) which were 
individually administered instead of saline to evaluate their curative effects. Three 
dosages of DMSO (25%, 50% and 75%, dissolved in saline) and NAC (150 mg/kg, 
300 mg/kg and 600 mg/kg, dissolved in 10 ml saline) were used. Seven animals 
received one dosage of each DMSO and NAC dosages respectively by gavage oral 
administration. A l l treated animals were sacrificed 24 h after receiving the 
administration of CCl4 or TCE. 
3.2.5.2 Biochemical assays. 
The method used for determination of transaminase activities of serum glutamic 
pyruvic transaminase (SGPT) and serum glutamic oxaloacetic transaminase (SGOT) 
followed that described in the section 3.2.1.3 except that the serum was not diluted 
with saline in TCE group. 
3.2.5.3 Organ weights. 
The livers and kidneys of each treatment group were dissected out from the 
bodies of the rats followed by the measurement of l iver and kidney weight. 
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3.2.5.4 Histopathological examination. 
Light microscopy 
A portion of the median lobe of the liver and left kidney of all treatment 
group was investigated. The method used in light microscopy was the same as 
described in section 3.2.1.5. 
3.2.6 Hepatoprotective effect of seaweeds，methanol extract against CCl4- and 
TCE-induced poisoning in rats. 
3.2.6.1 Preparation of methanol extracts of seaweeds. 
Methanol extracts of fresh samples of Myagropsis myagroides (S#3), 
Sargassum henslowianum (S#2), S. siliquastrum (S#4) and Galaxaura sp. (Gal) were 
used for the investigation. For extraction, washed seaweeds were weighed and 
blended with distilled water. They were kept at 4 °C for 1 day and then filtered 
through cotton gauze. The filtrates were centrifuged at 23,700 g (12000 rpm) for 20 
min. After centrifugation, the pellets were freeze dried. The freeze dried pellets were 
place in the Soxhlet apparatus to reflux for 6 h by using pure methanol (Ajax, 
Australia). The total amount of methanol extract products were combined and 
evaporated to dryness under vacuum at 40 °C by using the rotor evaporator. The fmal 
residue was stored into airtight glass vials for aspiration under nitrogen gas to form 
dark-green viscous semisolid (Fig 3.8). The final treated products were stored in the 
refrigerator until use. 
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3.2.6.2 Experimental protocol (Fig. 3.7). 
Carbon tetrachloride and trichloroethylene produce hepatotoxicity when taken 
in suitable dosage (1.25 ml/kg). The 20% (v/v) 0 fCCl4 (Sigma, U.S.A.) and TCE 
(Sigma, U.S.A.) were made by dissolving CCl4 and TCE individually in corn oil 
(Mazola, U.S.A.) and were administered to the rats by gavage oral administration 
and intraperitoneal route respectively. The 25% (v/v) of DMSO (Ajax, Australia) 
was made by dissolving it in 0.9% (v/v) saline and was administered to the rats by 
gavage oral administration. 
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Fig. 3.8 Methanol extract of seaweed (Sargassum henslowianum; S. siliquastrum; 
Myagropsis myagroides; and Galaxaura sp., from left to right) 
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The experiment was divided into two sets, namely: CCl4 group and TCE group. 
The two sets of experiment which were treated similarly to CCl4 group and TCE 
group in the section 3.2.5.1 except that each seaweeds methanol extract was 
individually administered instead of saline 6 h post-treatment of toxins (CCl4 and 
TCE) to evaluate their curative effects. The dosages of seaweed methanol extracts 
(300 mg/kg, dissolved in 25% DMSO) were used. Five animals received one dosage 
of each seaweed extract (Myagropsis myagroides (S#3), Sargassum henslowianum 
(S#2)，S. siliquastrum (S#4)) for the two sets of experiment except the TCE group 
had one additional set of experiment which received extract of Galaxaura sp. (Gal). 
A l l treated animals were sacrificed 24 h after receiving the administration ofthe CCl4 
and TCE. These two sets ofexperiment were compared with the vehicle-saline group, 
no treatment group and 25% DMSO group in the section 3.2.5.1. 
3.2.6.3 Biochemical assays. 
The method used for determination of transaminase activities of serum glutamic 
pyruvic transaminase (SGPT) and serum glutamic oxaloacetic transaminase (SGOT) 
followed that described in the section 3.2.1.3 except that the serum was not diluted 
with saline in TCE group. 
3.2.6.4 Organ weights. 
The livers and kidneys of each treatment group were dissected out from the 
bodies of the rats followed by the measurement of liver and kidney weight. 
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3.2.6.5 Histopathological examination. 
Light microscopy 
A portion of the median lobe of the liver and left kidney of all treatment 
group were investigated. The method used in light microscopy was the same as 
described in the section 3.2.1.5. 
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Chapter 4 RESULTS 
4.1. Acute hepatotoxicity test on aqueous seaweed extracts. 
4.1.1 The biochemical assays of the serum transaminase activity. 
Table 3: Effect of seaweed extracts on transaminase activities (SGPT and SGOT) in 
rats 
(Fig. 4.1，Fig. 4.2; p. 149 & p. 150 respectively) 
Treatment 
Parameter No Control S#2 S#2 S#2 .. S#3 S#3 s#3 
treatment 150mg/kg 300mg/kg 600mg/kg 150mg/kg 300mg/kg 600mg/kg 
SGPT 12i0.5 11±0.7 12±0.6 l l i 0 . 7 12±0.8 11±0.1 l l i 0 . 8 12±0.5 
(IU/L) 
SGOT 51±0.5 53±1.1 53±5.8 52±2.7 53i2.0 51±1.8 54土0.6 53i0.5 
(IU/L) 
Treatment 
Parameter — — S#4 S#4 S#4 Gal Gal — 
150mg/kg 300mg/kg 600mg/kg 150mg/kg 300mg/kg 
SGPT 12i0.7 11±1.1 11±0.6 11±.0.5 11±0.9 — 
(IU/L) 
SGOT 54±2.0 ‘ 53±.2.2 53±1.7 51±1.5 51 i l .6 — 
(IU/L) 
Each value represents the mean±S.E.M. of 5 treated rats 
Key: S#2= Sargassum henslowianum', S#3= Myagropsis myagroides\ S#4= Sargassum siliquastrum, 
Gal= Galaxaura sp. 
The values of SGPT and SGOT serum enzymes in all seaweed extract-treated group 
were comparable (p>0.05) with the values of the vehicle-saline control. 
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Comparison of the effect of different seaweed extracts. 
Different concentrations of all three different seaweed extracts showed no 
significant differences in their ability to increase the levels of SGPT and SGOT 
(p>0.05, Two-way ANOVA). The three types of seaweed extracts: S. henslowianum, 
M. myagroides, S. siliquastrum and Galaxaura sp. have the equal effect on the SGPT 
and SGOT level (p>0.05, Turkey HSD test). Furthermore, increasing the 
concentration of seaweed extracts caused no any effect in the levels of both SGPT 
and SGOT (p>0.05, Tukey HSD test). There is no any significant different to be 
noted in the test (p<0.05). 
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4.1.2 The organ weight. 
Table 4: Effect of seaweed extracts on organ weight (liver and kidney) in rats 
(Fig. 4.3, Fig. 4.4: p. 151 & p. 152 respectively) 
Treatment 
Parameter No Control S#2 S#2 S#2 S#3 S#3 S#3 
treatment 150mg/kg 300mg/kg 600mg/kg 150mg/kg 300mg/kg 600mg/kg 
l iver 3.25x10.2 3.32x10.2 3.37x10.2 3.32x10"^ 3.41x10.2 3.49xlQ-^ 3.27x10.2 3.37xl0.2 
we ight ±0.72x10-3 ±0.67x10"^ ±0.80x10"^ iL41xl0"^ +0_94xl0"^ i0.93xl0"^ il .81xl0'^ i0.92xl0"' 
(g/kg) 
kidney 4.4xl0"^ 4.2xl0"^ 4.0xl0'^ 4.1xl0"^ 4.0x10-3 4.2x10-3 4.1x10"^  4.1x10"^  
weight ±7.0x10-5 ±4.9x10-^  ±11x10'^  ±9.5x10-5 ±12x10.5 ±9.1x10-5 ±11x10-^  ±8.9x10-5 
(g/kg) • 
Treatment 
Parameter - - S#4 S#4 S#4 Gal Gal -
150mgy'kg 300mg/kg 600mg/kg 150mg/kg 300mg/kg 
l iver — — 3.53x10-2 3.34x10.2 3.55x10.2 3.29xlQ-^ 3.34x10"^ — 
weight ±0.88x10"^ il.48xlO_s ±0.75x10-^ ±0.86x10—3 ±0.91x10-^ 
(g/kg) 
kidney — — 4.2xlQ-^  4.2x10.3 4.0x10.3 4.2xlQ-^  42xlO"^ — 
weight ±13x10—5 ±12x10-5 ±15x10—5 ±5.8x10—5 ±8.7x10—5 
(御 ) 
Each value represents the mean±S.E.M. (organ weight/body weight) of 5 treated rats 
Key: S#2= Sargassum henslowianum\ S#3= Myagropsis myagroides\ S#4= Sargassum siliquastrum, 
Gal= Galaxaura sp. 
The values of liver weight and kidney weight (g/kg) in all seaweed extract-treated 
group were comparable (p>0.05) with the values of the vehicle-saline control. 
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Comparison of the effect of different seaweed extracts. 
Different concentrations of all three different seaweed extracts showed no 
significant differences in their ability to increase the acute increase of both liver and 
kidney weight (p>0.05, Two-way ANOVA). Furthermore, increasing the 
concentration of seaweed extracts caused no any effect in the values of both liver 
weight and kidney weight (p>0.05, Tukey HSD test). There is no any significant 
different to be noted in the test (p<0.05). 
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4.2 Curative and preventive tests of seaweed aqueous extracts against the 
CCl4-induced hepatotoxicity. 
4.2.1 The biochemical assays of the serum transaminase activity (Curative). 
Table 5: Effect of seaweed extracts on CCl4-induced elevation of SGPT and SGOT 
activities in rats (Curative) 
(Fig. 4.5, Fig. 4.6: p. 153 & p. 154 respectively) 
Treatment 
Parameter No Control CCl4 S#2 S#2 S#2 
treatment 1.25ml/kg 150mg/kg 300mg/kg 600mg/kg 
SGPT 11±0.5 1210.6 1859 1402 l i l 3 1021 
(IU/L) ±121 ±47.4** ±60.1** ±78.1** 
SGOT 51i0.8 54 i l .9 2452 1723 1450 1151 
(IU/L) ±173 ±60.1** ±36.0** ±97.1** 
Treatment 
P a r a m e t e r S # 3 S#3 S#3 S # 4 S # 4 S # 4 
150mg/kg 300mg/kg 600mg/kg 150mg/kg 300mg/kg 600mg/kg 
SGPT 1274 1115 867 1617 1414 1433 
(IU/L) ±132* ±19.8** ±90.0** ±29.4 ±46.5** ±52.8* 
SGOT 1697 1700 1554 1937 1635 1562 
(IU/L) ±176* ±45.5** ±98.0** ±35.4* ±52.5** ±80.6** 
Each value represents the mean±S.E.M. o f lO treated rats 
* Significantly different when compared with the toxin control, p< 0.05. 
** Significantly different when compared with the toxin control, p< 0.005. 
Key: S#2= Sargassum henslowianwn., S#3= Myagropsis myagroides\ S#4= Sargassum siliquastrum 
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Comparison of the effect of different seaweed extracts. 
Different concentrations of all three different seaweed extracts showed 
significant differences in their ability to reduce the levels of SGPT and SGOT 
(p<0.001, Two-way ANOVA). Of these three types of seaweed extracts, those from 
S. henslowianum and M. myagroides appeared to be equally effective in reducing the 
levels of SGPT (p>0.05, Tukey HSD test) and those from S. siliquastrum were the 
least effective. Furthermore, the extracts from S. henslowianum were the most 
effective in reducing the levels of SGOT (p<0.05, Tukey HSD test), whereas those 
from M. myogroides and S. siliquastrum were not as effective. The effects from the 
latter two species were not significantly different (p>0.05, Tukey HSD test). 
Increasing the concentration of seaweed extracts was effective in reducing the levels 
of both SGPT and SGOT but only up to a point for SGPT. Increasing the 
concentration of extracts from 300 to 600 mg/kg for any one of the three seaweed 
extracts did not significantly increase their effect in reducing the SGPT levels 
(p>0.05, Tukey HSD test). 
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4.2.2 The organ weight. (Curative) 
Table 6: Effect of seaweed extracts on CCl4-induced increase of liver and kidney 
weights in rats (Curative) 
(Fig. 4.7, Fig. 4.8: p. 155 & p. 156 respectively) 
Treatment 
Parameter No Control CCl4 S#2 S#2 S#2 
treatment 1.25ml/kg 150mg/kg 300mg/kg 600mg/kg 
liver 3.23x10-2 3.36x10—2 5.36x10-2 4.38xl0_2 4.36xl0_2 3.9xlQ-^ 
we ight ±0.68x10—3 ±0.79x10—3 ±1.04xl0-^ ±1.85x10-' il.85xlQ-^ i2.10xl0_3 
(g/kg) * * ** 
kidney 4.4xl0"^ 4.1xl0'^ 4.5xl0"^ 4.4xl0"^ 4.4x10-3 4.1x10"^ 
weight ±7.4x10-5 ±5.8x10-^ ±9.1x10' i7.4xl0"^ ±5.8x10-^ i9.1xl0'^ 
(g/kg) ** 
Treatment 
Parameter S#3 S#3 S#3 S#4 S#4 S#4 
150mg/kg 300mg/kg 600mg/kg 150mg/kg 300mg/kg 600mg/kg 
liver 4.86x10-2 4.70x10'^ 4.56x10"^ 5.31x10—2 5.00x10"^ 5.02x10"^ 
we ight ±1.69x10-3 ±1.89x10-3 ±0.72x10-^ ±1.30x10'^ ±1.30x10"^ ±1.09x10"^ 
(g/kg) * ** ** * * 
kidney 4.3xl0"^ 4.4xl0"^ 4.4xlO"^ 4.3xl0'^ 4.3xl0"^ 4.4x10"^ 
we ight ±1.1x10—4 ±1.1x10-4 ±7.63x10-5 ±7.2x10-5 i6.8xlO'5 i8.7xlO_5 
(g/kg) 
Each value represents the mean±S.E.M. (organ weight/body weight) of 10 treated 
rats 
* Significantly different when compared with the toxin control, p< 0.05. 
* * Significantly different when compared with the toxin control, p< 0.005. 
Key: S#2= Sargassum henslowianum; S#3= Myagropsis myagroides\ S # 4 = Sargassum siliquastrum 
60 
Comparison of the effect of different seaweed extracts. 
Different concentrations of all three different seaweed extracts showed 
significant differences in their ability to reduce the acute increase of liver weight 
only (p<0.001, Two-way ANOVA). Of these three types of seaweed extracts, those 
from S. henslowianum appeared to be more effective in reducing the acute increase 
of liver weight than M. myagroides (p<0.05, Tukey HSD test) and those from S. 
siliquastrum were the least effective. Furthermore, the extracts from S. 
henslowianum (600 mg/kg) was effective in reducing the acute increase of kidney 
weight only (p<0.05, Tukey HSD test), whereas those from S. henslowianum (150 
mg/kg and 300 mg/kg), M myogroides and S. siliquastrum were not effective at all. 
The effects from the latter species group were not significantly different Q)>0.05, 
Tukey HSD test). Increasing the concentration of seaweed extracts was effective in 
reducing the acute increase of liver weight and kidney weight but only up to a point 
for liver weight. Increasing the concentration of extracts from 300 to 600 mg/kg for 
any one of the three seaweed extracts did not significantly increase their effect in 
reducing the acute increase of liver weight except S. henslowianum (p>0.05, Tukey 
HSD test). 
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4.2.3 The biochemical assays of the serum transaminase activity. (Preventive) 
Table 7: Effect of seaweed extracts on CCl4-induced elevation of SGPT and SGOT 
activities in rats (Preventive) 
(Fig. 4.9，Fig. 4.10: p. 157 & p. 158 respectively) 
Treatment 
Parameter No Control CCl4 S#2 S#2 S#2 
treatment 1.25ml/kg 150mg/kg 300mg/kg 600mg/kg 
SGPT 10±0.2 12i0.2 1298 1294 1359 1208 
(IU/L) ±48 ±84.6 ±68.0 ±95.5 
SGOT 51i0.5 5 3 i l . l 1864 1835 1853 1753 
(IU/L) ±65 ±148 ±76.9 ±152 
Treatment 
Parameter S#3 S#3 S#3 S#4 S#4 S#4 
150mg/kg 300mg/kg 600mg/kg 150mg/kg 300mg/kg 600mg/kg 
SGPT 1096 1014 1043 1296 1288 1470 
(IU/L) ±64.9* ±42.4* ±55.6* ±66.4 ±62.7* ±32.2* 
SGOT 1844 1741 1717 1792 1860 1756 
(IU/L) ±220 ±50.2 ±125 ±47.9 ±48.2 ±56.6 
Each value represents the mean±S.E.M. of 7 treated rats 
* Significantly different when compared With the toxin control, p< 0.05. 
Key: S#2= Sargassum henslowianum\ S#3= Myagropsis myagroides\ S#4= Sargassum siliquastrum 
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Comparison of the effect of different seaweed extracts. 
Different concentrations of all three different seaweed extracts showed no 
significant differences in their ability to reduce the levels of SGPT and SGOT 
(p>0.05, Two-way ANOVA) except SGPT in all M. myagroides extracts treatment 
and 600 mg/kg S. siliquastrum extract treatment (p<0.05, Tukey HSD test). Of these 
three types of seaweed extracts, those from S. henslowianum and S. siliquastrum 
appeared to be equally effect in the levels of SGPT and SGOT (p>0.05, Tukey HSD 
test) except 600 mg/kg S. siliquastrum appeared to have the SGPT value higher than 
the toxin control (p<0.05, Tukey HSD test) and those from M. myagroides were the 
most effective in the reducing the levels of SGPT only. Furthermore, increasing the 
concentration of seaweed extracts was not effective in reducing the levels of both 
SGPT and SGOT, Increasing the concentration of extracts from 150 to 600 mg/kg for 
any one of the three seaweed extracts did not significantly affect the SGPT and 
SGOT levels (p>0.05, Tukey HSD test). 
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4.2.4 The organ weight. (Preventive) 
Table 8: Effect of seaweed extracts on CCl4-induced increase of liver and kidney 
weights in rats (Preventive) 
(Fig. 4.11, Fig. 4.12: p. 159 & p. 160 respectively) 
Treatment 
Parameter No Control CCl4 S#2 M2 S#2 
treatment 1.25ml/kg 150mg/kg 300mg/kg 600mg/kg 
l iver 3.29x10—2 3.29x10.2 4.91x10.2 5.01x10.2 4.68x10.2 4.34x10.2 
w e i g h t ±0.75x10-3 i0.49xl0"^ ±1.47x10-^ i0.99xl0'^ ±1.25x10-^ ±0.75x10—3 
(g/kg) * 
kidney 4.1xlQ-^ 4.1xlO_3 4.7xl0"^ 4.3xlQ-^ 4.2x10"^ 4.2x10"^ 
w e i g h t ±4.0x10-5 ±12x10.5 ±9.0x10"' ±15x10-4 ±1.1x10—4 ±1.1x10.4 
(g/kg) * * * 
Treatment 
Parameter S#3 S#3 S#3 S#4 S#4 S # 4 
150mg/kg 300mg/kg 600mg/kg 150mg/kg 300mg/kg 600mg/kg 
l iver 4.57x10-2 4.28xl0_2 4.41xl0_2 4.94x10"^ 4.98xl0_2 4.96x10"^ 
w e i g h t ±0.75x10-3 il.iOxlO_3 lL25xl0"^ il.04xl0_3 ±2.01x10—3 ±1.76x10'^ 
(g/kg) * ** 
kidney 4.4xl0"^ 4.1x10—3 4.1xl0"^ 4.4xlO_3 4.4xlQ-^ 4AxW^ 
w e i g h t ±1.5x10-4 ±0.6x10-^ ±0.3x10"^ ±5.0x10-^ ±9.0x10—5 ±11x10—5 
(g /kg) * ** ^ * ^ ** 
Each value represents the mean±S.E.M. (organ weight/body weight) of 7 treated rats 
* Significantly different when compared with the toxin control, p< 0.05. 
** Significantly different when compared with the toxin control, p< 0.005. 
Key: S#2= Sargassum henslowianum-, S#3= Myagropsis myagroides; S # 4 = Sargassum siliquastrum 
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Comparison of the effect of different seaweed extracts. 
Different concentrations of all three different seaweed extracts showed 
significant differences in their ability to reduce the acute increase of kidney weight 
only (p<0.001, Two-way ANOVA). Of these three types of seaweed extracts, those 
from S. henslowianum and M. myagroides appeared to be equally effective in 
reducing the acute increase of kidney weight (p>0.05, Tukey HSD test) and those 
from S. siliquastrum were the least effective besides the 600 mg/kg of those extracts 
were applied. Furthermore, the extracts from S. henslowianum (600 mg/kg) and M. 
myagroides (300 and 600 mg/kg) were the most effective in reducing the acute 
increase of liver weight (p<0.05, Tukey HSD test), whereas those from S. 
siliquastrum were not as effective at all in reducing the acute increase of liver weight. 
The effects from the latter species were not significantly different by their different 
treatment applied (p>0.05, Tukey HSD test). Increasing the concentration of seaweed 
extracts was not effective in reducing the acute increase of both liver and kidney 
weight. But, increasing the concentration of extracts from 300 to 600 mg/kg for any 
one of the three seaweed extracts did not significantly increase their effect in 
reducing the acute increase of liver (p>0.05, Tukey HSD test) besides the extracts 
from S. henslowianum (p<0.05, Tukey HSD test). 
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4.3 Acute hepatotoxicity test of trichlororethylene in rats administered by oral 
and intraperitoneal routes. 
4.3.1 Oral route. 
4.3.1.1 One-time oral route. 
(Table 9. Fig. 4.13, Fig. 4.14 & Fig. 4.17: p. 68, p.l61, p. 162 & p. 165 
respectively) 
Based on the table shown, significant difference (p<0.05) can be noted in 
transaminase activities and organ weight from the 40% to 60% TCE applied. The 
death ofexperimental animals was also noted in those dosages. 
4.3.1.2 Two-time oral route. 
(Table 10，Fig. 4.15, Fig. 4.16 & Fig. 4.18: p. 69, p. 163, p l64 & p. 166 
respectively) 
Based on the table shown, significant difference (p<0.05) can be noted in 
transaminase activities and organ weight at the 40% TCE applied. The death of 
experimental animals was also noted in that dosages. 100% of mortality rate was 
noted at 50% and 60% TCE applied. 
4.3.2 Intraperitoneal route. 
(Table 11，Fig. 4.19, Fig. 4.20 & Fig. 4.21: p. 70，p. 167, p. 168 & p. 169 
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respectively) 
Based on the table shown, significant difference (p<0.05) can be noted in 
transaminase activities at the 20% t TCE applied onwards. No significant difference 
can be noted in the liver and kidney weights except the 40% TCE was applied 
(p<0.05, kidney weight). The death of experimental animals was also noted in the 
dosages of 25% to 60% TCE. 100% of mortality rate was noted at 50% and 60% 
TCE applied. Only 20% TCE in i.p. can induce the elevated levels of SGPT and 
SGOT significantly (p<0.05) with the 100% survival rate obtained when compared 
with the vehicle-saline control. However, there is no significant difference in liver 
and kidney weights when compared with those from the vehicle-saline control. (20% 
TCE in i.p. is regarded as effective dose) 
4.3.3 Time course of the effective dose of20% TCE in i.p. route. 
(Table 12 & Fig. 4.22 to Fig. 4.25: p. 71，p. 170 to p. 173 respectively) 
Based on the table shown, significant difference (p<0.05) can be noted in 
transaminase activities in all time except 36 h to 102 h of SGPT levels. There is a 
trend of SGPT and SGOT levels to retum to normal. No significant difference can be 
noted in the liver and kidney weights except the 6 h (p<0.05). There are increase and 
decrease in size of liver and kidney respectively. 
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Table 9: Change of transaminase activities (SGPT and SGOT) and organ 
weight (liver and kidney) after a single oral dosage of TCE in 
different percentage. 
Group Dosage (%), No. of No. of survival rate SGPT SGOT Liver weight Kidney weight 
1.25 ml/kg animals survivors (。/。） (IU/L) (IU/L) (g/kg) (g/kg) 
used 
no “ l0 W l00 1 2 i 0 . 8 ~ ~ 5 1 i l . 2 ~ ~ 3 . 2 9 x l 0 ' ^ 4.2x10"^~~ 
treatment ±0.88x10.3 ±6.8x10.5 
vehicle- — 10 10 100 13+0.8 54+1.5 3.33xlQ-^  4.1xl0.3 
saline ±0.89x10"' ±6.4x10'' 
TCE 20% 20 7 7 100 12i0.6 55i3.3 3.65xl0"' 4.1xl0'' 
±0.80x10—3 ±6.7x10-5 
TCE 30% 30 7 7 100 l l i 0 . 7 55i5.0 3.81xlO'' 3.8xlO"' 
±0.58x10-^ ±15x10-5 
** 
TCE 35% 35 7 7 100 l l i 0 . 6 51i3.1 3.82xl0"^ 3.9x10.3 
±0.15x10-3 ±4.0x10-5 
* * * 
TCE 40% 40 30 12 40 20i0 .8 86i3.1 3.60xl0'' 3.9xl0'^ 
** ** ±0.59x10-3 ±5.3x10-5 
* * * * 
TCE 60% 60 10 3 30 26i4 .0 1 3 4 i l 6 5.14xl0"' 5.0x10.3 
** ** ±1.30x10-3 ±17x10-5 
** *本 
* Significantly different when compared with the vehicle-saline control, p< 0.05. 
** Significantly different when compared with the vehicle-saline control, p< 0.005. 
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Table 10: Change of transaminase activities (SGPT and SGOT) and organ ’ 
weight (liver and kidney) after a twice oral dosage of TCE in different 
percentage. 
Group Dosage (%), No. of animals No. of survivors survival rate SGPT SGOT Liver weight Kidney weight 
1.25 ml/kg used (%) (IU/L) (IU/L) (g/kg) (g/kg) 
no ™ f0 l0 l00 11+0.7~~50i0.5~~~3.21xlQ-^ 4.4xlQ-^ 
treatment i0.56xl0'^ ±6.7x10-' 
vehicle- — 10 10 100 lOiO.8 52+1.1 3.28xl0_2 4.3xlQ-^ 
saline lO_89xlO'^ ±5.0x10—5 
TCE 20% 20 7 7 100 14 l l .7 64i3.6 4.16xl0'^ 4.1x10.3 
• * ±0.56x10-3 ±9.7x10-' 
•女 
TCE 40% 40 10 4 40 18i2.4 71i3 .9 4.66xl0"' 4.8xl0"' 
* ** ±2.72x10-3 ±5.2x10-5 
** 本 
TCE 50% 50 5 0 0 — — — — 
TCE 60% 60 5 0 0 — — 一 — 
* Significantly different when compared with the vehicle-saline control, p< 0.05. 
** Significantly different when compared with the vehicle-saline control, p< 0.005. 
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Table 11: Change of transaminase activities (SGPT and SGOT) and organ 
weight (liver and kidney) after a i.p. dosage o fTCE in different 
percentage. 
Group Dosage (%), No. ofanimals No. of survival rate SGPT SGOT Liver Kidney weight 
1.25 ml/kg uscd survivors (%) (IU/L) (IU/L) weight (g/kg) 
(g/kg) 
no — 7 7 100 " ± 0 . 5 51 i0 .8 3.23x10'^ 4.4x10"^ 
treatment ±0.68x10" i7.4xl0"' 
3 
vehicle-sali — 10 10 100 12±0.3 51 i0 .7 3.36x10"^ 4.1x10"^ 
ne ±0.79x10— i5.8xlO_5 
3 
TCE 20% 20 11 11 100 1 6 i l . l 150i8.5 3.38x10-2 4.0x10.3 
* ** ±0.87x10- ±7.6x10-5 
3 
TCE 25% 25 10 8 80 45+5.7 200+9.9 3.44x10-^ 4.1xl0'^ 
** ** +1.03xlO" ±11x10-5 
3 
TCE 30% 30 10 8 80 106i2.1 222 i5 .6 3.20xlQ-' 4.1x10.3 
** ** ±0.59x10- ±7.0x10-5 
3 
TCE 40% 40 10 3 30 103i8.9 231 + 12 3_lOxlO"' 3.5x10.3 
** ** ±1.55x10- ±11x10-5 
• 3 本* 
TCE 50% 50 5 0 0 — — 一 一 
TCE 60% 60 5 0 0 — — 一 — 
* Significantly different when compared with the vehicle-saline control, p< 0.05. 
** Significantly different when compared with the vehicle-saline control, p< 0.005. 
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Table 12: Time course of transaminase activities (SGPT and SGOT) and organ 
weight (liver and kidney) after a i.p. dosage of 20% TCE in rats. 
Group Time (h) No. of animals SGPT (IU/L) SGOT (IU/L)"~Liver weight Kidney weight 
uscd (g/kg) (g/kg) 
vehic le -~regarded as 7 12±0.5 53i0 .8 3.33x10-2 3.9x10.3 
saline Oh ±0.72x10"^ ±4.8x10-5 
TCE 20% 6 8 3211.7 170i3.7 3.51xl0_2 3.9xlQ-^ 
** ** ±0.76x10-3 ±5.4x10-5 
* * 
TCE 20% 12 7 30+1.9 180i5.0 3.36x10—2 4Jxl0"^ 
** ** ±0.60x10-3 ±11x10-5 
TCE 20% 24 11 15i0.7 152i6.3 3.38x10—2 4.0xl0_3 
* ** ±0.87x10-3 ±7.6x10-5 
TCE 20% 27 6 15+0.4 81.4+7.8 3.31xlO_2 4.1xlO_3 
* ** ±0.53x10'' ±13x10-5 
TCE 20% 36 6 12i0.7 85.5i4.9 3.37x10'^ 4.1x10'^ 
** ±U4xlO_3 ±10xl0_5 
TCE 20% 48 6 1 2 i l . 3 68.5i5.0 3.40x10'^ 4.1x10"^ 
** ±1.12x10—3 ±8.2x10—5 
TCE 20% 72 6 12土1.1 58.4i4.1 3.29x10"^ 4.1x10.3 
* ±1.00x10-3 ±12x10-5 
TCE 20% 102 6 1 3 ± l i 58 .5 i l . 7 3.32x10"^ 4.1xlQ-^ 
** ±1.17x10-3 ±11x10-5 
* Significantly different when compared with the vehicle-saline control, p< 0.05. 
** Significantly different when compared with the vehicle-saline control, p< 0.005. 
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4.4 Curative and preventive tests of seaweeds aqueous crude extracts against the 
TCE effective dose-induced toxicity. 
4.4.1 The biochemical assays of the serum transaminase activity (Curative). 
Table 13: Effect of seaweed extracts on TCE-induced elevation of SGPT and SGOT 
activities in rats (Curative) 
(Fig. 4.26，Fig. 4.27: p. 174 & p. 175 respectively) 
Treatment 
Parameter No Control TCE S#2 S#2 S#2 — — 
treatment 1.25ml/kg 150mg/kg 300mg/kg 600mg/kg 
SGPT l l i 0 . 5 1110.8 14.25 11.32 11.56 1122 - -
(IU/L) ±1.3 ±0.89* ±1.09* .±1.08* 
SGOT 52 i l . 2 55 i l . 4 153.4 111.0 116.5 85.25 - -
(IU/L) ±6.4 ±16.9* ±2.80** ±4.36** 
Treatment 
Parameter S#3 S#3 S#3 S#4 S#4 S#4 Gal Gal 
150mg/kg 300mg/kg 600mg/kg 150mg/kg 300mg/kg 600mg/kg 150mg/kg 300mg/kg 
SGPT 13.15 13.40 10.61 15.34 12.40 11.47 13.24 10.79 
(IU/L) ±0.91* ±0.85* ±0.96** ±1.28 ±0.76* ±0.85* ±0.76* ±1.08** 
SGOT 101.4 100.0 87.94 130.5 128.1 126.5 125.8 92.57 
(IU/L) ±6.95** ±5.42** ±1.45** ±6.64 ±4.83* ±8.11* ±4.48* ±2.07** . 
Each value represents the mean±S.E.M. of 5 treated rats except seaweed 
extract-treated groups which have 6 treated rats in each group. 
* Significantly different when compared with the toxin control, p< 0.05. 
** Significantly different when compared with the toxin control, p< 0.005. 
Key: S#2= Sargassum henslowianum-, S#3= Myagropsis myagro ides ; S#4= Sargassum siliquastrum; 
Gal= Galaxaura sp. 
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Comparison of the effect of different seaweed extracts. 
Different concentrations of all three different seaweed extracts showed 
significant differences in their ability to reduce the levels of SGPT and SGOT 
(p<0.001, Two-way ANOVA). Of these four types of seaweed extracts, those from 
Galaxaura sp. could be the most effective than other species at their corresponding 
concentration (p<0.05, Turkey HSD test). S. henslowianum and M. myagroides 
appeared to be equally effective in reducing the levels of SGOT and SGPT (only at 
concentration of 600 mg/kg) (p>0.05, Tukey HSD test) and those from S. 
siliquastrum were the least effective. Furthermore, the extract from Galaxaura sp. 
(600 mg/kg) was the most effective in reducing the levels of SGPT and SGOT 
(p<0.05, Tukey HSD test), whereas those from S. henslowianum and M. myagroides 
were not as effective at that concentration. In general, increasing the concentration of 
seaweed extracts was effective in reducing the levels of both SGPT and SGOT 
except those from the SGOT of S. siliquastrum. Increasing the concentration of 
extracts from 300 to 600 mg/kg for any one of the three seaweed extracts (brown 
seaweeds) did significantly increase their effect in reducing the SGPT and SGOT 
levels (p<0.05, Tukey HSD test) except those from the SGPT level of. S. 
henslowianum and SGOT level of S. siliquastrum (p>0.05, Turkey HSD test). 
Moreover, increasing the concentration of extracts from 150 to 300 mg/kg of 
Galaxaura sp. did significantly increase the effect in reducing the SGPT and SGOT 
levels (p<0.05, Turkey HSD test). 
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4.4.4 The organ weight. (Preventive) 
Table 14: Effect of seaweed extracts on liver and kidney weights in TCE-treated rats 
(Curative) 
(Fig. 4.28, Fig. 4.29: p. 176 & p. 177 respectively) 
Treatment 
Parameter No Control TCE S#2 S#2 S#2 — — 
treatment 1.25ml/kg 150mg/kg 300mg/kg 600mg/kg 
l iver 3.33x10-2 3.35x10.2 3.36x10.2 3.42x10.2 3.48x10"^ 3.4x10.2 — — 
w e i g h t ±0.76x10—3 ±0.89x10-3 ±0.84x10.3 i0.95xl0_3 ±0.40x10—3 ±0.56x10-3 
(g/kg) 
kidney 4.2xlQ-^ 4.3xl0"^ 4.1xlO_3 3.9xlQ-^ 4.2xlO_3 4.1x10"^ — — 
w e i g h t ±6.3x10-5 i7.8xl0"^ ±7.3x10"' i7 .4xl0 ' ' i8Jxl0"^ +6_8xl0"^ 
(g/kg) 
Treatment 
Parameter S#3 S#3 S#3 S#4 S#4 S#4 Gal Gal 
150mg/kg 300mg/kg 600mg/kg 150mg/kg 300mg/kg 600mg/kg 150mg/^ kg 300mg/kg 
l iver 3.46x10.2 3.46xl0.2 3.45x10.2 3.61xlQ-^ 3.73x10.2 3.61x10.2 3.51x10.2 3.56x10.2 
w e i g h t ±0.90x10-3 ±0.73x10"^ ±0.54x10-3 ±0.50x10"^ ±0.96x10"^ +0.46xlQ-^ i0.42xlQ-^ ±0.80x10-3 
(g/kg) * * * 
1 
kidney 4.1xl0"^ 4.2xl0"^ 3.9xl0"^ 4.3xl0'^ 4.5xl0"^ 4.4x10—3 4.1xlO"^ 4.0xlQ-' 
w e i g h t ±8.5x10-5 ±7.8x10-5 ±12.0x10-5 i8.3xlO_5 i4.6xlO_5 ±9.28x10-5 i9.5xl0.5 ±9.3x10"^ 
(g /kg) * ** * 
Each value represents the mean±S.E.M. (organ weight^ody weight) of 5 treated rats 
except seaweed extract-treated groups which have 6 treated rats in each group. 
* Significantly different when compared with the toxin control, p< 0.05. 
** Significantly different when compared with the toxin control, p< 0.005. 
Key: S # 2 = Sargassum henslowianum-, S#3= Myagropsis myagro ides \ S # 4 = Sargassum si l iquastrum-, 
Gal= Galaxaura sp. 
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Comparison of the effect of different seaweed extracts. 
Different concentrations of all four different seaweed extracts showed no 
significant differences with the liver and kidney weights of toxin control (p>0.05, 
Two-way ANOVA) except S. siliquastrum. Of these four types of seaweed extracts, 
those from S. siliquastrum appeared to generate toxic effect in increase of liver and 
kidney weights (p<0.05, Tukey HSD test). Increasing the concentration of seaweed 
extracts was not effective in changing values of liver weight and kidney weight 
(p>0.05, Turkey HSD test). Increasing the concentration of extracts from 150 to 600 
mg/kg for any one of the three brown seaweed extracts and 150 to 300 mg/kg for the 
red seaweed extracts did not significantly increase their effect in any change of liver 
and kidney weights (p>0.05, Tukey HSD test). 
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4.4.3 The biochemical assays of the serum transaminase activity. (Preventive) 
Table 15: Effect of seaweed extracts on TCE-induced elevation of SGPT and SGOT 
activities in rats (Preventive) 
(Fig. 4.30, Fig. 4.31: p. 178 & p. 179 respectively) 
Treatment 
Parameter No Control TCE S#2 S#2 S#2 — — 
treatment 1.25ml/kg 150mgy'kg 300mg/kg 600mg/kg 
SGPT l l i 0 . 4 12i0.6 16 14.90 15.24 15.26 - ... 
(IU/L) 士3.1 ±0.96 ±1.10 ±0.90 
SGOT 5 1 i l . 2 49+3.0 152 103.0 104.9 103.3 - - . 
(IU/L) ±5.0 ±2.50** ±4.90** ±3.70** 
Treatment 
Parameter S#3 S#3 S#3 S#4 S#4 S#4 GaI Gal 
150mg/kg 300mg/kg 600mg/kg 150mg/kg 300mgy'kg 600mg/kg 150mg/kg 300mg/kg 
SGPT 15.43 15.91 15.24 12.98 12.59 12.16 14.44 12.45 
(IU/L) ±1.28 ±1.51 士0.85 ±0.51* ±1.15* ±0.85* ±0.99 ±0.90* 
SGOT 117.6 117.0 117.1 131.2 116.8 108.9 110.5 83.60 
(IU/L) ±5.81** ±4.41** ±4.24** ±8.37* ±2.28** ±5.36** ±6.24** ±12.4** 
Each value represents the mean±S.E.M. of 5 treated rats except TCE toxin control 
and seaweed extract-treated groups which have 6 treated rats in each group. 
* Significantly different when compared with the toxin control, p< 0.05. 
* * Significantly different when compared with the toxin control, p< 0.005. 
Key: S # 2 = Sargassum henslowianum-, S#3= Myagropsis myagroides; S#4= Sargassum siliquastrum; 
Gal= Galaxaura sp. 
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Comparison of the effect of different seaweed extracts. 
Different concentrations of all four different seaweed extracts showed 
significant differences in their ability to reduce the levels of SGPT and SGOT 
(p<0.05, Two-way ANOVA) except SGPT in all S. henslowianum and M 
myagroides extracts treatments (p>0.05, Tukey HSD test). Of these three types of 
seaweed extracts, those from S. henslowianum and M. myagroides appeared to be 
equally effect in the levels of SGPT (p>0.05, Tukey HSD test). Extracts from S. 
siliquastrum were the most effective in the reducing the levels of SGPT only (p<0.05, 
Turkey HSD test). Furthermore, increasing the concentration of seaweed extracts 
was not effective in reducing the levels of both SGPT and SGOT except Galaxaura 
sp. extracts (p<0.05, Turkey HSD test). Increasing the concentration of extracts from 
150 to 600 mg/kg for any one of the three seaweed extracts did not significantly 
effect in the SGPT and SGOT levels (p>0.05, Tukey HSD test) except S. 
siliquastrum (p<0.05, Turkey HSD test). 
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4.4.4 The organ weight. (Preventive) 
Table 16: Effect of seaweed extracts on liver and kidney weights in TCE-treated rats 
(Preventive) 
(Fig. 4.32, Fig. 4.33: p. 180 & p. 181 respectively) 
Treatment 
Parameter No Control TCE S#2 S#2 S#2 — — 
treatment 1.25ml/kg 150mg/kg 300mg/kg 600mg/kg 
l iver 3.31x10-2 3.31x10.2 3.30x10"^ 3.38x10"^ 3.34x10"^ 3.38x10"^ — — 
weight ±0.62x10-3 +0.84xl0"^ ±0.81x10.3 ±1.50x10-3 il.lOxlO'^ iL07xl0"^ 
(g/kg) 
kidney 4.1xl0"^ 4.2xl0"^ 4.2xl0"^ 4.2x10'^ 4.2x10*^ 4.2x10"^ — — 
weight ±6.7x10-5 ii2xlO_5 ±7.5x10'' illxlO_5 ±12x10.5 .±7.5x10-5 
(g /kg) 
Treatment 
Parameter S#3 S#3 S#3 S#4 S#4 S#4 Gal Gal 
150mg/kg 300mg/kg 600mg/kg 150mg/kg 300mg/kg 600mg/kg 150mg/kg 300mg/kg 
l iver 3.32x10-2 3.24x10-2 3.24x10-2 3.56x10.2 3.53xlO"^ 3.81x10.2 3.39x10.2 3.42x10.2 
weight ±0.39x10-3 ±1.29xl0"^ ±0.77x10-^ ±0.70x10-^ ±0.73x10-3 il.06xl0"^ i l .34xl0.3 i0.27xl0_3 
(g/kg) * * ” 
kidney 4_lxl0"^ 4.3xl0'^ 4.2xl0"^ 4.1x10.3 4.3xl0"^ 4.2x10"^ 4.3xl0"^ 4.2xl0"^ 
weight ±14x10—5 ±13x10-5 ±12x10-5 ±11x10-5 il5xlO_5 i8.7xlO_5 iMxlO'^ ±7.5x10-5 
( _ 
Each value represents the mean±S.E.M. (organ weight^ody weight) of 5 treated rats 
except TCE toxin control and seaweed extract-treated groups which have 6 treated 
rats in each group. 
* Significantly different when compared with the toxin control, p< 0.05. 
* * Significantly different when compared with the toxin control, p< 0.005. 
Key: S#2= Sargassum henslowianum-, S#3= Myagropsis myagro ides \ S#4= Sargassum siliquastrum-, 
Gal= Galaxaura sp. 
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Comparison of the effect of different seaweed extracts. 
Different concentrations of all four different seaweed extracts showed no 
significant differences in their ability to cause any effect of liver and kidney weights 
(p>0.05, Two-way ANOVA) except increase of liver weights with the S. 
siliquastrum extracts applied (p<0.05, Turkey HSD test). Of these four types of 
seaweed extracts, all appeared to be equally effective in the effect of liver and kidney 
weights (p>0.05, Tukey HSD test) besides those from S. siliquastrum were the most 
effective in causing the increase of liver and kidney weights. Increasing the 
concentration of seaweed extracts was not effective in causing the effect ofboth liver 
and kidney weight. But, increasing the concentration of extracts from 300 to 600 
mg/kg for S. siliquastrum extracts significantly increase their effect in the increase of 
liver weight (p<0.05, Tukey HSD test). 
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4.5 Antidotal effects of dimethyl sulfoxide (DMSO) and N-acetylcysteine (NAC) 
against CCl4- and TCE-induced poisoning in rats. 
4.5.1 The biochemical assays of the serum transaminase activity (Curative). 
Table 17: Effect o fDMSO and NAC on CCl4-induced elevation ofSGPT and SGOT 
activities in rats (Curative) 
(Fig. 4.34’ Fig. 4.35，Fig. 4.36 & Fig. 4.37: p. 182，p. 183 p. 184 & p. 185 respectively) 
Treatment 1 
Parameter No Control CCl4 DMSO DMSO DMSO 
treatment 1.25ml/kg 25% 50% 75% 
SGPT 12i0.7 12i0.5 1255 1252 343.9 287.4 
(IU/L) ±107 ±121 ±60.7** ±23.7** 
SGOT 48 i l . 8 51 i l . 7 2118 2143 1361 1355 
(IU/L) ±96.0 ±95.3 ±94.8** ±67.9** 
Treatment 2 
Parameter No Control CCl4 NAC NAC NAC 
treatment 1.25ml/kg 150 mg/kg 300 mg/kg 600 mgAcg 
SGPT 11±1.1 10+0.7 1235 1219 975.2 305.0 
(IU/L) ±97.0 ±123 ±156 ±66.8** 
SGOT 52 i l . 4 51 i l . 0 2097 1885 1780 1227 
(IU/L) ±96.0 ±97.2 ±72.9** ±102** 
Each value represents the mean±S.E.M. of 7 treated rats except no treatment and 
control groups which have 5 treated rats in each group. 
* Significantly different when compared with the toxin control, p< 0.05. 
** Significantly different when compared with the toxin control, p< 0.005. 
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Table 18: Effect ofDMSO and NAC on TCE-induced elevation of SGPT and SGOT 
activities in rats (Curative) 
(Fig. 4.38, Fig. 4.39, Fig. 4.40 & Fig. 4.41: p. 186，p. 187’ p. 188 & p. 189 respectively) 
Treatment 1 
Parameter No Control TCE DMSO DMSO DMSO 
treatment 1.25ml/kg 25% 50% 75% 
SGPT 13i0.7 12i0.5 16.06 15.58 11.88 11.94 
(IU/L) ±1.10 ±1.54 ±0.90* ±0.89* 
SGOT 52±1.1 50 i l .2 150.2 140.1 108.3 109.6 
(IU/L) ±8.52 ±2.54 ±6.96** ±4.28** 
Treatment 2 
Parameter No Control TCE NAC NAC NAC 
treatment 1.25ml/kg 150 mg/kg 300 mg/kg 600 mgy :^g 
SGPT 11±0.9 13i0.7 16.46 14.19 13.22 13.5 
(IU/L) ±1.14 ±0.98 ±1.29 ±1.31 
SGOT 53i0.5 51 + 1.0 151.3 132.6 99.13 85.38 
(IU/L) ±8.52 ±7.74 ±6.68** ±6.07** 
Each value represents the mean±S.E.M. of 6 treated rats except no treatment and 
control groups which have 5 treated rats in each group. 
* Significantly different when compared with the toxin control, p< 0.05. 
** Significantly different when compared with the toxin control, p< 0.005. 
81 
4.5.4 The organ weight. (Preventive) 
Table 19: Effect of DMSO and NAC on CCl4-induced increase of liver and kidney 
weights in rats (Curative) 
(Fig. 4.42，Fig. 4.43，Fig. 4.44 & Fig. 4.45: p. 190，p. 191 p. 192 & p. 193 respectively) 
Treatment 1 
Parameter No Control CCl4 DMSO DMSO DMSO 
treatment 1.25ml/kg 25% 50% 75% 
liver 3.28xl0_2 3.34x10"^ 5.36x10"^ 4.95x10'^ 4.92x10'^ 4.29x10"^ 
weight ±0.65x10-3 ±0.70x10-3 ±1.04x10-3 ±2.15x10-^ ±1.46x10-^ il.08xl0_3 
(g/kg) ** 
kidney 4.3xlO_3 4.2xlQ-^ 4.5xlO_3 4.4x10"^ ‘ 4.4x10"^ 4.4x10'^ 
weight ±6.6x10-5 ±5.2x10-5 i9.1xlO_5 ±13x10.5 ±11x10"^ i8.8xlO'5 
(g/kg) 
Treatment 2 
Parameter No Control CCl4 NAC NAC NAC 
treatment 1.25ml/kg 150mg/kg 300 mg/kg 600 mg/kg 
liver 3.30x10-2 3.33x10'^ 5.13xl0_2 4.86x10.2 4.89x10"^ 4.44xl0_2 
weight ±0.59x10-3 ±0.67x10-^ i0.98xl0_3 ±0.93x10-^ ±1.21x10"^ i0.88xl0_3 
(g/kg) * 
kidney 4.2x10"^ 4.1x10"^ 4.5x10"^ 4.5x10'^ 4.3x10'^ 4.3x10'^ 
weight ±5.9x10-5 ±5.0x10-5 ±8.7x10—5 ±8.2x10"^ ±9.5x10"^ i4.5xl0'^ 
( _ ： ！ 
Each value represents the mean±S.E.M. of 7 treated rats except no treatment and 
control groups which have 5 treated rats in each group. 
* Significantly different when compared with the toxin control, p< 0.05. 
** Significantly different when compared with the toxin control, p< 0.005. 
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Table 20: Effect o fDMSO and NAC on liver and kidney weights in TCE-treated rats 
(Curative) 
(Fig. 4.46, Fig. 4.47, Fig. 4.48 & Fig. 4.49: p. 194, p. 195 p. 196 & p. 197 respectively) 
Treatment 1 
Parameter No Control TCE DMSO DMSO DMSO 
treatment 1.25ml/kg 25% 50% 75% 
liver 3.31x10-2 3.30xl0_2 3.32xl0_2 3.22x10"^ 3.36x10.2 3.44xl0_2 
weight ±0.75x10-3 ±0.71x10"^ ±0.80x10-^ il.58xlO_3 il.49xlO_3 i0.99xl0_3 
(g/kg) 
kidney 4.1x10"^ 4.3x10"^ 4.0x10"^ 4.0x10"^ 4.2x10"^ 4.1x10"^ 
weight ±7.6x10-5 ±5.7x10-5 ±6.8x10"' i l l x lO_5 ilOxlO_5 ±13x10.5 
(g/kg) 
Treatment 2 
Parameter No Control TCE NAC NAC NAC 
treatment 1.25ml/kg 150mg/kg 300 mg/kg 600 mg/kg 
liver 3.32x10-2 3.31x10"^ 3.33x10"^ 3.40x10.2 3.47xl0_2 3.38x10"^ 
weight ±0.55x10-3 ±0.73x10"^ i0.78xl0_3 ±0.36x10"^ ±1.06x10-3 ±0.54x10"^ 
(g/kg) 
kidney 4.1x10'^ 4.3xlQ-^ 4.2x10"^ 4.1x10'^ 4.1x10"^ 4.0x10"^ 
weight ±5.6x10-5 ±6.3x10-5 ±7.3x10"' i9.5xlQ-^ ±10x10'^ ±12x10.5 
W 
Each value represents the mean+S.E.M. of 6 treated rats except no treatment and 
control groups which have 5 treated rats in each group. 
* Significantly different when compared with the toxin control, p< 0.05. 
** Significantly different when compared with the toxin control, p< 0.005. 
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4.5.3 The biochemical assays of the serum transaminase activity (Preventive). 
Table 21:Effect ofDMSO and NAC on CCl4-induced elevation ofSGPT and SGOT 
activities in rats (Preventive) 
(Fig. 4.50，Fig. 4.51，Fig. 4.52 & Fig. 4.53: p. 198，p. 199 p. 200 & p. 201respectively) 
Treatment 1 
Parameter No Control CCl4 DMSO DMSO DMSO 
treatment 1.25ml/kg 25% 50% 75% 
SGPT 12±0.5 11士0.7 1295 1295 1243 1079 
(IU/L) ±60.8 ±58.8 ±57.3 ±81.1* 
SGOT 52 i l . 0 5311.9 1736 1726 1709 1591 
(IU/L) ±102 ±45.9 ±’76.7 ±61.6** 
^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ W M H ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ H I ^ ^ ^ ^ ^ ^ ^ ^ M M M I ^ ^ ^ ^ ^ ^ ^ H ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ M H ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ H ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ n H ^ ^ ^ ^ ^ ^ ^ ^ ^ M M I ^ ^ ^ ^ n ^ ^ ^ ^ H a 
Treatment 2 
Parameter No Control CCl4 NAC NAC NAC 
treatment 1.25ml/kg 150mg/kg 300 mg/kg 600 mg/kg 
SGPT l l i 0 . 6 10+0.8 1283 1274 1296 1282 
(IU/L) ±77.0 ±178 ±69.5 ±74.9 
SGOT 52+1.0 52 i l .3 1887 1775 1774 1596 
(IU/L) ±92.2 ±138 ±101 ±129* 
Each value represents the mean±S.E.M. of 7 treated rats except no treatment and 
control groups which have 5 treated rats in each group. 
* Significantly different when compared with the toxin control, p< 0.05. 
** Significantly different when compared with the toxin control, p< 0.005. 
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Table 22: Effect ofDMSO and NAC on TCE-induced elevation of SGPT and SGOT 
activities in rats (Preventive) 
(Fig. 4.54, Fig. 4.55，Fig. 4.56 & Fig. 4.57: p. 202，p. 203 p. 204 & p. 205 respectively) 
Treatment 1 
Parameter No Control TCE DMSO DMSO DMSO 
treatment 1.25ml/kg 25% 50% 75% 
SGPT 13士0.7 12±0.5 15.89 14.88 15.00 15.01 
(IU/L) ±1.07 ±0.91 士0.91 ±0.82 
SGOT 52+1.1 50±1.2 152.5 154.2 150.8 153.9 
(IU/L) ±5.51 ±5.19 ±7.30 ±5.41 
Treatment 2 
Parameter No Control TCE NAC NAC NAC 
treatment 1.25ml/kg 150mg/kg 300 mg/kg 600 mg/kg 
SGPT l l i 0 . 9 13+0.7 15.88 15.73 15.78 15.63 
(IU/L) ±1.16 ±0.91 ±0.56 ±1.01 
SGOT 53i0.5 51 i l .0 150.0 152.2 153.9 147.0 
(IU/L) ±6.52 ±5.39 ±7.34 ±7.48 
Each value represents the mean±S.E.M. of 6 treated rats except no treatment and 
control groups which have 5 treated rats in each group. 
A l l values of SGPT and SGOT semm enzymes in all treated groups were comparable 
with (p>0.05) the values of the toxin control. 
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4.5.4 The organ weight. (Preventive) 
Table 23: Effect of DMSO and NAC on CCl4-induced increase of liver and kidney 
weights in rats (Curative) 
(Fig. 4.58, Fig. 4.59, Fig. 4.60 & Fig. 4.61: p. 206，p. 207 p. 208 & p. 209 respectively) 
Treatment 1 
Parameter No Control CCl4 DMSO DMSO DMSO 
treatment 1.25ml/kg 25% 50% 75% 
liver 3.38x10-2 3.30x10'^ 5.08xl0_2 4.43x10"^ 4.39xl0_2 4.00x10"^ 
weight ±0.74x10-3 ±0.50x10-^ i0.94xlQ-^ ±1.49x10'^ ±1.13x10"^ il.73xlQ-^ 
(g/kg) • • * • • * 
kidney 4.1xlO_3 4.1xlO_3 4.4x10'^ 4.4x10"^ 4.4xlQ-^ 4.4x10'^ 
weight ±4.6x10-5 ±6.2x10"^ ±7.9x10'' il4xlO_5 ±8.3x10'^ ±11x10"^ 
(g/kg) 
Treatment 2 
Parameter No Control CCl4 NAC NAC NAC 
treatment 1.25ml/kg 150 mg/kg 300 mg/kg 600 mg/kg 
liver 3.32x10-2 3.40x10"^ 5.22x10"^ 4.89x10"^ 4.29x10'^ 3.99x10"^ 
weight ±0.66x10-3 i0.57xlQ-^ i0.78xlQ-^ iL54xlQ-^ il.20xl0_3 ±0.48x10-3 
(g/kg) * • * • 
kidney 4.0xl0_3 4.1xlO_3 4.5xlO_3 4.1xlQ-^ 4.1xlO_3 4.1xlQ-^ 
weight ±5.5x10-5 ±6.1x10-5 ±9.7x10-5 ±7.3x10-5 ±7.8x10-5 ±7.0x10.5 
( _ ： ！ ！ * 
Each value represents the meaniS.E.M. of 7 treated rats except no treatment and 
control groups which have 5 treated rats in each group. 
* Significantly different when compared with the toxin control, p< 0.05. 
** Significantly different when compared with the toxin control, p< 0.005. 
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Table 24: Effect o fDMSO and NAC on liver and kidney weights in TCE-treated rats 
(Preventive) 
(Fig. 4.62, Fig. 4.63, Fig. 4.64& Fig. 4.65: p. 210，p. 211 p. 212 & p. 213 respectively) 
Treatment 1 
Parameter No Control TCE DMSO DMSO DMSO 
treatment 1.25ml/kg 25% 50% 75% 
liver 3.33x10-2 3.34x10"^ 3.35x10"^ 3.36x10"^ 3.31x10"^ 3.44x10"^ 
weight i0.68xlO_3 ±0.77x10"^ i0.96xl0_3 il.35xlO_3 ±1.32x10'^ ±0.76x10-3 
(g/kg) 
kidney 4.1x10"^ 4.2x10'^ 4.3x10'^ 4.3x10"^ 4.1x10'^ 4.3x10"^ 
weight ±5.4x10-5 ±7.4x10-5 ±8.8x10"' i l6xlO_5 ±11x10"^ i l2xlO_5 
(g/kg) 
Treatment 2 
Parameter No Control TCE NAC NAC NAC 
treatment 1.25ml/kg 150 mg/kg 300 mg/kg 600 mg/kg 
liver 3.33x10-2 3.33xlO_2 3.33xlO_2 3.44xl0_2 3.29xl0_2 3.48xl0_2 
weight ±0.51x10-3 ±0.57x10"^ i0.67xl0_3 i0.92xl0_3 ±1.30x10"^ i l .04xl0_3 
(g/kg) 
kidney 4.1x10.3 4.2xlO_3 4.2xlO_3 4.1xl0.3 4.3xlQ-^ 4.3xlO_3 
weight ±3.6x10-5 ±5.3x10-5 ±8.3x10"' i lSxlO"^ i94x lO '^ ±5.1x10-5 
( _ 
Each value represents the meaniS.E.M. of 6 treated rats except no treatment and 
control groups which have 5 treated rats in each group. 
A l l values of liver and kidney weights in all treated groups were comparable with 
(p>0.05) the values of the toxin control and saline-vehicle control. 
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4.6 Hepatoprotective effect of methanol extract of seaweeds against CCl4- and 
TCE-induced poisoning in rats. 
4.6.1 The biochemical assays of the serum transaminase activity (Curative). 
Table 25: Effect of methanol extract of seaweeds on CCl4 and TCE-induced 
elevation of SGPT and SGOT activities in rats (Curative) 
(Fig. 4.66, Fig. 4.67, Fig. 4.68 & Fig. 4.69: p. 214, p. 215 p. 216 & p. 217 respectively) 
Treatment 1 
Parameter N o C o n t r o l CCl4 D M S O S#2 S#3 S#4 — 
treatment 1.25ml/kg 25% 300mg/kg 300mg/kg 300mg/kg 
SGPT 11 12 1235 1243 688.7 • 1288 492.4 -
(IU/L) ±0.9 ±1.0 ±116 士103 ±50.9* ±94.4 ±42.5** 
SGOT 51 54 2119 2226 1630 1682 904.8 -
(IU/L) ±0.8 ±1.9 ±89.0 ±100 ±186* ±69.2* ±101** 
Treatment 2 
P a r a m e t e r N o C o n t r o l TCE D M S O S#2 S#3 S#4 Gal 
treatment 1.25ml/kg 25% 300mg/kg 300mg/kg 300mg/kg 300mgy^g 
SGPT 11 12 15.78 14.87 14.04 10.52 9.990 11.52 
(IU/L) 土0.8 ±0.8 ±1.03 ±1.16 ±0.82 ±0.32** ±0.87** ±0.67* 
SGOT 53 51 153.0 140 89.41 82.18 111.7 107.8 
(IU/L) ±0.3 ±1.7 ±6.50 ±2.03 ±3.53** ±2.35** ±5.55* ±6.23** 
Each value represents the mean±S.E.M. of 5 treated rats 
* Significantly different when compared with the toxin control, p< 0.05. 
* * Significantly different when compared with the toxin control, p< 0.005. 
Key: S#2= Sargassum henslowianum-, S#3= Myagropsis myagro ides ; S#4= Sargassum si l iquastrum; 
Gal= Galaxaura sp. 
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4.4.4 The organ weight. (Preventive) 
Table 26: Effect of methanol extract of seaweeds on liver and kidney weights in CCl4 
and TCE-treated rats 
(Fig. 4.70, Fig. 4.71, Fig. 4.72 & Fig. 4.73: p. 218，p. 219 p. 220 & p. 221 respectively) 
Treatment 1 
Parameter N o Contro l CCl4 DMSO S#2 S#3 S#4 — 
treatment 1.25ml/kg 25% 300mg/kg 300mg/kg 300mg/kg 
l iver 3.33x10-2 3.33x10'^ 5.23x10.2 4.94x10"^ 4.94x10'^ 5.00x10"^ 5.01x10"^ — 
weight ±0.48x10-3 ±0.59x10-^  il.llxlO-3 ±1.16x10-3 ±1.06x10-3 ±1.53x10-3 +!.06xl0"^ 
(g/lg) 
kidney 4.0xlQ-^ 4.1xlQ-^ 4.5xlQ-^ 4.4xlQ-^ 4.4x10-3 4.6x10"^ 4.2xlQ-^ — 
weight ±6.1x10-5 ±7.1x10"^ ±8.2x10"' ±8.5x10"' i4 .3xl0' ' i7.8xl0'^ i5.8xlO"^ 
(g/kg) 
Treatment 2 
Parameter N o Contro l TCE DMSO S#2 S#3 S#4 Gal 
treatment 1.25ml/kg 25% 300mg/kg 300mg/kg 300mg/kg 300mg/kg 
l iver 3.30x10-2 3.30xl0'^ 3.34xl0"' 3.30xl0'2 3.22x10"^ 3.47x10.2 3.26xl0"^ 3.34xl0"^ 
we ight ±0.70x10-3 i0.66xl0'^ ±0.88x10-^ ±1.04x10—3 ±1.02x10-3 ±0.63x10-3 ±1.18x10-3 ±0.82x10-3 
(g/lg) 
kidney 42xlO"^ 4.3xl0"^ 4.2xlQ-^ 4.2x10-3 4.2xl0"^ 4.2xlQ-^ 4.1xl0"^ 4.2x10"^ 
we ight ±5.4x10-5 ±8.0x10"^ ±6.5x10' ±7.2x10.5 i9 .0xl0' ' i2_7xl0"' ±14x10'' ±10x10'' 
W ： 
Each value represents the mean±S.E.M. of 5 treated rats 
A l l values of liver and kidney weights in: 1. CCl4-treated groups were comparable 
with (p>0.05) the values of the toxin control; 2. TCE-treated groups were 
comparable with (p>0.05) the values of the toxin control and saline-vehicle control. 
Key: S # 2 = Sargassum henslowianum-, S#3= Myagropsis myagroides\ S#4= Sargassum siliquastrum-, 
Gal= Galaxaura sp. 
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4.7 Histopathological examinations. 
In order to quantify the results, a grading system was adopted (Portmann et al., 
1975). This grading system is based on the histological change of the liver, especially 
the extent of the damaged area around the central vein. The scheme is shown as 
follows: 
Main histological features Grade 
Normal, no change 0 
Swelling of liver cell nuclei, minor vacuolation, no necrosis. + 
Single cell necrosis in centrilobular hepatocytes ++ 
Confluent necrosis of centrilobular hepatocytes +++ 
Confluent necrosis in continuity between adjacent lobules ++++ 
Massive necrosis leaving rim of liver cells around portal tracts +++++ 
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4.7.1 Acute hepatotoxicity test on aqueous seaweed extracts. 
Light microscopy 
A l l sections revealed no special difference when compared with the 
vehicle-saline control or no treatment groups in the curative test (0). 
a. No treatment group (Fig. 4.74 to Fig. 4.76: p. 222 to p. 224) 
No any treatments were given, food and water fully accessible except food 
which was withdrawn approximately 18 h before experiment. No sign of 
abnormalities were noted (0). 
Well distributed of hepatocyte cords around the central vein with the clear 
shown of sinusoids were noted. The healthy liver cells with clear stained of nucleus 
and cytoplasm were also observed. 
b. Vehicle-saline group control, curative (Fig. 4.77 to Fig. 4.79: p.224 to p. 226) 
vehicle, corn oil and saline (0.9% v/v) were fed to the animals. No sign of 
abnormalities were noted (0). 
Well distributed ofhepatocyte cords around the central vein with the clear 
shown of sinusoids and sinusoidal cells were noted. The healthy liver cells with clear 
stained of nucleus and cytoplasm were also observed (no difference when compared 
with the no treatment group). 
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4.7.2 Curative and preventive tests of seaweed aqueous extracts against the 
CCI4-induced hepatotoxicity. 
Light microxcopy 
a. No treatment group (Refer to section 4.7.1) 
b. Vehicle-saline group control, curative (Refer to section 4.7.1) 
c. Toxin control, curative (Fig. 4.80 to Fig. 4.82: p. 228 to p. 230) 
CCl4 (1.25 ml/kg) and saline (0.9% v/v) were fed to the animals. Serious 
necrosis was noted (+++++). 
The liver showed hydropic swelling and massive necrosis of hepatocytes in the 
centrilobular area (cv) with fat accumulation. Massive centrilobular necrosis was 
extended to the portal tract, leaving a rim of cells appeared normal only. Swollen 
cells were identified by enlargement and the pale staining of cytoplasm (balloon cells) 
and necrotic cells were identified by pyknotic nuclei and ruptured plasma membrane. 
Cells containing lipid were identified by round droplets within the cytoplasm in high 
power micrograph (x293) . Liver vacuolization and serious sinusoidal congestion 
with the condensed nucleus were evidenced. Well distributed of hepatocyte cords 
around the central vein cannot be seen. 
d. CCl4 + aqueous extract ofS. henslowianum, curative. (Fig. 4.83 to Fig. 4.88: p. 
230 to p. 236) 
S. henslowianum (15 mg/ml sal ine� 
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CCU (1.25 ml/kg) was fed to the animals, followed by 10 ml/kg of aqueous 
seaweed extract orally, S. henslowianum (15 mg/ml saline). Serious necrosis was 
noted (+++++). 
The liver showed hydropic swelling and massive necrosis of hepatocytes in the 
centrilobular area with fat accumulation. Massive centrilobular necrosis was 
extended to the portal tract, leaving a rim of cells appeared normal only. Moreover, 
necrotic area was observed near the central vein. Swollen cells, pyknotic nuclei and 
ruptured plasma membrane were identified. Liver vacuolization and serious 
sinusoidal congestion with the condensed nucleus were evidenced in high power 
micrograph ( x 194). Well distributed of hepatocyte cords around the central vein 
cannot be seen. As a result, the S. henslowianum (15 mg/ml saline) extract exhibited 
the effect similar to the toxin control. 
S. henslowianum (60 mg/ml saline� 
CCl4 (1.25 ml/kg) was fed to the animals, followed by 10 ml/kg of aqueous 
seaweed extract orally, S. henslowianum (60 mg/ml saline), mild necrosis was noted 
(++). 
The liver showed hydropic swelling and a very little necrosis of hepatocytes in 
the centrilobular area with fat accumulation. Massive centrilobular necrosis was not 
noted. Moreover, a clear shown of necrotic area was not noted near to the central 
vein. Few amounts of swollen cells could be observed. In addition, a large range of 
regeneration zone around the central vein accompanied by the present of mitotic 
figures. Liver vacuolization and sinusoidal congestion were still evidenced in high 
power micrograph ( x 1 94). But, the condition was not as severe as toxin control. 
Well distributed of hepatocyte cords around the central vein could be seen close tu 
the central vein. As a result, the S. henslowianum (60 mg/ml saline) extract exhibited 
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excellent hepatoprotective effect to relieve the CCl4-induce hrepatotoxicity. 
e. CCl4 + aqueous extract of Myagropsis myagroides, curative. (Fig. 4.89 to Fig. 
4.93: p.236 to p. 240) 
Mva^ropsis mvagroides (15 mg/ml saline� 
CCl4 (1.25 ml/kg) was fed to the animals, followed by 10 ml/kg of aqueous 
seaweed extract orally, Myagropsis myagroides (15 mg/ml saline). Serious necrosis 
was"noted (+++++). 
The liver showed hydropic swelling and massive necrosis of hepatocytes in the 
centrilobular area with fat accumulation. Massive centrilobular necrosis was 
extended to the portal tract, leaving a rim of cells appeared normal only. Moreover, 
necrotic area was observed near to the central vein. Swollen cells, pyknotic nuclei 
and ruptured plasma membrane were identified. Liver vacuolization and serious 
sinusoidal congestion with the condensed nucleus were evidenced in high power 
micrograph (x297) . Moreover, well distributed of hepatocyte cords around the 
central vein cannot be seen. As a result, the Myagropsis myagroides (15 mg/ml saline) 
extract exhibited the effect similar to the toxin control and S. henslowianum (15 
mg/ml saline) extract. 
In the Myagropsis myagroides (15 mg/ml saline) extract-treated rat's liver 
section selected. The evidence of regeneration zone appeared to increasing as 
compared with the 15 mg/ml saline-treated one. 
Mvagropsis mva^roides (60 mg/ml saline� 
CCl4 (1.25 ml/kg) was fed to the animals, followed by 10 ml/kg of aqueous 
seaweed extract orally, Myagropsis myagroides (60 mg/ml saline), mild necrosis was 
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noted (between ++ and +++). 
The liver showed hydropic swelling and a few necrosis of hepatocytes in the 
centrilobular area with fat accumulation. Massive centrilobular necrosis was not 
being noted. Moreover, a clear shown of necrotic area was being noted near to the 
central vein. However, the condition was less severe than 15 mg/ml saline one. A 
number of swollen cells could be observed. In addition, a large range of regeneration 
zone around the central vein accompanied by the present of mitotic figures. Liver 
vacuolization and sinusoidal congestion were still evidenced in high power 
micrograph ( x 194). But, the condition was not as severe as toxin control. Well 
distributed of hepatocyte cords around the central vein could not be seen close to the 
central vein. As a result, the Myagropsis myagroides (60 mg/ml saline) extract 
exhibited a good hepatoprotective effect to relieve the CCl4-induce hrepatotoxicity. 
And it was not as good as S. henslowianum (60 mg/ml saline) extract. 
f. CCl4 + aqueous extract of S. siliquastrum, curative. (Fig. 4.94 to Fig. 4.97: p. 
242 to p. 244) 
S. siliquastrum (15 mg/ml saline) 
CCl4 (1.25 ml/kg) was fed to the animals, followed by 10 ml/kg of aqueous 
seaweed extract orally, S. siliquastrum (15 mg/ml saline). Serious necrosis was noted 
(+++++). 
The liver showed hydropic swelling and massive necrosis of hepatocytes in the 
centrilobular area with fat accumulation. Massive centrilobular necrosis was 
extended to the portal tract, leaving a rim of cells appeared normal only. Moreover, 
necrotic area was observed near to the central vein. Swollen cells, pyknotic nuclei 
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and ruptured plasma membrane were identified. Liver vacuolization and serious 
sinusoidal congestion with the condensed nucleus were evidenced in high power 
micrograph (x297). Moreover, well distributed of hepatocyte cords around the 
central vein cannot be seen. As a result, the S. siliquastrum (15 mg/ml saline) extract 
exhibited the effect similar to the toxin control, S. henslowianum and Myagropsis 
myagroides (15 mg/ml saline) extracts. 
S. siliquastrum (60 mg/ml saline、 
CCl4 (1.25 ml/kg) was fed to the animals, followed by 10 ml/kg of aqueous 
seaweed extract orally, S. siliquastrum (60 mg/ml saline). Necrosis was noted 
(++++). 
The liver showed hydropic swelling and a moderate necrosis of hepatocytes in 
the centrilobular area with fat accumulation. Massive centrilobular necrosis was not 
being noted. Moreover, a clear shown of necrotic area was being noted near to the 
central vein. However, the condition was less severe than 15 mg/ml saline one. A 
number of swollen cells could be observed. In addition, a large range of regeneration 
zone around the central vein accompanied by the present of mitotic figures.. But, the 
condition was not as good as the same dosages of the other two seaweed extracts. 
Well distributed of hepatocyte cords around the central vein could not be seen close 
to the central vein. As a result, the S. siliquastrum (60 mg/ml saline) extract exhibited 
fair hepatoprotective effect to relieve the CCl4-induce hepatotoxicity. And it was not 
as good as S. henslowianum and Myagropsis myagroides (60 mg/ml saline) extract. 
Light microscopy of H & E-stained kidney sections taken at 24 h after CCl4 
administration to toxin control rats, vehicle-saline control and all other treatments 
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rats whatever curative or preventive, did not reveal any significant morphological 
alterations (Fig. 4.98 & Fig. 4.99: p. 246). A l l treatment shown revealed no 
difference when compared with the vehicle-saline control. 
g. Toxin control, preventive. (Fig. 4.100 & Fig. 4.101: p. 248) 
CCl4 (1.25 ml/kg) and saline (0.9% v/v) were fed to the animals. Serious 
necrosis was noted (+++++). The result is similar to the toxin control in curative one. 
h. CCl4 + aqueous extracts, preventive. (Fig. 4.102 & Fig. 4.103: p. 250) 
CCl4 (1.25 ml/kg) and saline (0.9% v/v) were fed to the animals before the 10 
ml/kg of aqueous seaweed extract orally. Serious necrosis was noted (+++++) in all 
sections. 
A l l aqueous seaweed extracts treatment exhibited the effect similar to the toxin 
control in preventive test. Even the most effective of S. henslowianum extract (60 
mg/ml saline) in curative test still revealed the extensive necrosis of hepatocytes 
around the central vein region in the preventive test. And the S. siliquastrum extract 
(60 mg/ml saline) exhibited the similar effect to the S. henslowianum extract (60 
mg/ml saline) one. So, all treatment shown revealed no signs of hepatoprotective 
effect. 
SEM microscopy (Fig. 4.104 to Fig. 4.107: p. 252 to p. 254) 
a. Vehicle-saline group control, curative. 
Vehicle, corn oil and saline (0.9% v/v) were fed to the animals. No signs of 
abnormalities were noted. 
Normal hepatocytes cords linings with clear shown of normal nuclei and 
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sinusoids could be seen, 
b. Toxin control, curative. 
CCl4 (1.25 ml/kg) and saline (0.9% v/v) were fed to the animals. Serious 
necrosis was noted with clear shown of necrotic cell and group of vacuolization close 
around the central vein. That damage features could be seen clearly in high power 
micrographs (Fig. 4.106 & Fig. 4.107: p. 254). 
TEM microscopy (Fig. 4.108 to Fig. 4.111: p. 256 to p. 258) 
a. Vehicle-saline group control, curative. 
vehicle, corn oil and saline (0.9% v/v) were fed to the animals. No signs of 
abnormalities were noted. 
TEM observations of vehicle-saline control revealed no sign of alteration in the 
ultrastructure of the hepatocytes. Clear shown of mitochondria and rough 
endoplasmic reticulum (rER) etc. expressed the sign ofhealthy stage. 
b. Toxin control, curative (Fig. 4.112 to Fig. 4.116: p. 260 to p. 264) 
CCl4 (1.25 ml/kg) and saline (0.9% v/v) were fed to the animals. Serious 
necrosis was noted. 
TEM observations of toxin control revealed serious sign of alteration in the 
ultrastructure of the hepatocytes. The increase of intracellular lipid and the swollen 
of mitochondria and rough endoplasmic reticulum could be seen clear in all 
magnifications. The early and final stages of injury could be seen clearly by the 
reveal of the swollen of mitochondria and necrotic cell respectively. In the highest 
magnification, the swollen mitochondria, with roughly granular appearance and lipid 
droplet; the dilation and fragmentation of the rER, could be seen. 
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4.7.3 Acute hepatotoxicity test ofTCE in rats by oral and intraperitoneal routes 
(Fig. 4.117 to Fig. 4.125: p. 266 to p. 274) 
Al l liver sections exhibited no abnormality when compared with the 
vehicle-saline control. Even the effective dose of TCE (20% TCE, 1.25 ml/kg) also 
revealed no special difference when compared with the vehicle-saline control (0). 
Light microscopy of H & E-stained kidney sections taken at 24 h after 20% 
TCE effective administration to toxin control rats, did not reveal any significant 
morphological alterations in oral or i.p. routes except 30% TCE in i.p. route one, 
showing abnormal kidney cells. Actually, there was no necrosis in the renal cortex. 
Moreover, no reveal of morphological change in glomerulus. However, distal and 
proximal tubules dilation together with the cell debris could be seen clearly in the 
low and medium power micrographs (Fig. 4.120 & Fig. 4.121: p. 270). In addition, 
cell debris and detachment of brush border could also be observed in the proximal 
tubules from the high power micrographs (Fig. 4.122 & Fig. 4.123: p. 272). 
SEM microscopy (Fig. 4.124 & Fig. 4.125: p. 274) 
In the 20% TCE effective dose treatment. No reveal of abnormality could be 
seen in the liver SEM liver sections. Clear shown of hepatocytes, sinusoids and 
normal nucleus could be seen. There was no difference when compared with the 
vehicle-saline control in curative test. 
TEM microscopy (Fig. 126 & Fig. 129: p. 276 & p. 278) 
TEM observations of 20% TCE effective dose revealed no special sign of 
alteration in the ultrastructure of the hepatocytes. Clear shown of mitochondria and 
rER and other organelles could be seen clearly. However, the increase number of 
99 
vacuoles were observed in certain areas (Fig. 4.127: p. 276). Moreover, in the 
highest magnification, no sign of abnormality was seen in the mitochondria. 
However, swollen rER could be seen clearly. 
4.7.4 Curative and preventive tests of seaweed aqueous extracts against the TCE 
effective dose-induced toxicity. 
Based on the result of light microscopy from section 4.7.3. aqueous seaweed 
extracts treatment at the highest dosage (60 mg/ml saline) were selected to study in 
light microcopy (liver and kidney sections). No reveal of abnormality could be seen. 
And the result drawn from the study is no special difference when compared with the 
vehicle-saline control group (Liver sections: (0)). 
4.7.5 Antidotal effects of dimethyl sulfoxide (DMSO) and N-acetylcysteine (NAC) 
against CCl4- and TCE-induced poisoning in rats. 
Light microscopy 
a. CCl4 + DMSO, curative. (Fig. 4.130 to Fig. 4.132: p. 280 to p. 282) 
DMSO 25% in saline 
CCl4 (1.25 ml/kg) was fed to the animals, followed by 10 ml/kg o fDMSO 25% 
orally. Serious necrosis was noted (+++++). 
The liver shown exhibited the morphological changes similar to the toxin 
control. The massive necrosis closed to the central vein, necrotic cells, swollen cells 
and vacuolization could all be seen close around the central vein. 
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DMSO 75% in saline 
CCl4 (1.25 ml/kg) was fed to the animals, followed by DMSO 75% orally, 
moderate necrosis was noted (+++). 
The liver showed hydropic swelling and a moderate necrosis of hepatocytes in 
the centrilobular area with fat accumulation. Massive centrilobular necrosis was not 
being noted. However, a clear shown of necrotic area was noted near to the central 
vein. Few amount of swollen cells could be observed. In addition, a large range of 
regeneration zone around the central vein accompanied by the present of mitotic 
figures. Liver vacuolization and sinusoidal congestion were still evidenced in high 
power micrograph ( x 1 94). But, the condition was not as severe as toxin control. 
Well distributed of hepatocyte cords around the central vein could be seen close to 
the central vein. As a result, the DMSO 75% dosage exhibited a good 
hepatoprotective effect to relieve the CCl4-induce hrepatotoxicity. 
b. CCl4 + NAC, curative. (Fig. 4.133 to Fig. 4.139: p. 282 to p. 288) 
NAC (15 mg/ml saline) 
CCl4 (1.25 ml/kg) was fed to the animals, followed by 10 ml/kg of NAC (15 
mg/ml saline) orally. Serious necrosis was noted (+++++). 
The liver shown exhibited the morphological changes similar to the toxin 
control. The massive necrosis closed to the central vein, necrotic cells, swollen cells 
and vacuolization could all be seen close around the central vein. 
In NAC (30 mg/ml saline) treatment, the sign of regeneration can be seen as the 
result of increase the area of regeneration zone (Fig. 4.136: p. 286). 
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NAC (60 mg/ml saline) 
CCl4 (1.25 ml/kg) was fed to the animals, followed by NAC (60 mg/ml saline) 
orally, moderate necrosis was noted (++). 
The liver showed hydropic swelling and a mild necrosis of hepatocytes in the 
centrilobular area with fat accumulation. Massive centrilobular necrosis was not 
being noted. Although a clear shown of necrotic area was noted, it was only in a mild 
condition. Few amount of swollen cells could be observed. In addition, a large range 
of regeneration zone around the central vein accompanied by the present of mitotic 
figures. Liver vacuolization and sinusoidal congestion were still evidenced in high 
power micrograph ( x297). But, the condition was not as severe as toxin control. As 
a result, the NAC (15 mg/ml saline) dosage exhibited excellent hepatoprotective 
effect to relieve the CCl4-induce hrepatotoxicity. 
The DMSO and NAC treatment in CCl4, preventive test, showed massive 
necrosis around the central vein (+++++). The results were similar to the toxin 
control group (curative or preventive). Besides, no morphological change could be 
seen in the renal cortex ofkidney sections. 
The DMSO and NAC treatment in TCE, curative or preventive, all showed no 
morphological difference in liver and kidney sections when compared with the 
vehicle-saline control (Liver sections: (0)). 
4.7.6 Hepatoprotective effect of methanol extract of seaweeds against CCl4- and 
TCE-induced poisoning in rats. 
a. Toxin control, curative 
102 
CCU (1.25 ml/kg) and saline (0.9% v/v) were fed to the animals. Serious 
necrosis was noted (+++++). 
The result of morphological changes in this toxin group was similar to the toxin 
control group (Fig. 4.80 to Fig. 4.82: p. 228 to p. 230). 
b. CCI4 + methanol extract of S. henslowianum, curative (Fig. 4.140 & Fig. 4.141: 
p. 290) 
S. henslowianum (30 mg/ml 25% DMSO) 
CCl4 (1.25 ml/kg) was fed to the animals, followed by 10 ml/kg of aqueous 
seaweed extract orally, S. henslowianum (30 mg/ml 25% DMSO). Moderate necrosis 
was noted (+++). 
The liver showed hydropic swelling and moderate necrosis of hepatocytes in the 
centrilobular area. Massive centrilobular necrosis was not noted. Necrotic area was 
observed quite far away to the central vein. Swollen cells and ruptured plasma 
membrane were identified. Slightly liver vacuolization and was evidenced in high 
power micrograph ( x 194). Although well distributed ofhepatocyte cords around the 
central vein cannot be seen, a large range of regeneration zone around the central 
vein accompanied by the present of mitotic figures. As a result, the S. henslowianum 
extract (15 mg/ml 25% DMSO) exhibited certain effect to act against the 
CCl4-induced hepatotoxicity. 
Mva^ropsis mva2r0ides (30 mg/ml 25% DMSO^ (Fig. 4.142 & Fig. 4.143: p. 292) 
CCl4 (1.25 ml/kg) was fed to the animals, followed by 10 ml/kg of methanol 
seaweed extract orally, M. myagroides (30 mg/ml 25% DMSO). Serious necrosis 
103 
was noted (between +++ and ++++). 
The liver showed hydropic swelling and massive necrosis of hepatocytes in the 
centrilobular area with fat accumulation. Moreover, necrotic area was observed 
near to the central vein. Swollen cells and ruptured plasma membrane were identified. 
Liver vacuolization and serious sinusoidal congestion were evidenced in high power 
micrograph ( x l 8 8 ) . Moreover, well distributed of hepatocyte cords around the 
central vein cannot be seen. The necrotic cells were close to the central vein. 
However, a mitotic figure was identified to indicate the liver cells may have certain 
degree or regeneration. As a result, the Myagropsis myagroides (30 mg/ml 25% 
DMSO) extract exhibited the least or no hepatoprotective effect to the CCl4-induced 
hepatotoxicity. 
S. siliauastrum GO mg/ml 25% DMSO�(Fig. 4.144 & Fig. 4.145: p. 294) 
CCl4 (1.25 ml/kg) was fed to the animals, followed by 10 ml/kg of aqueouj 
seaweed extract orally, S. siliquastrum (30 mg/ml 25% DMSO). Mi ld necrosis was 
noted (between ++ and +++). 
The liver showed hydropic swelling and a few necrosis of hepatocytes in the 
centrilobular area with fat accumulation. Massive centrilobular necrosis was not 
being noted. Moreover, a clear shown of necrotic area was not being noted. Few 
amount of swollen cells could be observed. In addition, a large range of regeneration 
zone around the central vein accompanied by the present of mitotic figures could be 
observed. Liver vacuolization and sinusoidal congestion were still evidenced in high 
power micrograph ( x 1 92). But, the condition was not as severe as toxin control. 
Although well distributed of hepatocyte cords around the central vein could not be 
seen close to the central vein, the potential of recovery could be seen by the increase 
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number of mitotic figures mentioned above. As a result, the S. siliquastrum (30 
mg/ml 25% DMSO) extract exhibited very good hepatoprotective effect to relieve 
the CCl4-induce hepatotoxicity as compared with the other two methanol extracts of 
seaweed. 
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Chapter 5 DISCUSSION 
Acute hepatotoxicity test on aqueous seaweed extracts 
Determination of serum activities of hepatic enzymes released from the injured 
liver has become one of the useful experimental tools in evaluation of hepatotoxicity 
(Plaa & Hewitt，1982). Moreover, the increase in the activities ofSGPT and SGOT is 
considered as a reliable index of liver damage (Wang et al., 1996). In the present 
study, the preliminary tests of the possible hepatotoxicity of aqueous extract 
seaweeds were done. The result from biochemical analyses and histopathological 
examinations showed that all aqueous seaweed extracts in different dosages would 
not cause any biochemical and histopathological change in both liver and kidney of 
the rats. As a result, all aqueous extracts used in the present study by oral 
administration may be assumed to have no hepatotoxic or nephrotoxic effects in rats 
at the range of dosages used. 
Curative and preventive tests of seaweed aqueous extracts against the 
CCI4-induced hepatotoxicity. 
CCl4 is commonly used as a toxin model to evaluate hepatotoxicity (Plaa & 
Hewitt, 1982). When the liver is injured as a result of the introduction of infectious 
agents or chemicals, the serum levels of SGPT and SGOT are raised significantly, 
accompanied with the increase in weight o f both liver and kidney (Kluwe, 1981; 
Iglesia et al., 1982). The increase in SGPT and SGOT levels have been attributed to 
damage to the structural integrity o f the liver (Chenoweth & Hake, 1962). They may 
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be released from the cytoplasm into the blood circulation rapidly after rupture of the 
plasma membrane and cellular damage (Sallie et al., 1991). At a suitable dosage, 
CCl4 causes extensive necrosis in the liver centrilobular regions around the central 
veins (Slater, 1966). The mechanism of CCl4 hepatotoxicity is considered to be the 
result from activation of CCl4 by cytochrome P-450 system in the hepatocyte's 
endoplasmic reticulum to the reactive metabolite, CCl3 •, which can form covalent 
products with macromolecules and lipid and interact with O2 to generate CCl3O2 
which in turn initiates lipid peroxidation of membrane lipids and the endoplasmic 
reticulum rich in polyunsaturated fatty acids (Slater, 1966; Recknagel, 1967; 
Klaassen & Plaa，1969; Packer et al., 1978; Gilani & Janbaz，1995a，b and c; Jazbaz 
& Gilani, 1995;)，causing the disintegration of lysosomal, mitochondrial and cellular 
membranes and leading finally to cell necrosis (Slater, 1972; Recknagel et al., 1982). 
After administration of a single dosage of CCl4 given by gavage, the centrilobular 
necrosis begins to develop with evidence of the lesion by 12 h and full-blown 
necrosis by 24 h. The liver may be restored to normal within 14 days with the 
removal of the residues of necrotic tissue (Smuckler, 1975). As a result, the 24 hours 
period is well adopted as a toxicity end-point. 
In the present investigation, there are considerable increases in the serum levels 
of SGPT and SGOT in toxin control rats, which are significantly different from those 
of both the vehicle-saline control group and no treatment group. This in tum 
indicated that there was damage of the organ to which the enzymes are specific. 
Moreover, the liver and kidney weights also increase significantly after the 
application suitable dosage (1.25 ml/kg) of 20% CCl4 applied. 
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The hepatotoxicity in biochemical analysis could be compared with that of the 
histopathological studies. Histopathological studies further provide detailed 
information about the degree of hepatic lesion. In the light microscopy observations, 
acute liver damage induced by CCl4 in the toxin control group can be illustrated by 
the presence of massive centrilobular necrosis around the central veins, ballooning 
degeneration and cellular infiltration as well as fat accumulation of the liver. The 
massive centrilobular necrosis is extended to the portal tract, leaving a rim of cells 
appeared normal only. These results can be seen in both curative and preventative 
tests. Thus, the CCl4 applied could cause the acute injury of liver biochemically and 
histologically. In SEM observations, the three dimensional structure of rat liver can 
be seen (Gaudio et al., 1993). The presence of necrotic cells and groups of 
vacuolization were clearly seen on the liver fracture. The normal nucleus and well 
distributed of hepatocyte cords with clear pattem of sinusoids cannot be noted when 
compared with SEM samples of the vehicle-saline control group. In TEM 
observations, it can yield clues to the mechanisms of hepatotoxicity by studying the 
structural changes and rate of its development induced by toxic agents (Zimmerman, 
1982). The TEM micrographs shown could illustrate the rate of CCl4 toxicity 
development (Figs. 4.112 to 4.116: p. 260 to p. 264). The increase of intracellular 
lipids; mitochondrial swelling, dilation; swelling and fragmentation of rough 
endoplasmic reticulum as well as the necrosis of the whole cell unit could be elicited 
by CCl4-induced hepatotoxicity. As reported previously, CCl4 can induce fatty liver 
associated with fat accumulation (Reynolds, 1963). The probable sites of extraneous 
free radical formation are the mitochondria and the endoplasmic reticulum initially 
(Slater, 1966). However, mitochondrial swelling has been described in the early 
stage of CCl4 intoxication (Recknagel & Malamed, 1956), though a structure 
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bounded by a single lipoprotein membrane (endoplasmic reticulum) would be far 
more sensitive to damage induced by free radical attack than a double-layered 
membrane as in the mitochondria (Slater, 1966). In addition, changes of 
mitochondria can reveal the rate of mechanism of CCl4 toxicity by its effect on (1) 
mitochondrial membrane, which either disrupts or else simply fuses to become single, 
though unbroken; (2) the cristae, which break up into granulation and disappear; (3) 
the matrix, which assumes a roughly granular or filamentous appearance and the 
final phase of mitochondrial transformations into lipid droplets in hepatic cell 
(Rouiller, 1964). The liver sections of vehicle-saline control group showed a normal 
cell pattern of hepatocyte cords with well-shown of sinusoids and normal nucleus in 
SEM. Moreover, the clear fine structure of normal organelles inside the cells can also 
be revealed by TEM. The biochemical and histopathological studies aim to 
successfully interpret the mechanisms culminating in necrosis (Slater, 1966). As a 
result, the detection of early damage from measurement of enzyme levels of serum in 
the biochemical tests can fully complement with the histopathological examinations 
in light microscopy, SEM and TEM, which show the acute elevated levels of SGPT 
and SGOT accompanied with a severe centrilobular necrosis and fatty degeneration 
of liver after the administration of a suitable dosage (1.25 ml/kg) of 20% CCl4 to rats 
(Slater, 1966). The present results in the acute CCl4-induced hepatic injuries could be 
used as a model for the screening ofhepatoprotective agents (Plaa & Hewitt, 1982). 
Of the three species of seaweeds under study, the aqueous extracts of S. 
henslowianum and M. myagroides administered at all three dosages (150 mg/kg, 300 
mg/kg and 600 mg/kg saline) exhibited significant hepatoprotection against 
CCl4-induced liver injury in rats by reducing the acute increase of SGPT and SGOT 
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levels. S. siliquastrum also showed significantly hepatoprotective effect but only at 
the higher dosages. Of these three seaweed species, S. henslowianum appeared to be 
the most effective and promising in the histopathological examination to show the 
least necrosis when compared with S. siliquastrum. However, little necrotic cells 
could still be found far away from the central vein. The similar curative effects of 
that extracts could also be seen to treat against the CCl4-induced enlargement of the 
liver weights. Nevertheless, the significantly reduced of kidney weight could be seen 
only when the highest dosage of S. henslowianum extract was applied. According to 
the histopathological study of the kidney sections, although there was a significant 
increase of kidney weight in the toxin control group, histopathological changes in the 
sections were not detected. It is probably due to the reason that many common strains 
of laboratory rats are relatively resistant to acute nephrotoxic effects of CCl4 and the 
reason is still unclear (Striker et al., 1968; Kluwe, 1982; Elfarra, 1993). Therefore, 
the liver could well be illustrated to be the main target site of CCl4-induced toxicity 
in this test. 
Based on the preventive test of the aqueous extracts on CCl4 hepatotoxicity, 
there was significant decrease in the serum levels of SGPT in rats treated with M. 
myagroides extracts in three different dosages. However, no significant difference 
can be seen in their SGOT levels. It indicated that M. myagroides offered a 
significant hepatoprotection to prevent the acute elevation of SGPT. As SGPT is 
specific in the liver, the aqueous extracts of M. myagroides may exhibit a good effect 
in preventive purpose. The same result can also be seen in the effects to reduce the 
acute increase in weights of liver and kidney. Nevertheless, the massive necrosis 
could still be found in the histopathological examination of the liver in all treatments 
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even in the most effective one, S. henslowianum (60 mg/ml saline). Therefore, 
preventive effects of seaweed extracts were not good enough to protect the liver 
against the acute CCl4-induced hepatotoxicity. Assumably, the aqueous extracts of 
seaweeds in the preventive test may not exhibit the protective effect to preserve the 
structural integrity of the hepatocellular membrane against CCl4. Besides, the result 
of SGPT levels and liver weight analysis of S. siliquastrum indicated it had the leasi 
effect in preventing the acute CCl4-induced hepatotoxicity. Based on the result of 
SGPT level at dosage of 600 mg/kg saline, it probably exerted a certain degree of 
adverse effect to the liver in this stage, as a significant difference was shown in 
SGPT level which was higher than that of the toxin control. Owing to the fact that 
SGPT is more specific in the liver, the increase of this enzyme levels may attribute to 
the damage of liver cells. Furthermore, the effect of S. siliquastrum extract exhibited 
only a little or no hepatoprotctive effect in the enzyme assays and histopathological 
examination throughout the curative and preventive test against CCl4-induced 
hepatotoxicity. Therefore, it may be regarded as a negative control. The significant 
raise in SGPT in the preventative test may be attributed to some experimental 
adverse condition. 
The hepatoprotective effects of seaweed in preventive mode was not as good as 
those in the curative mode. The main possible reason may be due to the aqueous 
nature of the extract of seaweeds. They may be absorbed and excreted easily from 
the rat. Besides, the dosage applied to the rats in preventive mode was given 6 hours 
before the toxin treatment. Most or all of the potential active compound(s) may be 
excreted out from the body through urination or other biochemical mechanisms. The 
residues inside the body may not exert a significant protective effect to relieve the 
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CCU-induced heaptotoxicity. Some preventive studies performed require the 
experimental animals to receive several doses of potential antidote for about 3 
consecutive days before toxin treatment (Montilla et al., 1990; Gilani & Janbaz， 
1995b). 
The aqueous seaweed extracts ( M myagroides, S. henslowianum and S. 
siliquastrum) probably acted to preserve the structural integrity of the plasma cellular 
membrane of the hepatocytes to protect it from breakage by the reactive metab0lite3 
produced. S. henslowianum appears to have the best overall curative action, followed 
by M. myagroides and S. siliquastrum. Furthermore, the hepatoprotective activity of 
the extracts is also possibly due to their antioxidant properties; acting as scavengers 
of free radicals such as superoxide and alkoxy radicals (Ooi, 1996). The curative 
action on hepatic injury by the crude seaweed extracts may have been due to the 
presence of some active components which can protect the liver against liver plasma 
membrane alteration or promote cellular mitosis action for the repair of the liver cells. 
Some of these may involve active binding sites as indicated by the saturation of their 
effects with higher concentration of seaweed extracts. 
TCE toxicity test 
In the TCE toxicity test, TCE administered in a single or twice oral dosage 
(40% of TCE) exhibited the significant effects in all tested parameters. Although the 
biochemical analysis and organ weights of both liver and kidney also showed that 
there were abnormalities when given certain percentages of TCE, no 
histopathological changes in both liver and kidney sections at those dosages or even 
1 1 2 
in other dosages were observed. Therefore, it indicated that the main target site of 
TCE might not be the liver or kidney at those dosages. Threshold limit of mortality is 
around 40% TCE or above. 
Based on the TCE toxicity test by i.p. route, the induction of toxicity became 
more prominent. From 20% TCE onwards, the significant elevated levels of SGPT 
and SGOT were clearly shown. The values of enzyme levels increased i f the 
percentage of TCE increased. Dose-response relationship could roughly be achieved. 
However, this relationship would not be obtained from 30% to 40% TCE 
administration as the SGPT and SGOT elevation appeared to have a trend to level off. 
It might be due to the approach of the maximum tolerance point (threshold) around 
the 40% of TCE. Treated animals died when the threshold was reached or beyond. 
The significant change in kidney weight was noted when 40% of TCE was applied. 
Besides, the presence of significant histopathological changes in kidney cortex could 
also be detected from the 30% TCE onwards. The renal injuries consisted of the 
degeneration and dilation of the convoluted tubules (proximal and distal tubules) 
with the plugging of cellular debris in the lumen. However, conspicuous difference 
in the liver structure or liver weight was observed in all toxin treatments when 
compared with the vehicle-saline control group. As a result, the liver might not be 
the main target site for the TCE toxicity in i.p. route. Based on the analysis of SGPT 
and SGOT levels, the elevation of these enzymes indicated that the toxicity was 
generated from the liver, especially the levels of SGPT which is specific in the liver. 
However, no significant effect was found as analysed on histopathological data and 
liver weight. In addition, although there was no significant change in kidney weight 
after these TCE treatment, significant toxicological effect in the kidney proximal and 
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distal tubules accompanied with the decrease in the kidney weight were found in 
30% TCE treatment group. It indicated that the kidney may be the target sites prior to 
the liver at this dosage. This is in agreement with some research that has indicated 
little or no hepatotoxic effects following TCE exposure (Waters, 1977). Moreover, it 
was reported that the induction of liver lesion and transaminase activities could only 
be achieved after the pretreatment of phenobarbital (Allemand et al., 1978; Rouisse 
& Chakrabarti, 1996). According to the result ofAl lemand et al. (1978)，TCE itself 
does not bind to proteins. However, phenobarbital-pretreated rats causes the covalent 
binding of a chemically reactive metabolite of TCE to hepatic proteins of the liver 
tissue where it is formed by a cytochrome P-450-dependent reaction. The 
cytochrome P-450 isozymes such as CYP2E1, involve effectively in the TCE 
biotransformation (Hanioka et al., 1997). As a result, cell necrosis may be due to the 
formation of reactive metabolite(s). Hepatic glutathione decreases after TCE 
administration to the non-pretreated rats, and it has been suggested that TCE may be 
metabolized into a glutathione conjugate (Reynold et al., 1975). Based on in vitro 
test, the addition of glutathione to the incubation mixture decreases the amount of 
TCE metabolite bound to microsomal proteins (Allemand et al., 1978). It was that 
proposed a chemically reactive metabolite(s) formed by cytochrome P-450, 
trichloroethylene epoxide, which reacts with and binds to either proteins or 
glutathione to cause the toxicity. 
In the present TCE toxicity study by oral and i.p, route, it may be further 
concluded that the reactive metabolite formed: 1) may not be adequate enough to 
cause the necrosis by binding to proteins, or 2) may prefer binding with glutathione. 
As one type of nephrotoxic glutathione S-conjugates is exemplified by the conjugates 
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of TCE (Elfarra, 1993). The nephrotoxicity seen in rats appears to attribute to a 
second minor pathway involving glutathione conjugation of TCE (Green et al., 1997). 
The S-( 1,2-dichlorovinyl)-L-cysteine (DCVC) and S-( 1,2-dichlorovinyl)glutathione 
(DCVG) formed in vivo from that pathway are extremely low in rats and appears 
relatively insignificant when compared to the concentration of S-conjugates formed 
in vivo by other nephrotoxic haloalkenes such as dichloroacetylene (Dekant et al., 
1990; Green et al., 1997). As a result, the metabolic formation o fDCVC and DCVG 
from TCE in rats may readily explain the acute nephrotoxicity observed after high 
dosages o fTCE applied (Dekant et al., 1990). The nephrotoxicity of these conjugates 
requires cleavage of the corresponding cysteine conjugates by cysteine conjugate 
P-lyase to generate reactive thiols which are believed to be the proximate or ultimate 
toxic species (Elfarra, 1984). Therefore, the nephrotoxicity of TCE found in certain 
dosages by i.p. route may attribute to the conjugation ofTCE. Owing to the reason of 
minor pathway and extremely low concentration of conjugates formed. The 
significant nephrotoxicity generated could be observed only in higher dosages by i.p. 
(1.25 ml/kg of 30% TCE or higher). According to some related experiments, TCE 
may cause death of rats i f a threshold is reached. Beyond this threshold injury 
progresses, culminating in organ failure and animal death as the final stage 
(Mangipudy et al., 1995; Rao et al., 1997; Soni et al., 1998). 
In addition, the effective dose of TCE by i.p. route which could generate 
significant elevation of SGPT and SGOT with no mortality of tested animals, was 
more prominent than via oral administraion. It was probably due to the toxic agents 
administered by i.p. route generally elicited greater effect and produced more rapia 
response than by oral route (Klaassen & Eaton, 1991). Therefore, it may also be used 
as a toxin model for the evaluation of protective effects of potential antidotes in this 
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research like CCl4 for the screening of possible protective agents. 
In the histopathological examination, light microscopy and SEM revealed that 
the effective dose of TCE administration exhibited no damage on both liver and 
kidney sections in rats. However, in the TEM, all organelles appeared normal except 
lipid droplets, which seemed to have increased a little bit. In addition, one important 
finding noted was the dilation of rER. As ER is also involved in lipid metabolism 
(Miyai, 1991)，the increase of lipid droplets may attribute to the effect of lipid 
metabolism in rER. As a result, this finding may further conclude that the liver may 
not be the main target site of TCE toxicity like CCl4. However, the liver may be 
affected by TCE to cause minor damage to hepatocytes. It caused a little bit increase 
in SGPT levels. As a raised activity of SGOT may be due to liver disease, 
myocardial disease, skeletal muscle disease, renal infarction, haemolysis or 
hypothyroidism. Based on the present study, the reason for elevation of SGOT may 
primarily due to the damage of kidney at this point. However, it is still too 
preliminary to explain whether the actual main target site(s) is/are existed. 
Time course study in effective dose of TCE 
According to the time course study, the effective dose of TCE causes the 
significant raise of SGPT and SGOT levels around 6 to 12 hours. The peak value of 
SGPT and SGOT were seen at 6 hours and 12 hours respectively. Based on this study, 
both enzyme values seem to have a trend to return back to normal. As SGPT value of 
TCE treated group could retum to normal state at 27 hours later, SGOT value 
remained slightly higher than that ofthe vehicle-saline group even at 102 hours later. 
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However, based on light microscopy, there was no significant pathological change in 
the sections of liver and kidney in the whole time course. This is probably because 
the toxicity is expressed only after the capacity to detoxify the chemical of the body 
has been exceeded (Rouisse & Chakrabarti，1986). As a result, this study can further 
conclude that liver and kidney might not be the main target site of TCE because 
conspicuous enzymes elevation which exceeds the body detoxification system could 
not cause any significant damage to the organ structure though the significant change 
in the organs weight at 6 hours after treatment. Especially in the liver, TCE only 
generated a minor damage to the liver, because the liver is an organ with high power 
of regeneration (Smuckler, 1975). Thus, SGPT level may retum to normal state after 
certain period. Besides liver and kidney, other organs may be the target sites for TCE 
to generate acute toxicity. 
Curative and preventive tests of seaweed aqueous extracts against the TCE 
effective dose-induced toxicity. 
In this curative test, of the four species of seaweeds under study, aqueous 
extracts of S. henslowianum and M myagroides administered at all three dosages 
(150 mg/kg, 300 mg/kg and 600 mg/kg) exhibited significant protection against 
TCE-induced injury in rats by reducing the acute increase of SGPT and SGOT levels. 
The extract of S. siliquastrum also exerted a significant hepatoprotective effect but 
only at the higher dosages (300 mg/kg and 600 mg/kg). Of these three seaweed 
species, S, henslowianum appeared to be the most promising and effective one. The 
protective effect of seaweeds in this study was similar to the curative effect in CCl4 
one. As a result, aqueous extracts of seaweeds might contain certain active 
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component(s) which could relief the TCE-induced toxicity. Based on the SGPT 
values, the conspicuous reduction in this enzyme might indicate the possible 
existence of hepatoprotective agent(s) in the extracts. Besides, the active components 
seemed to protect the actual target site(s) of TCE to retum the elevated levels of 
SGOT back to the normal state. Moreover, the red macroalgae, Galaxaura sp. (for 
preliminary investigation), exhibited a significant curative effect to TCE-induced 
elevated level of SGPT and SGOT even at the 30 mg/ml saline dosage administered. 
The effect is comparable with that of the 60 mg/ml saline extracts of S. 
henslowianum and M myagroides. Therefore, Galaxaura sp. could also be regarded 
as an effective agent in this test. 
In the liver and kidney weight analysis, no significant change could be seen 
except those treated with S. siliquastrum. Both liver and kidney weights exhibited the 
significant increase when compared with the TCE toxin control. At this point, S. 
siliquastrum extracts may more or less exert a certain degree of adverse effect to the 
liver and kidney. However, its actual mechanism of action was still obscure now. 
This result may be complementary with the one in curative test against CCl4. As a 
result, S. siliquastrum exhibited a quite inconclusive statement about its action on 
CCl4- and TCE-induced toxicity. Therefore, it may act as a negative control in both 
tests. 
In the corresponding preventive test, there were no significant protective effect 
of S. henslowianum and M myagroides extracts to reduce the elevated level of SGPT 
except that of S. siliquastrum extracts and Galaxaura sp extract (30 mg/ml saline). 
Nevertheless, there was a significant action in reducing the SGOT level when each of 
all seaweed extracts was administered. It showed that the extracts could exert a 
certain protective effect against the acute elevated level of SGOT. The preventive 
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effect of those extracts is similar to that of the curative test. Moreover, S. 
henslowianum, M. myagroides and S. siliquastrum showed more or less similar effect 
in this preventive test besides the red macroalga, Galaxaura sp., which exhibited the 
most prominent effect even at 30 mg/ml saline when compared with other seaweed 
extracts at the same dosage. Consequently, it has a potential to exert a good antidotal 
effect against the TCE-induced toxicity. 
Antidotal effects of dimethyl sulfoxide (DMSO) and N-acetylcysteine (NAC) 
against CCl4- and TCE-induced poisoning in rats. 
Based on the curative and preventive test, it is generally accepted that the 
curative treatment is better than the preventive treatment. The possible reasons may 
be due to that DMSO and NAC are easily excreted from the body before the toxin 
treatment, owing to the presence of sulfide group in their structure. Moreover, they 
are water-soluble compounds. They may be easily absorbed in and removed out from 
the body through urination (Klaassen & Rozman, 1991) . As a result, only small 
amount of residue remains inside the body to achieve the antidotal effect. 
According to the results of DMSO and NAC against CCl4-induced heptotoxicity, 
post-treatment of DMSO and NAC proved to have a remarkable protective action 
against chemically induced elevation of SGPT and SGOT level. The same positive 
effect of protection could also be seen in the organs weight analysis to reduce 
chemically induced increase of both liver and kidney weights. However, this effect is 
significant only at the highest dosage. Besides, the protective effect of these two 
treatments could be confirmed by the histopathological examination of liver cells. 
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The evidence of scanty necrotic cells accompanied with the presence of wide range 
of regeneration zone and mitotic figures indicated that DMSO and NAC were active 
principles to relief the damage of liver. The dose-response relationship can be seen in 
the histopathological analysis. Especially in the NAC treatment at the higher dosages, 
significantly reduced SGPT and SGOT levels together with the convincing evidence 
in histopathological examinations could be shown in CCl4-induced hepatotoxicity in 
rats. The result obtained from both biochemical and histopathological tests were 
quite similar to that of S. henslowianum extract treatment against CCl4-induced 
hepatotoxicity at the corresponding dosages. The conspicuous recovery of liver cells 
accompanied with the large range of regeneration zone and scanty necrotic cells were 
evident of its protective effect. As a result, NAC exerted an excellent protective 
effect like S. henslowianum extract in the curative test. Besides, in the effect of 
TCE-induced toxicity test, DMSO and NAC in the higher dosages also exhibited the 
significant protective action to reduce the elevated levels of SGPT and SGOT. 
Especially in NAC treatment at the highest dosage, the result obtained from the 
biochemical tests is quite similar to that of S. henslowianum extract treatment against 
TCE-induced toxicity at the corresponding dosage. 
DMSO and NAC are important chemical antioxidant (Achudume, 1991; 
Flanagan & Meredith, 1991; Sies, 1993). The interesting properties of DMSO for its 
effect to arrest microsomal enzyme activity (Achudume, 1991), and its inhibitory 
effect on cytochrome P-450-based metabolism (Lind & Gandolfi，1997), might result 
in a lack of bioactivation of CCl4 to its toxic intermediates, CCl3 . According to 
Siegers (1978), the reduction in paracetamol and bromobenzene-induced liver GSH 
depletion brought about by DMSO indicates a curb on the formation of conjugates 
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between glutathione and hepatotoxic metabolites. Therefore, GSH can contribute 
significantly to the intracellular defense system by its powerful consumer of 
superoxide, singlet oxygen and hydroxyl radicals (Miesel & Zuber, 1993). 
Furthermore, NAC can also be used for the synthesis of cysteine and GSH (Sies, 
1993). As a result, the hepatoprotective effect o fDMSO and NAC can be promising. 
Based on the above reasons, the possible effect of seaweed extracts may be due to 
the properties of antioxidant or the scavenging activity against CCl4- and 
TCE-induced production of reactive metabolite(s) on the target organ(s). The 
antidotal effect of DMSO against CCl4, in the present study, appears to be quite 
convincing. 
There were little information about the DMSO and NAC's protective effect 
against CCl4 and TCE-induced toxicity in rat. However, several reports have 
illustrated the presence of antioxidant properties. The antidotal properties of DMSO 
may be due to the inhibition of microsomal oxidation to inhibit the reactive 
metabolites formation to cause the damage (Lind & Gandolfi, 1997) and the 
regulation of the GSH concentration to protect the liver damage from the reactive 
metabolites. As the highly reactive metabolites formed from CCl4 or TCE can 
combine to the sulfhydryl groups of proteins and inactivation of proteins leads to 
death of liver cells and, consequently, liver necrosis (Kr6ger et al., 1997). GSH 
protects liver proteins because it competes with reactive metabolites for the reaction 
with the proteins. Although the main target site(s) for TCE in the present study is still 
obscure, the protective effects of seaweeds, DMSO and NAC were rather ascertain. 
Based on the protective properties o fDMSO and NAC, the possible reactive agent(s) 
generated from TCE may possibly be free radical which may affect the target site(s) 
to induce the prominent elevated level of SGOT. Nevertheless, the possible main 
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target sites may be other organs rather than the liver or kidney. 
Hepatoprotective effect of methanol extract of seaweeds against CCl4- and 
TCE-induced poisoning in rats 
According to the experiment of protective effect of seaweed's methanol extracts, 
in general, all exhibited significant protective effect in lowering the acute elevated 
levels of SGPT and SGOT levels induced by CCl4. The methanol extract of S. 
siliquastrum showed the most prominent protective effect against CCl4-induced 
hepatotoxicity. Conversely, the M. myagroides extract exhibited the least effect, 
especially in the SGPT level which is comparable with the 25% DMSO control 
group. Although the presence of very significant data in reducing the level of 
SGPT and SGOT, the histopathological examination on S. siliquastrum treated liver 
sections revealed no conspicuous evidence about recovery or large range of 
regeneration zone when compared with the most effective one, S. henslowianum, in 
the curative test against CCl4-induced hepatotoxicity. Moreover, the liver and kidney 
weight showed no significant difference when compared with that of the toxin 
control and 25% DMSO control groups. 
In the curative test against TCE-induced toxicity, in general, all extracts showed 
significant effect in lowering the SGPT and SGOT levels. The M. myagroides extract 
exhibited very prominent protective effect against the acute elevated levels of SGPT 
and SGOT. The methanol extracts may contribute different effect or action on the 
CCl4 and TCE-induced toxicity. However, they all exert a positive effect in reducing 
the extent of toxicity induced by both toxins. Based on this primarily test, the 
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methanol extracts showed a quite conspicuous effect in lowering the acute elevated 
transaminases activity. However, histopathological examinations did not show any 
conspicuous and convincing evidence to support the effective effects on enzyme 
assays, like aqueous extracts in the CCl4 curative test. Obviously, the methanol 
extracts are lipid-soluble while aqueous extracts are water-soluble that the active 
constituents may be different in both extracts. As a result, it may generally conclude 
that both extracts (aqueous and methanol) contained different types of active 
ingredient(s) to protect the liver injury induced from CCl4 in different extent. 
Furthermore, it must be noted that the methanol extracts of S. siliquastrum and S. 
henslowianum at the dosage of 30 mg/ml saline showed the better result than the 
aqueous extracts of S. henslowianum at the same dosage. Therefore, the primary 
assumption could be drawn that the possible hepatoprotective effect of methanol 
extracts is better than that of the aqueous ones. The possible component(s) in the 
methanol extracts may be phenol or polyphenols which are organic in nature (Lee et 
al.，1996). It is different from the aqueous extracts which are probably 
polysaccharides or glycoproteins in nature (Harada et al., 1997). Furthermore, the 
hepatoprotective activity of the extracts was also possibly due to their antioxidant 
properties, acting as scavengers of free radicals. The curative action on hepatic injur> 
by the methanol extracts protected against liver plasma membrane peroxidative 
degradation or promoted cellular mitosis action for the repair ofthe liver cells. Some 
of these may involve active binding sites. It must be noted, however, that the possible 
mechanisms of protection are still obscure at this stage and more investigations are 
needed to clarify the active components of the seaweed's extracts (both aqueous and 
methanol extract) and study their modes of the hepatoprotective effect in the future 
study. 
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Chapter 6 CONCLUSION 
Based on the results obtained, several conclusions on the present study can be 
drawn: 
1. According to the preliminary tests on the hepatotoxicity, biochemically and 
histopathologically in the curative mode, all aqueous seaweed extracts used at 
their particular dosages contained no hepatotoxic or nephrotoxic agent to cause 
significant damage to both liver and kidney of the rats. 
2. In hepatoprotective screening of seaweed extracts, Sargassum henslowianum 
and Myagropsis myagroides have the most effective hepatoprotective effect 
against the CCl4-induced toxicity in the curative test. The same result can be 
demonstrated in the TCE curative test. The extracts of seaweeds are probably 
associated with (a) their antioxidant properties to act as a free radicals scavenger 
or antilipoperoxidant activity to remove highly reactive intermediates, (b) their 
cell division enhancement to promote regeneration or recovery from the damage. 
The same positive effect can also be shown in the DMSO and NAC treatment. 
3. Based on the TCE toxicity test, intraperitoneal route is the most effective way 
to generate the toxic effect by the elevation of both SGPT and SGOT levels 
when compared with oral route. The effective toxic dose o fTCE has been found 
to be 20% of TCE in corn oil which is administrated at the dosage of 1.25 ml/kg. 
This dosage is the same as CCl4 one. However, it cannot generate the promising 
effects like CCl4 in histopathological analysis, according to the 
histopathological analysis in TEM. The effective dose of TCE can generate 
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certain toxic effects on the liver with a slight increase of lipid droplets and 
dilation of rER. However, conspicuous damage like necrosis cannot be found. It 
indicates that the main target site(s) may attribute to the reason for the SGOT 
elevation. Moreover, the free radical may be involved to induce the elevation of 
SGOT level. Further investigation should be followed to identify the main target 
site(s). 
4. The seaweed extracts, DMSO and NAC exhibit a better protective effect in 
curative mode than that of preventive mode. It indicates the curative mode is 
more direct than the preventive one. As the antidote treatment is 6 hours before 
the toxin treatment, the possible action of excretion through urination or other 
mechanisms may occur to remove all or most of active agent(s) out of the body. 
5. In the study of methanol extract of seaweeds, the protective effect can be 
ascertained by the enzyme assay and histopathological examinations. However, 
the result ofhistopathological examination is not as good as that of the curative 
one even the prominent transaminase activity has been proved. 
6. The possible active agents in the methanol extracts are not the same as those 
in the aqueous extracts. As the methanol extracts are organic in nature to which 
the presence of phenolic compounds (phenols or polyphenol), organic acid etc. 
compounds may be possible. The aqueous extracts mainly contain 
water-soluble compounds, mostly carbohydrate and proteins like 
polysaccharides and glycoprotein. The actual substance(s) or mechanism which 
contribute to the protective effect is still speculative now. 
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These studies represent only the first stages into investigations on the protective 
properties of potential antidotes against CCl4 and TCE-induced injury. It must be 
noted, however, that the possible mechanisms of protection on both toxicity 
generated from CCl4 and TCE are rather speculative at this stage and more 
investigations are needed to identify the active principles of the seaweeds and 
elucidate their modes of the hepatoprotective action in further studies.. 
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Appendix A: Procedure for preparing a calibration curve to 
measure the serum glutamic pyruvic transaminase (SGPT) and 
serum glutamic oxaloacetic transaminase (SGOT) activities. 
1. Different volume of the solutions was added as indicated in the table: 
Test tube no. 0 1 2 3 4 
Distilled water (ml) ^ ~ ~ o i ~ ~ ~ o ] ~ ~ 0 ^ ~ ~ o T ~ 
Calibration standard solution (ml)* 0 0.05 0.1 0.15 0.2 
Substrate (ml)** 0.5 0.45 0.4 0.35 0.3 
SGPT activity (IU/L) 0 23 50 83 125 
SGOT activity (IU/L) 0 20 55 95. 148 
2. 0.5 ml color reagent was added to each tube. The tubes were shaken gently and 
left at room temperature for 20 minutes. 
3. 0.4 M sodium hydroxide solution was added to each tube and mixed by 
inversion. 
4. the tubes were left for at least 8 minutes. 
5. the absorbance at wavelength 505 nm was read and recorded by using distilled 
waster as reference. 
6. SGPT and SGOT calibration curves of absorbance values versus the 
corresponding units of SPT and SGOT was plotted. 
* Calibration standard solution is 1.5 m M of sodium pyruvate in phosphate buffer of 
pH 7.5. • 
* * Substrate solution: 
0.2 M ofDL-aspartate and 1.8 m M of a-ketoglutaric acid for SGOT. 
0.2 M ofDL-alanine and 1.8 m M of a-ketoglutaric acid for SGPT. 
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Appendix B: Procedure for determining the serum glutamic 
pyruvic transaminase (SGPT) and serum glutamic oxaloacetic 
transaminase (SGOT) activities. 
1. 0.05 ml of serum was added to a test tube. 
2. 0.25 ml subrate solution (0.2 M of DL-alanine and 1.8 mM of a-ketoglutaric 
acid in phosphate buffer of pH 7.5) was added into the test tube containing the 
serum. 
3. the tube was shaken gently and left in water bath for 30 minutes. 
4. 0.25 ml of the color reagent ( l m M of 2,4-dinitrophenylhydrazine (DNP) in 1 M 
hydrochloric acid) was added. 
5. the test tube was shaken gently and left at room temperature for 20 minutes. 
6. 2.5 ml of 0.4 M of sodium hydroxide was added and mixed by inversion. 
7. the tube was left for at least 8 minutes. 
8. the absorbance at wavelength 505 nm was read and recorded by using distilled 
waster as reference. 
9. SGPT activity was determined from the calibration curve of SGPT. 
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Appendix C: Procedure for determining the serum glutamic 
oxaloacetic transaminase (SGOT) activities. 
1. 0.05 ml of serum was added to a test tube. 
2. 0.25 ml subrate solution (0.2 M of DL-aspartate and 1.8 mM of a-ketoglutaric 
acid in phosphate buffer of pH 7.5) was added into the test tube containing the 
serum. 
3. the tube was shaken gently and left in water bath for 30 minutes. 
4. 0.25 ml of the color reagent ( l m M of 2,4-dinitrophenylhydrazine (DNP) in 1 M 
hydrochloric acid) was added. 
5. the test tube was shaken gently and left at room temperature for 20 minutes. 
6. 2.5 ml of 0.4 M sodium hydroxide was added and mixed by inversion. 
7. the tube was left for at least 8 minutes. 
8. the absorbance at wavelength 505 nm was read and recorded by using distilled 
waster as reference. 
9. SGOT activity was determined from the calibration curve of SGOT. 
• 
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Appendix D: Tissue Preparation Procedure for Light 
Microscopy (sample thickness is 5-7 nm) 
PROCEDURE REAGENTS TIME 
Fixing Bouin' s Fluid -24 hours 
Processing Dehvdration: 
50% Ethanol 1 hour 
70% Ethanol 1 hour 
85% Ethanol 2 hours 
95% Ethanol 2 hours 
100% Ethanol 1 hour 
100% Ethanol 1 hour 
100% Ethanol 1 hour 
Clearing: 
Xylene: Ethanol (1:1) 1 /2 hour 
Xylene 1/2 hour 
Xylene 1/2 hour 
Infiltration: 
Paraffm wax 1/2 hour 
Paraffin wax 1/2 hour 
Paraffin wax (Vacuum aspiration 1/2 hour 
i f necessary) 
Embedding: 
Paraffm wax (allow to cool and 
trim) 
Sectioning Section at 5 ^m thick, adhere on slides by egg albumin 
and dry on warm plate or oven ovemight 
Staining Dewax: 
Xylene 5 min 
Xylene 5 min 
Hydration: 
100% Ethanol 1 min 
95% Ethanol 1 min 
70% Ethanol 1 min 
50% Ethanol 1 min 
30% Ethanol 1 min 
running tap water 1 min 
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Staining: 
Mayer，s Hematoxylin -20 min 
tap water 1 min 
1% Acid Alcohol ~5 sec 
tap water 1 min 
Scott’ s tap water 2 min 
tap water 1 min 
0.5% aqueous Eosin 3 min 
tap water 1 min 
Dehydration: 
70% Ethanol short/fast 
95% Ethanol short/fast 
100% Ethanol 2min 
100% Ethanol 2min 
Xylene:Ethanol 2 min 
Xylene 2 min 




Appendix E: Tissue Preparation Procedure for TEM 
PROCEDURE REAGENT TIME TEMP. REMARKS 
Fixation 2.5% glutaraldehyde in 4 hours 4 °C 
phosphate buffer (mince 
specimen into 1 mm cubes 
with a sharp blade after 1 -2 
hour fixation) 
buffer Wash Phosphate buffer 5 - 10 mins R. T. 
Phosphate buffer 5 - 10 mins R. T. 
Post-fixation 1% osmium tetroxide in 2 hours R.T. 
phosphate buffer . 
buffer wash Phosphate buffer 5 - 10 mins R. T. 
Phosphate buffer 5 - 10 mins R.T. 
Dehydration 50% ETOH 5 - l O m i n s . R.T. volume of 
70% ETOH 5 - l O m i n s R.T. reagent 
85% ETOH 5 - l O m i n s R.T. required〜3 
95% ETOH 5 - l O m i n s R.T. ml / vial 
95% ETOH 10-15mins R.T. 
100% ETOH 10-15mins R.T. 
100% ETOH 10-15mins R.T. 
100% ETOH 10-15mins R.T. 
Infiltration 100% ETOH: Pure spurr 1 - 4 hours R. T. 
(2:1) 
100% ETOH: Pure spurr 1 - 4 hours R. T. 4.5 ml 
( 1 : 1 ) Spurr/vial 
100% ETOH: Pure spurr Overnight R. T. 
(1:2) 
Pure spurr ‘ 2 - 3 hours R. T. 
Pure spurr 2 - 3 hours R. T. 
Pure spurr 2 - 3 hours R.T. 10 ml 
Spurr / vial 
Embedding Pure spurr 8 - 16 hours 68 °C 〜0.3 ml 
Spurr / block 
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Appendix F: Tissue Preparation Procedure for SEM 
I =gg -^ ~—~^^^~^~~~^ ~^^  
PROCEDURE REAGENT TIME TEMP. REMARKS 
Fixation 2.5% glutaraldehyde in ~2 - 24 hours R. T. - Glutaraldehyde 
phosphate buffer solution prepared 
can be kept at 4 °C 
for no longer than 2 
weeks 
buffer Wash Phosphate buffer 5 - lOmins R.T. 
Phosphate buffer 5 -10 mins R.T. 
Post-fixation 1% osmium tetroxide 1 - 2 hours R.T. - To prepare OsO4, 
in phosphate buffer . add PB and stand 
0 /N at R. T. for 
complete 
. dissolution 
-OsO4 must be 
kept in the dark in 
-20 °C freezer 
-Discard OsO4 i f it 
tums from pale 
yellow to colorless 
buffer wash Phosphate buffer 5 - 10 mins R. T. 
Phosphate buffer 5 - 10 mins R.T. 
Dehydration 50% ETOH 15mins R.T. 
70% ETOH 15mins R.T. 
85% ETOH 15mins R.T. 
95% ETOH 15mins R.T. 
95% ETOH ’ 15mins R.T. 
100% ETOH 15mins R.T. 
100% ETOH 15mins R.T. 
100% ETOH 15mins R.T. | 
Critical Point drying (liquid CO2) 
Coating Coat the specimen with gold / palladium by sputter coater | 
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Appendix G: Reagent preparation for TEM 
1. Phosphate buffer (0.1 M, pH 7.2) 
(a) Solution A stock 
Na2HPO4 (anhydrous form): 7.10 gm / 250 ml 
(b) Solution B stock 
NaH2PO4.2H2O: 3.90 gm /125 ml 
Mix 2 stock solution as follows: (Storage ofbuffer is not recommended because of 
microbial growth) 
Solution A (ml) Solution B (ml) Distilled water (ml) Final volume (ml) 
36 [4 50 m 
n ^ foo ^ 
i ^ 42 m ^ 
I sssssssss • ^=sa= 一 
2. Methanolic uranyl stain 
(a) weigh out 0.25 gm uranyl acetate into a 25 ml volumetric flask 
(b) add ~ 20 ml methanol to the flask, and shake until completely dissolved 
(c) add methanol to the 25 ml mark 
(d) filter with millipore filter 
(e) aliquot to 0.75 ml / eppendorf tube-
(f) store at 4 °C in the dark (remain effective for at least 1 month) 
(g) discard stain i f it tums cloudy 
3. Reynold's lead citrate stain 
(a) weigh out 2.01 gm sodium citrate.2H2O and 1.33 gm lead nitrate, and add 30 ml 
of fresh distilled H2O to a 50 ml volumetric flask 
(b) shake thoroughly for 1 min and intermittently for 30 mins 
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(c) add 8.0 ml 1 M NaOH and shake until completely dissolved 
(d) add distilled H2O to the 50 ml mark 
(e) filter with millipore filter 
(f) aliquot to 0.75 ml / eppendorf tube 
(g) freshly prepare the 1 M NaOH (1.0 gm NaOH / 25 ml) 
(h) store in an air-tight container (remain effective for up to 6 months) 
(i) discard stain i f it turn cloudy 
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Appendix H: Reagent preparation for SEM 
1. Phosphate buffer (0.1 M, pH 7.2) 
(a) Solution A stock 
Na2HPO4 (anhydrous form): 7.10 gm / 250 ml) 
(b) Solution B stock 
NaH2O4.2H2O: 3.90 gm /125 ml 
Mix 2 stock solutions as follows: (storage of buffer in not recommended because of 
microbial growth) 
Solution A (ml) Solution B (ml) Distilled water (ml) Final volume (ml) 
36 U 50 1^ 
n ^ i ^ ^ 
i ^ 42 i ^ m 
I === •'•- _•-••' ‘ •丨 I •— -• -
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Appendix I: The Procedure for fllm development and photo 
printing 
1. Kodak TMX 100 Film (135 or 120) Development (in darkness) 
PROCEDURE DILUTION |TEMPERATURE| TIME 
(STOCK: CC) 
WATER) 
Running tap water ™ ™ Twice 
Kodar D76 developer 1 : 1 20 12mins 
(shake gently) 
Running tap water ™ ；™ Twice 
Iiford Hypam rapid fixer 1 :4 20 2 mins 
(reusable for 3 times) (shake gently) 
Running tap water — ™ At least 15 mins 
2. Kodak TEM Film Development (under safe light) 
PROCEDURE DILUTION |TEMPERATURE| TIME 
(STOCK : WATER) (^C) 
Kodar D19 developer 2 : 3 20 4 mins 
(shake gently) 
Running tap water ™ ^ 2 mins 
Iiford Hypam rapid fixer 1 :4 20 2 mins 
(reusable for 3 times) (shake gently) 
Running tap water ™ - ^ Atleast 15 mins 
L_ 丄 • I F -^^ -*^ ^^ ^~—^—^—^^ ^ h 
3. Photo Printing (under safe light) 
PROCEDURE ~ D I L U T I O N TEMPERATURE “ TIME ^ 
(STOCK : WATER) (^C) 
Multigrade IIfospeed 1 :9 20 1 min 
paper developer (use with 1 day) 
Stop bath 1 : 19 ^ 5 secs 
(use 28% acetic acid 
stock) 
IIford Hypam rapid fixer 1 : 9 ^ 1 mins 
_ Running tap water --- --- A t leas t l5mins 
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The graph of SGPT (lU/L) against 
the different treatment (sample test) 
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Figure 4.1: Effect of extract (at dosages of 150 mg/kg, 300 mg/kg and 600 mg/ kg 
except Galaxaura sp. at dosages of 150 mg/kg and 300 mg/kg) of three species of 
seaweeds on the level of SGPT activity. Each value represents the meaniS.E.M. o f5 
treated rats. Values statistically significantly different from that of vehicle-saline 
control group are not noted. 
Key: S#2= Sargassum henslowicmum; S#3= Myagropsis myagroides\ S#4= Sargassum siliquastrum, 
Gal= Galaxaura sp. 
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The graph of SGOT (lU/L) against 
the different treatment (sample test) 
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Figure 4.2: Effect of extract (at dosages of 150 mg/kg, 300 mg/kg and 600 mg/ kg 
except Galaxaura sp. at dosages of 150 mg/kg and 300 mg/kg) of three species of 
seaweeds on the level of SGOT activity. Each value represents the meaniS.E.M. of5 
treated rats. Values statistically significantly different from that of vehicle-saline 
control group are not noted. 
Key: S#2= Sargassum henslowianum-, S#3= Myagropsis myagroides-, S#4= Sargassum siliquastrum, 
Gal= Galaxaura sp. ‘ 
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The graph of l iver weight (g/kg) against 
the different treatment (sample test) 
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Figure 4.3: Effect of extract (at dosages of 150 mg/kg, 300 mg/kg and 600 mg/ kg 
except Galaxaura sp. at dosages of 150 mg/kg and 300 mg/kg) of three species of 
seaweeds on effect of liver weight. Each value represents the meaniS.E.M. of 5 
treated rats. Values statistically significantly different from that of vehicle-saline 
control group are not noted. 
Key: S#2= Sargassum henslowianum; S#3= Myagropsis myagroides\ S#4= Sargassum siliquastrum, 
Gal= Galaxaura sp. 
151 
The graph of kidney weight (g/kg) again 
the different treatment (sample test) 
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Figure 4.4: Effect of extract (at dosages of 150 mg/kg, 300 mg/kg and 600 mg/ kg 
except Galaxaura sp. at dosages of 150 mg/kg and 300 mg/kg) of three species of 
seaweeds on effect of kidney weight. Each value represents the meaniS.E.M. of 5 
treated rats. Values statistically significantly different from that of vehicle-saline 
control group are not noted. 
Key: S#2= Sargassum henslowianum; S#3= Myagropsis myagroides; S#4= Sargassum siliquastrum, 
Gal= Galaxaura sp. 
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The graph of SGPT (IU/L) against 
2500 000 the different treatment (Curative) 
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Figure 4.5: Effect of extract (at dosages of 150 mg/kg, 300 mg/kg and 600 mg/ kg) 
of three species of seaweeds on CCl4-induced elevation of SGPT activity (Curative). 
Each value represents the meaniS.E.M. of 10 treated rats. Values statistically 
significantly different from that of toxin control group are indicated by * (p<0.05) 
and **(p<0.005). 
Key: S#2= Sargassum henslowianum\ S#3= Myagropsis myagroides\ S#4= Sargassum siliquastrum 
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The graph of SGOT (RJ/L) against 
the different treatment (Curative) 
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Figure 4.6: Effect of extract (at dosages of 150 mg/kg, 300 mg/ kg and 600 mg/ kg ) 
of three species of seaweeds on CCl4-induced elevation of SGOT activity (Curative). 
Each value represents the mean±S.E.M. of 10 treated rats. Values statistically 
significantly different from that of toxin control group are indicated by * (p<0.05) 
and **(p<0.005). 、 
Key: S#2= Sargassum henslowianum., S#3= Myagropsis myagroides\ S#4= Sargassum siliquastrum 
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the different treatment (Curative) 
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Figure 4.7: Effect of extract (at dosages of 150 mg/kg, 300 mg/ kg and 600 mg/ kg ) 
of three species of seaweeds on CCl4-induced increase of liver weight (Curative). 
Each value represents the meaniS.E.M. of 10 treated rats. Values statistically 
significantly different from that of toxin control group are indicated by * (p<0.05) 
and **(p<0.005). 
Key: S#2= Sargassum henslowianum\ S#3= Myagropsis myagroides; S#4= Sargassum siliquastrum 
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the different treatment (Curative) 
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Figure 4.8: Effect of extract (at dosages o f l 5 0 mg/kg, 300 mg/ kg and 600 mg/ kg ) 
of three species of seaweeds on CCl4-induced increase of kidney weight (Curative). 
Each value represents the mean±S.E.M. of 10 treated rats. Values statistically 
significantly different from that of toxin control group are indicated by * (p<0.05) 
and **(p<0.005). 
Key: S#2= Sargassum henslowicmum; S#3= Myagropsis myagroides; S#4= Sargassum siliquastrum 
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Figure 4.9: Effect of extract (at dosages of 150 mg/kg, 300 mg/kg and 600 mg/ kg) 
of three species of seaweeds on CCl4-induced elevation of SGPT activity 
(Preventive). Each value represents the meaniS.E.M. of 7 treated rats. Values 
statistically significantly different from that of toxin control group are indicated by * 
(p<0.05). 
Key: S#2= Sargassum henslowianum-, S#3= Myagropsis myagroides\ S#4= Sargassum siliquastrum 
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Figure 4.10: Effect of extract (at dosages of 150 mg/kg, 300 mg/kg and 600 mg/ kg) 
of three species of seaweeds on CCl4-induced elevation of SGOT activity 
(Preventive). Each value represents the meaniS.E.M. of 7 treated rats. Values 
statistically significantly different from that of toxin control group are not noted. 
Key: S#2= Sargassum henslowianum; S#3= Myagropsis myagroides\ S#4= Sargassum siliquastru 
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Figure 4.11: Effect of extract (at dosages o f l 5 0 mg/kg, 300 mg/ kg and 600 mg/ kg ) 
of three species of seaweeds on CCl4-induced increase of liver weight (Preventive). 
Each value represents the mean±S.E.M. of 7 treated rats. Values statistically 
significantly different from that of toxin control group are indicated by * (p<0.05) 
and **(p<0.005). 
Key: S#2= Sargassum henslowianum-, S#3= Myagropsis myagroides; S#4= Sargassum siliquastrum 
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Figure 4.12: Effect of extract (at dosages of 150 mg/kg, 300 mg/ kg and 600 mg/ k g ) 
ofthree species of seaweeds on CCl4-induced increase ofkidney weight (Preventive). 
Each value represents the meaniS.E.M. of 7 treated rats. Values statistically 
significantly different from that of toxin control group are indicated by * (p<0.05) 
and **(p<0.005). 
Key: S#2= Sargassum henslowianum\ S#3= Myagropsis myagroides\ S#4= Sargassum siliquastrum 
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Figure 4.13: Effect on SGPT, one-time oral dosage of TCE in different percentages 
applied. Each value represents the meaniS.E.M. of corresponding number rats used. 
Values statistically significantly different from that of vehicle-saline control group 
are shown. 
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Figure 4.14: Effect on SGOT, one-time oral dosage of TCE in different percentages 
applied. Each value represents the meaniS.E.M. of corresponding number rats used. 
Values statistically significantly different from that of vehicle-saline control group 
are shown. 
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Figure 4.15: Effect on SGPT, two-time oral dosage o fTCE in different percentages 
applied. Each value represents the meaniS.E.M. of corresponding number rats used. 
Values statistically significantly different from that of vehicle-saline control group 
are shown. ‘ 
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The graph of SGOT (lU/L) against 
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Figure 4.16: Effect on SGOT, two-time oral dosage o f T C E in different percentages 
applied. Each value represents the meaniS.E.M. of corresponding number rats used. 
Values statistically significantly different from that of vehicle-saline control group 
are shown. 
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Figure 4.17: Effect on liver and kidney weights, one-time oral dosage of TCE in 
different percentages applied. Each value represents the mean±S.E.M. of 
corresponding number rats used. Values statistically significantly different from that 
ofvehicle-saline control group are shown. 
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Figure 4.18: Effect on liver and kidney weights, two-time oral dosage of TCE in 
different percentages applied. Each value represents the meaniS.E.M. of 
corresponding number rats used. Values statistically significantly different from that 
ofvehicle-saline control group are shown. 
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Figure 4.19: Effect on SGPT, i.p. dosage of TCE in different percentages applied. 
Each value represents the meaniS.E.M. of corresponding number rats used. Values 
statistically significantly different from that of vehicle-saline control group are 
shown. 
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Figure 4.20: Effect on SGOT, i.p. dosage of TCE in different percentages applied. 
Each value represents the mean±S.E.M. of corresponding number rats used. Values 
statistically significantly different from that of vehicle-saline control group are 
shown. 
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Figure 4.21: Effect on liver and kidney weights, i.p. dosage of TCE in different 
percentages applied. Each value represents the mean±S.E.M. of corresponding 
number rats used. Values statistically significantly different from that of 
vehicle-saline control group are shown. 
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Figure 4.22: Effect on SGPT, i.p. effective dose of 20% TCE in different times 
(Time course). Each value represents the mean±S.E.M. of corresponding number rats 
used. Values statistically significantly different from that of vehicle-saline control 
group (0 h) are shown. • 
0 h: (N=7); 6 h: (N=8); 12 h: (N=7); 24 h: (N=11); 27 to 102 h: (N=6) 
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Figure 4.23: Effect on SGOT, i .p. effective dose of 20% TCE in different times 
(Time course).. Each value represents the mean±S.E.M. of corresponding number 
rats used. Values statistically significantly different from that of vehicle-saline 
control group (0 h) are shown. 
0 h: CN=7); 6 h: GSf=8); 12 h: (N=1); 24 h: 0^=11); 27 to 102 h: (N=6) 
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Figure 4.24: Effect on liver weight, i.p. effective dose of20% TCE in different times 
(Time course). Each value represents the mean±S.E.M. of corresponding number rats 
used. Values statistically significantly different from that of vehicle-saline control 
group (0 h) are shown. � 
0 h: (N=7); 6 h: G^=8); 12 h: (N=7); 24 h: OSf=l 1)； 27 to 102 h: 0sN6) 
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Figure 4.25: Effect on kidney weight, i.p. effective dose of 20% TCE in different 
times (Time course). Each value represents the meaniS.E.M. of corresponding 
number of rats used. Values statistically significantly different from that of 
vehicle-saline control group (0 h) are shown. 
0 h: 0^=7); 6 h: 0Sf=8); 12 h: (N=7); 24 h: 0^=11); 27 to 102 h: Q^=6) 
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Figure 4.26: Effect of extract (at dosages o f l 5 0 mg/kg, 300 mg/kg and 600 mg/ kg 
for brown seaweed; 150 mg/kg and 300 mg/kg for red seaweed) of four species of 
seaweeds on TCE-induced elevation of SGPT activity (Curative). Each value 
represents the mean±S.E.M. Values statistically significantly different from that of 
toxin control group are indicated by * .(p<0.05). 
Key: S#2= Sargassum henslowianum\ S#3= Myagropsis myagroides- S#4= Sargassum siliquastrunr, 
Gal= Galaxaura sp. 
no treatment: (N=5); vehicle-saline: (N=5); 20%TCE: (N=5); S#2, S#3, S#4 and Gal: (N=6) 
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Figure 4.27: Effect of extract (at dosages o f l 5 0 mg/kg, 300 mg/kg and 600 mg/ kg 
for brown seaweed; 150 mg/kg and 300 mg/kg for red seaweed) of four species of 
seaweeds on TCE-induced elevation of SGOT activity (Curative). Each value 
represents the mean±S.E.M. Values statistically significantly different from that of 
toxin control group are indicated by * (p<0.05). 
Key: S#2= Sargassum henslowianum\ S#3= Myagropsis myagroides\ S#4= Sargassum siliquastrum; 
Gal= Galaxaura sp. 
no treatment: (N=5); vehicle-saline: (N=5); 20%TCE: (N=5); S#2, S#3, S#4 and Gal: (N-6) 
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Figure 4.28: Effect of extract (at dosages of 150 mg/kg, 300 mg/kg and 600 mg/ kg 
for brown seaweed; 150 mg/kg and 300 mg/kg for red seaweed) of four species of 
seaweeds on TCE-treated rats of liver weight (Curative). Each value represents the 
mean±S.E.M Values statistically significantly different from that of toxin control 
group are indicated by * (p<0.05) and **(p<0.005). 
Key: S#2= Sargassum henslowianum; S#3= Myagropsis myagroides; SU4= Sargassum siliquastrum' 
Gal= Galaxaura sp. 
no treatment: (N=5); vehicle-saline: (N=5); 20%TCE: (N=5); S#2, S#3, S#4 and Gal: (N=6) 
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Figure 4.29: Effect of extract (at dosages of 150 mg/kg, 300 mg/kg and 600 mg/ kg 
for brown seaweed; 150 mg/kg and 300 mg/kg for red seaweed) of four species of 
seaweeds on TCE-treated rats of kidney weight (Curative). Each value represents the 
mean±S.E.M. Values statistically significantly different from that of toxin control 
group are indicated by * (p<0.05) and **(p<0.005). 
Key: S#2= Sargassum henslowianum\ S#3= Myagropsis myagroides., S#4= Sargassum siliquastrum-, 
Gal= Galaxaura sp. 
no treatment: 0^=5); vehicle-saline: 0^=5); 20%TCE: 0^=5); S#2, S#3, S#4 and Gal: 0^=6) 
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Figure 4.30: Effect of extract (at dosages o f l 5 0 mg/kg, 300 mg/kg and 600 mg/ kg 
for brown seaweed; 150 mg/kg and 300 mg/kg for red seaweed) of four species of 
seaweeds on TCE-induced elevation of SGPT activity (Preventive). Each value 
represents the mean±S.E.M. Values statistically significantly different from that of 
toxin control group are indicated by * (p<0.05). 
Key: S#2= Sargassum henslowianum-, S#3= Myagropsis myagroides., S#4= Sargassum siliquastrum-
Gal= Galaxaura sp. 
no treatment: (N=10); vehicle-saline: (N=5); 20%TCE, S#2, S#3, S#4 and Gal: (N=6) 
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Figure 4.31: Effect of extract (at dosages of 150 mg/kg, 300 mg/kg and 600 mg/ kg 
for brown seaweed; 150 mg/kg and 300 mg/kg for red seaweed) of four species of 
seaweeds on TCE-induced elevation of SGOT activity (Preventive). Each value 
represents the mean±S.E.M. Values statistically significantly different from that of 
toxin control group are indicated by * (p<0.05), ** (p<0.005). 
Key: S#2= Sargassum henslowianum-, S#3= Myagropsis myagroides\ S#4= Sargassum siliquastrum-, 
Gal= Galaxaura sp. 
no treatment: (N=10); vehicle-saline: (N=5); 20%TCE, S#2, S#3, S#4 and Gal: (N=6) 
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Figure 4.32: Effect of extract (at dosages of 150 mg/kg, 300 mg/kg and 600 mg/ kg 
for brown seaweed; 150 mg/kg and 300 mg/kg for red seaweed) of four species of 
seaweeds on liver weight ofTCE-treated rats (Preventive). Each value represents the 
mean±S.E.M. Values statistically significantly different from that of toxin control 
group are indicated by * (p<0.05) and **(p<0.005). 
Key: S#2= Sargassum henslowianum\ S#3=Myagropsis myagroides; S#4= Sargassum siliquastrum] 
Gal= Galaxaura sp. 
no treatment: 0^=10); vehicle-saline: (N=5); 20%TCE, S#2, S#3, S#4 and Gal: 0^=6) 
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Figure 4.33: Effect of extract (at dosages o f l 5 0 mg/kg, 300 mg/kg and 600 mg/ kg 
for brown seaweed; 150 mg/kg and 300 mg/kg for red seaweed) of four species of 
seaweeds on kidney weight of TCE-treated rats (Preventive). Each value represents 
the mean±S.E.M. Values statistically significantly different from that o f tox in control 
group are indicated by * (p<0.05) and **(p<0.005). 
Key: S#2= Sargassum henslowianum- S#3=Myagropsis myagroides- S#4= Sargassum siliquastrum-, 
Gal= Galaxaura sp. 
no treatment: (N=10); vehicle-saline: (N=5); 20%TCE, S#2, S#3, S#4 and Gal: (N=6) 
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Figure 4.34: Effect of DMSO (at dosages of 25%, 50% and 75%) on CCl4-induced 
elevation of SGPT activity (Curative). Each value represents the mean±S.E.M. of 7 
treated rats except no treatment and control groups which have 5 treated rats in each 
group. Values statistically significantly different from that of toxin control group are 
indicated by * {p<0.05) and **(p<0.005). 
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Figure 4.35: Effect o fDMSO (at dosages of25%, 50% and 75%) on CCl4-induced 
elevation of SGOT activity (Curative). Each value represents the meaniS.E.M. of 7 
treated rats except no treatment and control groups which have 5 treated rats in each 
group. Values statistically significantly different from that of toxin control group are 
indicated by * (p<0.05) and **(p<0.005). 
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Figure 4.36: Effect o f N A C (at dosages of 150 mg/kg, 300 mg/kg and 600 mg/kg) 
on CCl4-induced elevation of SGPT activity (Curative). Each value represents the 
mean±S.E.M. of 7 treated rats except no treatment and control groups which have 5 
treated rats in each group. Values statistically significantly different from that of 
toxin control group are indicated by **(p<0.005). 
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Figure 4.37: Effect o f N A C (at dosages of 150 mg/kg, 300 mg/kg and 600 mg/kg) 
on CCl4-induced elevation of SGOT activity (Curative). Each value represents the 
mean±S.E.M. of 7 treated rats except no treatment and control groups which have 5 
treated rats in each group. Values statistically significantly different from that of 
toxin control group are indicated by **(p<0.005). 
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Figure 4.38: Effect of DMSO (at dosages of25%, 50% and 75%) on TCE-induced 
elevation of SGPT activity (Curative). Each value represents the meaniS.E.M. of 6 
treated rats except no treatment and control groups which have 5 treated rats in each 
group. Values statistically significantly different from that of toxin control group are 
indicated by * (p<0.05) and **(p<0.005). 
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Figure 4.39: Effect of DMSO (at dosages o f25%, 50% and 75%) on TCE-induced 
elevation of SGOT activity (Curative). Each value represents the meaniS.E.M. of 6 
treated rats except no treatment and control groups which have 5 treated rats in each 
group. Values statistically significantly different from that of toxin control group are 
indicated by * (p<0.05) and **Q)<O.aO5). 
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Figure 4.40: Effect of NAC (at dosages of 150 mg/kg, 300 mg/kg and 600 mg/kg) 
on TCE-induced elevation of SGPT activity (Curative). Each value represents the 
mean±S.E.M. of 6 treated rats except no treatment and control groups which have 5 
treated rats in each group. Values statistically significantly different from that of 
toxin control group is not noted. 
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Figure 4.41: Effect o f N A C (at dosages of 150 mg/kg, 300 mg/kg and 600 mg/kg) 
on TCE-induced elevation of SGOT activity (Curative). Each value represents the 
mean±S.E.M. o f 6 treated rats except no treatment and control groups which have 5 
treated rats in each group. Values statistically significantly different from that of 
toxin control group are indicated by **^)<0.005). 
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Figure 4.42: Effect o fDMSO (at dosages of25%, 50% and 75%) on CCl4-induced 
increase of liver weight (Curative). Each value represents the meaniS.E.M. of 7 
treated rats except no treatment and control groups which have 5 treated rats in each 
group. Values statistically significantly different from that of toxin control group are 
indicated by * (p<0.05) and **Qx0.005). 
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Figure 4.43: Effect o fDMSO (at dosages of25%, 50% and 75%) on CCl4-induced 
increase of kidney weight (Curative). Each value represents the meaniS.E.M. of 7 
treated rats except no treatment and control groups which have 5 treated rats in each 
group. Values statistically significantly different from that of toxin control group are 
indicated by * (p<0.05) and **(p<0.005). 
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Figure 4.44: Effect of NAC (at dosages of 150 mg/kg, 300 mg/kg and 600 mg/kg) 
on CCl4-induced increase of liver weight (Curative). Each value represents the 
mean±S.E.M. of 7 treated rats except no treatment and control groups which have 5 
treated rats in each group. Values statistically significantly different from that of 
toxin control group are indicated by * (p<0.05) and **(p<0.005). 
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Figure 4.45: Effect o f N A C (at dosages of 150 mg/kg, 300 mg/kg and 600 mg/kg) 
on CCl4-induced increase of kidney weight (Curative). Each value represents the 
mean±S.E.M. of 7 treated rats except no treatment and control groups which have 5 
treated rats in each group. Values statistically significantly different from that of 
toxin control group are indicated by * (p<0.05). 
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Figure 4.46: Effect o fDMSO (at dosages of25%, 50% and 75%) on liver weight of 
TCE-treated rats (Curative). Each value represents the mean±S.E.M. of 6 treated rats 
except no treatment and control groups which have 5 treated rats in each group. 
Values statistically significantly different from that of toxin control group are not 
noted. 
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Figure 4.47: Effect o fDMSO (at dosages of25%, 50% and 75%) on kidney weight 
of TCE-treated rats (Curative). Each value represents the meaniS.E.M. o f 6 treated 
rats except no treatment and control groups which have 5 treated rats in each group. 
Values statistically significantly different from that of toxin control group are not 
noted. 
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Figure 4.48: Effect o f N A C (at dosages of 150 mg/kg, 300 mg/kg and 600 mgy^g) 
on liver weight of TCE-treated rats (Curative). Each value represents the 
mean±S.E.M. of 6 treated rats except no treatment and control groups which have 5 
treated rats in each group. Values statistically significantly different from that of 
toxin control group are not noted. 
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Figure 4.49: Effect o f N A C (at dosages of 150 mg/kg, 300 mg/kg and 600 mg/kg) 
on kidney weight of TCE-treated rats (Curative). Each value represents the 
meaniS.E.M. of 6 treated rats except no treatment and control groups which have 5 
treated rats in each group. Values statistically significantly different from that of 
toxin control group are not noted. 
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Figure 4.50: Effect o fDMSO (at dosages of25%, 50% and 75%) on CCU-induced 
elevation ofSGPT activity (Preventive). Each value represents the mean±S.E.M. o f7 
treated rats except no treatment and control groups which have 5 treated rats in each 
group. Values statistically significantly different from that of toxin control group are 
indicated by * (p<0.05). 
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Figure 4.51: Effect of DMSO (at dosages of25%, 50% and 75%) on CCl4-induced 
elevation of SGOT activity (Preventive). Each value represents the meaniS.E.M. of 
7 treated rats except no treatment and control groups which have 5 treated rats in 
each group. Values statistically significantly different from that of toxin control 
group are indicated by **Q)<0.005). 
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Figure 4.52: Effect of NAC (at dosages of 150 mg/kg, 300 mg/kg and 600 mg/kg) 
on CCl4-induced elevation of SGPT activity (Preventive). Each value represents the 
mean±S.E.M. of 7 treated rats except no treatment and control groups which have 5 
treated rats in each group. Values .statistically significantly different from that of 
toxin control group are not noted. 
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Figure 4.53: Effect o f N A C (at dosages of 150 mg/kg, 300 mg/kg and 600 mg/kg) 
on CCl4-induced elevation of SGOT activity (Preventive). Each value represents the 
meaniS.E.M. of 7 treated rats except no treatment and control groups which have 5 
treated rats in each group. Values ,statistically significantly different from that of 
toxin control group are indicated by *(p<0.05). 
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Figure 4.54: Effect of DMSO (at dosages of25%, 50% and 75%) on TCE-induced 
elevation of SGPT activity (Preventive). Each value represents the meaniS.E.M. o f6 
treated rats except no treatment and control groups which have 5 treated rats in each 
group. Values statistically significantly different from that of toxin control group are 
not noted. 
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Figure 4.55: Effect of DMSO (at dosages of25%, 50% and 75%) on TCE-induced 
elevation of SGOT activity (Preventive). Each value represents the meaniS.E.M. of 
6 treated rats except no treatment and control groups which have 5 treated rats in 
each group. Values statistically significantly different from that of toxin control 
group are not noted. , 
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Figure 4.56: Effect o f N A C (at dosages of 150 mg/kg, 300 mg/kg and 600 mg/kg) 
on TCE-induced elevation of SGPT activity (Preventive). Each value represents the 
mean±S.E.M. o f 6 treated rats except no treatment and control groups which have 5 
treated rats in each group. Values statistically significantly different from that of 
toxin control group is not noted. 
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Figure 4.57: Effect o f N A C (at dosages of 150 mg/kg, 300 mg/kg and 600 mg/kg) 
on TCE-induced elevation of SGOT activity (Preventive). Each value represents the 
mean±S.E.M. of 6 treated rats except no treatment and control groups which have 5 
treated rats in each group. Values statistically significantly different from that of 
toxin control group are not noted. 
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Figure 4.58: Effect o fDMSO (at dosages of25%, 50% and 75%) on CCl4-induced 
increase of liver weight (Preventive). Each value represents the meaniS.E.M. of 7 
treated rats except no treatment and control groups which have 5 treated rats in each 
group. Values statistically significantly different from that of toxin control group are 
indicated by **(p<0.005). 
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the different treatment (Preventative) 
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Figure 4.59: Effect o fDMSO (at dosages of25%, 50% and 75%) on CCl4-induced 
increase of kidney weight (Preventive). Each value represents the meaniS.E.M. of 7 
treated rats except no treatment and control groups which have 5 treated rats in each 
group. Values statistically significantly different from that of toxin control group are 
not noted. 
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Figure 4.60: Effect of NAC (at dosages of 150 mg/kg, 300 mg/kg and 600 mg/kg) 
on CCl4-induced increase of liver weight (Preventive). Each value represents the 
meaniS.E.M. of 7 treated rats except no treatment and control groups which have 5 
treated rats in each group. Values statistically significantly different from that of 
toxin control group are indicated by **QD<0.005). 
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Figure 4.61: Effect of NAC (at dosages of 150 mg/kg, 300 mg/kg and 600 mg/kg) 
on CCl4-induced increase of kidney weight (Curative). Each value represents the 
mean±S.E.M. of 7 treated rats except no treatment and control groups which have 5 
treated rats in each group. Values-statistically significantly different from that of 
toxin control group are indicated by * (p<0.05). 
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Figure 4.62: Effect o fDMSO (at dosages of25%, 50% and 75%) on liver weight of 
TCE-treated rats (Preventive). Each value represents the meaniS.E.M. of 6 treated 
rats except no treatment and control groups which have 5 treated rats in each group. 
Values statistically significantly different from that of toxin control group are not 
noted. 
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Figure 4.63: Effect o fDMSO (at dosages of25%, 50% and 75%) on kidney weight 
ofTCE-treated rats (Preventive). Each value represents the meaniS.E.M. o f6 treated 
rats except no treatment and control groups which have 5 treated rats in each group. 
Values statistically significantly different from that of toxin control group are not 
noted. 
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Figure 4.64: Effect of NAC (at dosages of 150 mg/kg, 300 mg/kg and 600 mg/kg) 
on liver weight of TCE-treated rats (Preventive). Each value represents the 
meaniS.E.M. of 6 treated rats except no treatment and control groups which have 5 
treated rats in each group. Values statistically significantly different from that of 
toxin control group are not noted. 
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Figure 4.65: Effect of NAC (at dosages of 150 mg/kg, 300 mg/kg and 600 mg/kg) 
on kidney weight of TCE-treated rats (Preventive). Each value represents the 
mean±S.E.M of 6 treated rats except no treatment and control groups which have 5 
treated rats in each group. Values statistically significantly different from that of 
toxin control group are not noted. 
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Figure 4.66: Effect of methanol extract (at dosage of 300 mg/kg) of three species of 
seaweed on CCl4-induced elevation of SGPT activity (Curative). Each value 
represents the meaniS.E.M. of 5 treated rats. Values statistically significantly 
different from that of toxin control group are indicated by * (p<0.05) and 
**(p<0.005). 
Key: S#2= Sargassum henslowianum\ S#3= Myagropsis myagroides\ S#4= Sargassum siliquastrum 
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Figure 4.67: Effect of methanol extract (at dosage of 300 mg/kg) of three species of 
seaweed on CCl4-induced elevation of SGOT activity (Curative). Each value 
represents the mean±S.E.M. of 5 treated rats. Values statistically significantly 
different from that of toxin control group are indicated by * Q)<0.05) and 
**Q3<0.005). 
Key: S#2= Sargassum henslowianum', S#3= Myagropsis myagroides; S#4= Sargassum siliquastrum 
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Figure 4.68: Effect of methanol extract (at dosage of 300 mg/kg) of three species of 
seaweed on TCE-induced elevation of SGPT activity (Curative). Each value 
represents the mean±S.E.M. of 5 treated rats. Values statistically significantly 
different from that of toxin control group are indicated by • (p<0.05) and 
**0D<O.OO5). 
Key: S#2= Sargassum henslowianum-, S#3= Myagropsis myagroides; S#4= Sargassum siliquastrum; 
Gal= Galaxaura sp. 
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Figure 4.69: Effect of methanol extract (at dosage of 300 mg/kg) of three species of 
seaweed on TCE-induced elevation of SGOT activity (Curative). Each value 
represents the mean±S.E.M. of 5 treated rats. Values statistically significantly 
different from that of toxin control group are indicated by * (p<0.05) and 
**(p<0.005). 
Key: S#2= Sargassum henslowianum-, S#3,= Myagropsis myagroides; S#4= Sargassum siliquastrum., 
Gal= Galaxaura sp. 
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Figure 4.70: Effect of methanol extract (at dosage of 300 mg/ kg) of three species of 
seaweed on CCl4-induced increase of liver weight (Curative). Each value represents 
the mean±S.E.M. of 5 treated rats. Values statistically significantly different from 
that of toxin control group are indicated by * (p<0.05) and **(p<0.005). 
Key: S#2= Sargassum henslowianum-, S#3= Myagropsis myagroides\ S#4= Sargassum siliquastrum 
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Figure 4.71: Effect of methanol extract (at dosage of 300 mg/ kg) of three species of 
seaweed on CCl4-induced increase of kidney weight (Curative). Each value 
represents the meaniS.E.M. of 5 treated rats. Values statistically significantly 
different from that of toxin control group are indicated by * (p<0.05) and 
**(p<0.005). 
Key: S#2= Sargassum henslowianum; S#3= Myagropsis myagroides; S#4= Sargassum siliquastrum 
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Figure 4.72: Effect of methanol extract (at dosage of 300 mg/ kg) of three species of 
seaweed on liver weight of TCE-treated rats (Curative). Each value represents the 
meaniS.E.M. of 5 treated rats. Values statistically significantly different from that of 
toxin control group are not noted. 
Key: S#2= Sargassum henslowianum-, S#3= Myagropsis myagroides\ S#4= Sargassum siliquastrum-
Gal= Galaxaura sp. 
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Figure 4.73: Effect of methanol extract (at dosage of 300 mg/ kg) of three species of 
seaweed on kidney weight of TCE-treated rats (Curative). Each value represents the 
mean±S.E.M. of 5 treated rats. Values statistically significantly different from that of 
toxin control group are not noted. 
Key: S#2= Sargassum henslowianum; S#3= Myagropsis myagroides; S#4= Sargassum siliquastrum-, 
Gal= Galaxaura sp. 
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Fig. 4.74 Micrograph of the liver of rat from no treatment group showing 
normal hepatocytes around the central vein region, cv, central vein; p, 
portal triad. 
(60 X，H & E) 
Fig. 4.75 Micrograph of the liver of rats from no treatment group showing 
normal hepatocytes around the central vein region, cv, central vein; si, 
sinusoid; p, portal triad. 


















Fig. 4.76 Micrograph of the liver of rat from no treatment group showing normal hepatocytes 
around the central vein region, cv, central vein; si, sinusoid; p，portal 
triad. 
(587 X, H & E) 
Fig. 4.77 Micrograph of the liver of rat from vehicle-saline curative group 
showing normal hepatocytes around the central vein region, cv, 
central vein; p, portal triad. 
(40 X，H & E) 
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Fig. 4.78 Micrograph of liver of rat from the vehicle-saline curative group 
showing normal hepatocytes around the central vein region, cv, 
central vein; p, portal triad; si, sinusoid. 
( 1 4 7 x , H & E ) 
Fig. 4.79 Micrograph of the liver of rat from the vehicle-saline curative group 
showing normal hepatocytes around the central vein region, cv, 
central vein; p, portal triad; si, sinusoid. 



































Fig. 4.80 Micrograph of the liver of CCl4-treated rat from toxin control curative 
group showing extensive necrosis of hepatocytes around the central vein 
region as compared with the control group, cv, central vein; na, necrotic 
area; p, portal triad. 
(60 X, H & E) 
Fig. 4.81 Micrograph of the liver of CCl4-treated rat from toxin control curative 
group showing extensive necrosis of hepatocytes around the central 
vein region as compared with the control group, cn, condensed 







Fig. 4.82 Micrograph of the liver of CCl4-treated rat from toxin control curative 
group showing extensive necrosis of hepatocytes around the central 
vein region as compared with the control group, cn, condensed 
nucleus; cv, central vein; na, necrotic area; sc, swellen cell; v, 
vacuolation 
(293 x，H&E) 
Fig. 4.83 Effect of seaweed extract (S#2: S. henslowianum, 15 mg/ml saline) on 
the liver of CCl4-treated rat showing extensive necrosis ofhepatocytes 
around the central vein region as compared with the toxin control 
curative group, cn, condensed nucleus; cv, central vein; sc, swellen 
cell; V, vacuolation. 






Fig. 4.84 Effect of seaweed extract (S#2: S. henslowianum, 15 mg/ml saline) on 
the liver of CCl4-treated rat showing extensive necrosis ofhepatocytes 
around the central vein region as compared with the toxin control 
curative group, cn, condensed nucleus; cv, central vein; na, necrotic 
area; sc，swellen cell; v，vacuolation. 
(194 x , H & E : ) 
Fig. 4.85 Effect of seaweed extract (S#2: S. henslowianum, 60 mg/ml saline) on 
the liver of CCl4-treated rat showing very little necrosis of 
hepatocytes around the central vein region as compared with the toxin 
control curative group, cv, central vein; rz, regeneration zone. 
(95 x , H & E ) 
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Fig. 4.86 Effect of the seaweed extract (S#2: S. henslowianum, 60 mg/ml saline) 
on the liver of CCl4-treated rat (duplicated) showing very little 
necrosis of hepatocytes around the central vein region as compared 
with the toxin control curative group, cv, central vein; p, portal triad; 
rz, regeneration zone. 
(60 X, H & E) 
Fig. 4.87 Effect of the seaweed extract (S#2: S. henslowianum, 60 mg/ml saline) 
on the liver of CCl4-treated rat (duplicated) showing very little 
necrosis of hepatocytes around the central vein region as compared 
with the toxin control curative group. But, vacuolation can still be 
observed around the central vein, cv, central vein; nc, necrotic cell; rz, 
regeneration zone; sc, swellen cells; v, vacuolation. 












Fig. 4.88 Effect of the seaweed extract (S#2: S. henslowianum, 60 mg/ml saline) 
on the liver of CCl4-treated rat (duplicated) showing very little 
necrosis of hepatocytes around the central vein region as compared 
with the toxin control curative group. But, vacuolation can still be 
observed around the central vein. Large regeneration zone can be seen, 
cv, central vein; mf, mitotic figure; nc, necrotic cell; rz, regeneration 
zone; sc, swellen cells; v, vacuolation. 
(194 x , H & E ) 
Fig. 4.89 Effect of the seaweed extract (S#3: Myagropsis myagroides, 15 
mg/ml saline ) on the liver of CCl4-treated rat showing extensive 
necrosis of hepatocytes around the central vein region as compared 
with the toxin control curative group, cv, central vein; na, necrotic 
area; rz, regeneration zone. 





Fig. 4.90 Effect of the seaweed extract (S#3: Myagropsis myagroides, 15 
mg/ml saline) on the liver of CCl4-treated rat showing extensive 
necrosis of hepatocytes around the central vein region as compared 
with the toxin control curative group, cv, central vein; mf, mitotic 
figure; na, necrotic area; rz, regeneration zone; v, vacuolation. 
(297 X, H & E) 
Fig. 4.91 Effect of the seaweed extract (S#3: Myagropsis myagroides, 30 
mg/ml saline) on the liver of CCl4-treated rat showing few necrosis of 
hepatocytes around the central vein region as compared with the toxin 
control curative group. Medium area of regeneration zone can be seen, 
cv, central vein; pv, hepatic portal vein; rz, regeneration zone. 
(60 X，H & E) 
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Fig. 4.92 Effect of the seaweed extract (S#3: Myagropsis myagroides, 60 
mg/ml saline) on the liver of CCl4-treated rat showing few necrosis of 
hepatocytes around the central vein region as compared with the toxin 
control curative group. Large area of regeneration zone can be seen, 
cv, central vein; na, necrotic area; rz, regeneration zone. 
(60 X，H & E) 
Fig. 4.93 Effect of the seaweed extract (S#3: Myagropsis myagroides, 60 
mg/ml saline) on the liver of CCl4-treated rat showing few necrosis of 
hepatocytes around the central vein region as compared with the toxiri 
control curative group. Large area of regeneration zone can be seen, 
cv, central vein; mf, mitotic figure; na, necrotic area; rz, regeneration 
zone; V, vacuolization. 





Fig. 4.94 Effect of the seaweed extract (S#4: S. siliquastrum, 15 mg/ml saline) 
on the liver of CCl4-treated rat showing extensive necrosis of 
hepatocytes around the central vein region as compared with the toxin 
control curative group, cv, central vein; na, necrotic area; p, portal 
triad. 
(60 X, H & E) 
Fig. 4.95 Effect of the seaweed extract (S#4: S. siliquastrum, 15 mg/ml saline) 
on the liver of CCl4-treated rat showing extensive necrosis of 
hepatocytes around the central vein region as compared with the toxin 
control curative group, cv, central vein; cn, condensed nucleus; nc, 
necrotic cell; v, vacuolization. 






Fig. 4.96 Effect of the seaweed extract (S#4: S. siliquastrum, 60 mg/ml saline) 
on the liver of CCl4-treated rat showing necrosis of hepatocytes 
around the central vein region as compared with the toxin control 
curative group. Medium regeneration zone can hardly be seen, cv, 
central vein; cn, condensed nucleus; nc, necrotic cell; rz, regeneration 
zone. 
(95 x , H & E ) 
Fig. 4.97 Effect of the seaweed extract (S#4: S. siliquastrum, 60 mg/ml saline) 
on the liver of CCl4-treated rat showing necrosis of hepatocytes 
around the central vein region as compared with the toxin control 
curative group, cv, central vein; cn, condensed nucleus; mf, mitotic 
figure; nc, necrotic cell; p, portal triad; rz, regeneration zone. 





Fig. 4.98 Micrograph of the liver of rat from the vehicle-saline curative group 
(renal cortex) showing normal kidney cells, d，distal tubules; g， 
glomerulus; p, proximal tubules 
( 1 5 5 x , H & E ) 
Fig. 4.99 Micrograph of the liver of rat from the vehicle-saline curative group 
(renal cortex) showing normal kidney cells showing normal kidney 
cells, bb, brush border; d, distal tubules; g, glomerulus; p, proximal 
tubules 







Fig. 4.100 Micrograph of the liver of CCl4-treated rat from toxin control 
preventive group showing extensive necrosis of hepatocytes around 
the central vein region as compared with the vehicle-saline curative 
group, cv, central vein; na, necrotic area; p, portal triad. 
(97 X, H & E：) 
Fig. 4.101 Micrograph of the liver of CCl4-treated rat from toxin control curative 
group showing showing extensive necrosis of hepatocytes around the 
central vein region as compared with the vehicle-saline curative group, 
cn, condensed nucleus; cv, central vein; na, necrotic area; p, portal 
triad; sc, swellen cell; v, vacuolation 
(192 x , H & ^ 
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Fig. 4.102 Effect of the seaweed extract (S#2: S. henslowianum, 60 mg/ml 
saline), preventive, on the liver of CCl4-treated rat showing extensive 
necrosis of hepatocytes around the central vein region as compared 
with the toxin control preventive group, cn, condensed nucleus; cv, 
central vein; nc, necrotic cell. 
( 1 9 4 x , H & E ) 
Fig. 4.103 Effect of the seaweed extract (S#4: S. siliquastrum, 60 mg/ml saline) 
on the liver of CCl4-treated rat showing extensive necrosis of 
hepatocytes around the central vein region as compared with the toxin 
control preventive group, cv, central vein; cn, condensed nucleus; nc, 







Fig. 4.104 Scanning electron micrograph of the liver of rat from the 
vehicle-saline curative group showing normal hepatocytes cords 
linings, h, hepatocyte; n, normal nuclues; si, sinusoid. 
(1 200 X) 
Fig. 4.105 Scanning electron micrograph of the liver of CCl4-treated rat from 
toxin control curative group showing extensive necrosis of 
hepatocytes around the central vein region and the clear vacuolization 
as compared with the vehicle-saline curative group, cv, central vein; 
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Fig. 4.106 Scanning electron micrograph of the liver of CCl4-treated rat from 
toxin control curative group showing extensive necrosis of 
hepatocytes around the central vein region and the clear of 
vacuolization as compared with the vehicle-saline curative group, cv, 
central vein; gv, groups of vacuolization 
(1 800 X) 
Fig. 4.107 Scanning electron micrograph of the liver of CCl4-treated rat 
(duplicated) from toxin control curative group showing extensive 
necrosis of hepatocytes around the central vein region and the clear of 
vacuolization as compared with the vehicle-saline curative group, cv, 
central vein; gv, groups of vacuolization; nc, necrotic cell; v, 
vacuolization 




I ^ M I 
WBU^^m 
H H ^ ^ 9 i 
255 
Fig. 4.108 Transmission electron micrograph of the rat from the vehicle-saline 
curative group showing normal hepatocyte with clear shown of 
organelles inside, bc, bile canaliculi; e, erythrocyte; L, lipid droplet; 
Ly, lysosome; m, mitochondria; n, normal nucleus; no, nucleolus; rER, 
rough endoplasmic reticulum; si, sinusoid; slc, sinusoid lining cell. 
(5 700 X) 
Fig. 4.109 Transmission electron micrograph of the rat from the vehicle-saline 
curative group showing normal hepatocyte with clear shown of 
organelles inside, bc, bile canaliculi; L, lipid droplet; Ly, lysosome; m, 
mitochondria; n, normal nucleus; rER, rough endoplasmic reticulum. 







































Fig. 4.110 Transmission electron micrograph of the liver of rat from the 
vehicle-saline curative group showing normal hepatocyte with clear 
shown of organelles inside. Ly, lysosome; m, mitochondria; n, normal 
nucleus; rER， rough endoplasmic reticulum; sER, smooth 
endoplasmic reticulum. 
(20 000 X) 
Fig. 4.111 Transmission electron micrograph of the liver of rat from the 
vehicle-saline curative group showing normal hepatocyte with clear 
shown of organelles inside, m, mitochondria; r, ribosome; rER, rough 
endoplasmic reticulum. 













Fig. 4.112 Transmission electron micrograph of the liver of CCl4-treated rat from 
the toxin control curative group: showing early stage of injury in 
certain area, e，erythrocyte; L, lipid droplet; Ly, lysosome; m， 
mitochondria; n, normal nucleus; no, nucleolus; rER, rough 
endoplasmic reticulum; si, sinusoid; srER, swollen rough endoplasmic 
reticulum. 
(7 200 X) 
Fig. 4.113 Transmission electron micrograph of the liver of CCl4-treated rat from 
the toxin control curative group showing early stage of injury in 
hepatocyte. e, erythrocyte; L，lipid droplet; sm, swollen mitochondria; 
an, abnormal nucleus; si, sinusoid; v, vacuolization. 









Fig. 4.114 Transmission electron micrograph of the liver of CCl4-treated rat from 
the toxin control curative group showing final stage of injury in 
hepatocyte, necrotic cell. L, lipid droplet; m, mitochondria; sm, 
swollen mitochondria; nf, fragment of nucleus; v, vacuolization. 
(5 700 X) 
Fig. 4.115 Transmission electron micrograph of the liver of CCl4-treated rat from 
the toxin control curative group showing early stage of injury of 
organelles inside hepatocyte. m, mitochondria; srER, swollen rough 
endoplasmic reticulum. 
(36 000 X) 
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Fig. 4.116 Transmission electron micrograph of the liver of CCl4-treated rat from 
the toxin control curative group showing early stage of injury of 
organelles inside hepatocyte. cr, cristae; L, lipid droplet; sm, swollen 
mitochondria; srER, swollen rough endoplasmic reticulum. 




Fig. 4.117 Micrograph of the liver of rat from vehicle-saline curative group in i.p. 
showing normal hepatocytes around the central vein region, cv, 
central vein; si, sinusoid; slc, sinusoid lining cell. 
(227 X，H & E) 
Fig. 4.118 Micrograph of the liver of 20% TCE-treated (i.p.) rat from effective 
dose of curative group showing no necrosis of hepatocytes around the 
central vein region as compared with the control group (Fig. 4.117). 










Fig. 4.119 Micrograph of the renal cortex of 20% TCE-treated (i.p.) rat from 
effective dose of curative group showing normal kidney cell, bb， 
brush border; d, distal tubules; g，glomerulus; p, proximal tubules. 





Fig. 4.120 Micrograph of the renal cortex of 30% TCE-treated (i.p.) rat from the 
TCE curative group showing abnormal kidney cell (dilated tubules), d, 
distal tubules; g, glomerulus; p, proximal tubules. 
(60 X, H & E) 
Fig. 4.121 Micrograph of the renal cortex of 30% TCE-treated (i.p.) rat from the 
TCE curative group showing abnormal kidney cell (dilated tubules), 







Fig. 4.122 Micrograph of the renal cortex of 30% TCE-treated (i.p.) rat from the 
TCE curative group showing abnormal kidney cell (dilated tubules), 
cd, cell debris, d，distal tubules; g, glomerulus; p, proximal tubules. 
(188 x，H&E；) 
Fig. 4.123 Micrograph of the proximal tubules of 30% TCE-treated (i.p.) rat 
from the TCE curative group showing dilated proximal tubules with 





Fig. 4.124 Scanning electron micrograph of liver of 20% TCE-treated (i.p.) rat 
from effective dose of curative group showing normal hepatocyte 
cords linings, h, hepatocyte; n, normal nuclues; si, sinusoid 
(1 800 X) 
Fig. 4.125 Scanning electron micrograph of liver of 20% TCE-treated (i.p.) rat 
(duplicated) from effective dose of curative group showing normal 
hepatocytes cords linings, h, hepatocyte; n, normal nuclues; si, 
sinusoid 




















































Fig. 4.126 Transmission electron micrograph of the liver of 20% TCE-treated 
(i.p.) rat from effective dose of curative group showing normal 
hepatocyte with clear shown of organelles inside (no signs of 
abnormal). Ly，lysosome; m，mitochondria; n, normal nucleus; no, 
nucleolus; rER, rough endoplasmic reticulum; sER, smooth 
endoplasmic reticulum. 
(1 2000 X) 
Fig. 4.127 Transmission electron micrograph of liver of 20% TCE-treated (i.p.) 
rat from effective dose of curative group showing hepatocyte with 
many large vacuoles with l ipid inside, m，mitochondria; n, normal 
nucleus; rER, rough endoplasmic reticulum; vo, vacoule 




Fig. 4.128 Transmission electron micrograph of the liver of 20% TCE-treated 
(i.p.) rat from effective dose of curative group showing mitochondria 
and slightly swollen rough endoplasmic reticulum, m, mitochondria; n, 
normal nucleus; r, ribosome; srER, swollen rough endoplasmic 
reticulum. 
(3 6000 X) 
Fig. 4.129 Transmission electron micrograph of the liver of 20% TCE-treated 
(i.p.) rat (duplicated) from effective dose of curative group showing 
mitochondria and slightly swollen rough endoplasmic reticulum, cr, 
cristae; Ly, lysosome; m, mitochondria; r, ribosome; srER, swollen 
rough endoplasmic reticulum. 
(3 6000 x) 
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Fig. 4.130 Effect of the DMSO 25% on the liver of CCl4-treated rat showing 
massive necrosis of hepatocytes around the central vein region as 
compared with the toxin control curative group, cv, central vein; cn, 
condensed nucleus; na, necrotic area; nc, necrotic cell; v, 
vacuolization; sc, swollen cell. 
(188 x , H & E : ) 
Fig. 4.131 Effect of the DMSO 75% on the liver of CCl4-treated rat showing few 
necrosis of hepatocytes with large range of regeneration zone around 
the central vein region as compared with the toxin control curative 
group, cv, central vein; na, necrotic area; rz, regeneration zone. 






Fig. 4.132 Effect of the DMSO 75% on the liver of CCl4-treated rat (duplicated) 
showing few necrosis of hepatocytes with large range of regeneration 
zone around the central vein region as compared with the toxin 
control curative group, cv, central vein; cn, condensed nucleus; mf, 
mitotic figure; na, necrotic area; nc, necrotic cell; v, vacuolization; sc, 
swollen cell 
(194 x，H&E) 
Fig. 4.133 Effect of the NAC (15 mg/ml saline) on the liver of CCl4-treated rat 
showing massive necrosis of hepatocytes with small range of 
regeneration zone around the central vein region as compared with the 
toxin control curative group, cv, central vein; na, necrotic area; rz, 
regeneration zone. 





Fig. 4.134 Effect of the NAC (15 mg/ml saline) on the liver of CCl4-treated rat 
showing massive necrosis of hepatocytes with small range of 
regeneration zone around the central vein region as compared with the 
toxin control curative group, cv，central vein; na, necrotic area; sc, 
swollen cell; v, vacuolization. 
(190 x , H & ^ 
Fig. 4.135 Effect of the NAC (15 mg/ml saline) on the liver of CCl4-treated rat 
(duplicated) showing massive necrosis of hepatocytes with small 
range ofregeneration zone around the central vein region as compared 
with the toxin control curative group, cv, central vein; cn, condensed 
nucleus; na, necrotic area; nc, necrotic cell; sc, swollen cell; v, 
vacuolization. 





Fig. 4.136 Effect of the NAC (30 mg/ml saline) on the liver of CCl4-treated rat 
showing necrosis of hepatocytes with large range of regeneration zone 
around the central vein region as compared with the toxin control 
curative group, cv, central vein; na, necrotic area; p, portal triad; rz, 
regeneration zone. 
(60 X, H & E) 
Fig. 4.137 Effect of the NAC (60 mg/ml saline) on the liver of CCl4-treated rat 
showing few necrosis of hepatocytes with very large range of 
regeneration zone around the central vein region as compared with the 
toxin control curative group, cv, central vein; na, necrotic area; rz, 
regeneration zone. 






Fig. 4.138 Effect of the NAC (60 mgAnl saline) on the liver of CCl4-treated rat 
(duplicated) showing few necrosis of hepatocytes with very large 
range of regeneration zone around the central vein region as compared 
with the toxin control curative group, cv, central vein; na, necrotic 
area; rz, regeneration zone. 
(95 x , H & E ) 
Fig. 4.139 Effect of the NAC (60 mg/ml saline) on the liver of CCl4-treated rat 
(duplicated) showing massive necrosis of hepatocytes with very large 
range of regeneration zone around the central vein region as compared 
with the toxin control curative group, cv, central vein; cn, condensed 
nucleus; mf, mitotic figure; nc, necrotic cell; rz, regeneration zone; v， 
vacuolization. 
(297 X，H & E) 
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Fig. 4.140 Effect of the seaweed's methanol extract (S#2: S. henslowianum, 30 
mg/ml 25% DMSO) on the liver of CCl4-treated rat showing necrosis 
of hepatocytes with large range of regeneration zone around the 
central vein region as compared with the toxin control curative group 
(DMSO 25% and saline treatment), cv, central vein; nc, necrotic cell; 
rz, regeneration zone. 
(96 X, H & E) 
Fig. 4.141 Effect of the seaweed's methanol extract (S#2: S. henslowianum, 30 
mg/ml 25% DMSO) on the liver of CCl4-treated rat showing necrosis 
of hepatocytes with large range of regeneration zone around the 
central vein region as compared with the toxin control curative group 
(DMSO 25% and saline treatment), cv, central vein; mf, mitotic figure; 
nc, necrotic cell; rz, regeneration zone. 







Fig- 4.142 Effect of the seaweed's methanol extract (S#3: Myagropsis 
myagroides, 30 mg/ml 25% DMSO) on the liver of CCl4-treated rat 
showing massive necrosis of hepatocytes around the central vein 
region as compared with the toxin control curative group (DMSO 
25% and saline treatment), cv, central vein; na，necrotic area. 
(97 X, H & E) 
Fig- 4.143 Effect of the seaweed's methanol extract (S#3: Myagropsis 
myagroides, 30 mg/ml 25% DMSO) on the liver of CCl4-treated rate 
showing massive of necrosis of hepatocytes around the central vein 
region as compared with the toxin control curative group (DMSO 
25% and saline treatment), cv, central vein; mf, mitotic figure; nc, 
necrotic cell; v, vacuolization. 







Fig. 4.144 Effect of the seaweed's methanol extract (S#4: S. siliquastrum, 30 
mgAnl 25% DMSO) on the liver of CCl4-treated rat showing few 
necrosis of hepatocytes with large range of regeneration zone around 
the central vein region as compared with the toxin control curative 
group (DMSO 25% and saline treatment), cv, central vein; na, 
necrotic area; nc, necrotic cell; p, portal triad; rz, regeneration zone. 
(96 X，H & E) 
Fig. 4.145 Effect of the seaweed's methanol extract (S#4: S. siliquastrum, 30 
mg/ml 25% DMSO) on the liver of CCl4-treated rat showing few 
necrosis of hepatocytes with large range of regeneration zone around 
the central vein region as compared with the toxin control curative 
group (DMSO 25% and saline treatment), cv，central vein; cn, 
condensed nucleus; mf, mitotic figure; nc, necrotic cell; v, 
vacuolization. 
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